data_2g35_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g35 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.539 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 44' ' ' ILE . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 35' ' ' ARG . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.549 ' HG ' ' NE2' ' A' ' 77' ' ' GLN . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.549 ' NE2' ' HG ' ' A' ' 61' ' ' SER . 24.0 mm-40 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.5 m95 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.592 0.71 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.59 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.57 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.4 m95 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.675 0.75 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.563 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.563 ' H ' ' HG ' ' B' ' 5' ' ' SER . 17.3 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 24' ' ' ARG . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.521 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 36' ' ' VAL . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.547 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.615 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.535 ' CD ' HE22 ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.535 HE22 ' CD ' ' A' ' 80' ' ' GLU . 48.6 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 46.1 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.611 0.719 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.426 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 76' ' ' VAL . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.424 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' A' ' 61' ' ' SER . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 60' ' ' LYS . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 55.3 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 37.0 m95 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.522 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' CYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.624 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.624 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.501 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 47.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 92' ' ' ILE . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 32.2 m95 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.703 0.763 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.509 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.504 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.504 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' O ' ' OG ' ' A' ' 75' ' ' SER . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 62' ' ' PHE . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 ' N ' ' HG ' ' A' ' 75' ' ' SER . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 82' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.436 HD11 HG23 ' A' ' 92' ' ' ILE . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 32.1 m95 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.603 0.716 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.596 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.596 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.582 ' HG1' ' HG ' ' A' ' 75' ' ' SER . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.536 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.413 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.582 ' HG ' ' HG1' ' A' ' 63' ' ' THR . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 92' ' ' ILE . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 48.1 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.669 0.747 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 44' ' ' ILE . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' O ' ' OG ' ' A' ' 75' ' ' SER . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 62' ' ' PHE . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 56.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 92' ' ' ILE . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 44.7 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.621 0.724 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 22' ' ' VAL . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 44' ' ' ILE . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 48' ' ' SER . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.604 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.604 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.444 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.503 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 46.3 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 37.8 m95 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.551 0.691 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 1.2 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.516 ' H ' ' HG ' ' B' ' 5' ' ' SER . 14.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.503 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 28' ' ' ILE . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.581 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.537 ' NE2' ' OE2' ' A' ' 80' ' ' GLU . 48.9 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 31.3 m95 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.67 0.747 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 25' ' ' LEU . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.43 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.639 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.43 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.571 ' HG1' ' CA ' ' A' ' 81' ' ' GLY . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' CA ' ' HG1' ' A' ' 78' ' ' THR . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.9 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.5 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.638 0.732 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.453 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' N ' ' HG ' ' A' ' 61' ' ' SER . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 74' ' ' TYR . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 60' ' ' LYS . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 45.0 m95 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.623 0.725 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.432 ' OE2' ' OH ' ' A' ' 74' ' ' TYR . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.509 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.438 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.6 m95 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.573 0.701 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.541 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 44' ' ' ILE . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 51' ' ' ASN . 1.0 OUTLIER -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.619 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.619 ' N ' ' HG ' ' A' ' 61' ' ' SER . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.529 ' CD ' HE22 ' A' ' 83' ' ' GLN . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.529 HE22 ' CD ' ' A' ' 80' ' ' GLU . 31.0 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.665 0.745 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 9.3 mptt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.547 ' N ' ' HG ' ' A' ' 61' ' ' SER . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.54 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 61' ' ' SER . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' HE22 ' A' ' 83' ' ' GLN . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.486 HE22 ' CD ' ' A' ' 80' ' ' GLU . 53.2 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 94' ' ' ILE . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 56.0 m95 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.556 0.693 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.602 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.602 ' H ' ' HG ' ' B' ' 5' ' ' SER . 19.2 mt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.515 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 44' ' ' ILE . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.45 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.45 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 3.7 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' LYS . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 94' ' ' ILE . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.588 0.709 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.601 ' H ' ' HG ' ' B' ' 5' ' ' SER . 17.0 mt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.526 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.603 ' NE ' HE21 ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.603 HE21 ' NE ' ' A' ' 35' ' ' ARG . 7.3 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.666 ' N ' HD21 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 78' ' ' THR . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.407 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.407 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 48.6 m95 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 28' ' ' ILE . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.537 ' H ' ' HG1' ' A' ' 29' ' ' THR . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 50.7 m95 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.707 0.765 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.426 ' O ' ' OG ' ' A' ' 75' ' ' SER . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.435 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.435 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' HE21 ' A' ' 83' ' ' GLN . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.486 HE21 ' CD ' ' A' ' 80' ' ' GLU . 52.2 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.3 m95 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.622 0.725 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.42 ' N ' ' HG ' ' B' ' 5' ' ' SER . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.701 ' H ' ' HG ' ' B' ' 5' ' ' SER . 25.3 mt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.554 ' HZ3' ' CD2' ' A' ' 21' ' ' LEU . 9.5 mmmt . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' CD2' ' HZ3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HZ3' ' NH2' ' A' ' 54' ' ' ARG . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.551 ' NH2' ' HZ3' ' A' ' 53' ' ' LYS . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.486 ' HG ' ' H ' ' A' ' 62' ' ' PHE . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.486 ' H ' ' HG ' ' A' ' 61' ' ' SER . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.488 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' LYS . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 82' ' ' GLU . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.494 HE22 ' CD ' ' A' ' 80' ' ' GLU . 50.4 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 34.9 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.633 0.73 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.659 ' H ' ' HG ' ' B' ' 5' ' ' SER . 30.0 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 3' ' ' THR . 6.7 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.6 mptt -70.02 11.86 0.27 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.403 -0.811 . . . . 0.0 109.278 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER -170.27 62.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.409 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -132.6 110.29 10.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.62 -0.99 68.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.88 129.37 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.433 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 106.02 15.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -68.96 151.57 46.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.44 -0.788 . . . . 0.0 109.338 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 5.0 -72.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 123.415 0.686 . . . . 0.0 112.299 -178.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.64 4.01 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' LYS . 14.2 mmmt -49.31 124.96 10.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -60.85 -8.64 3.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -79.7 -174.48 4.35 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.843 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt -138.7 158.21 44.66 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.539 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 44' ' ' ILE . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 35' ' ' ARG . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.549 ' HG ' ' NE2' ' A' ' 77' ' ' GLN . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.549 ' NE2' ' HG ' ' A' ' 61' ' ' SER . 24.0 mm-40 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.62 -24.32 42.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -71.91 -37.67 70.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.587 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -80.79 -13.76 58.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.0 109.388 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.08 -15.81 49.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 110.098 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 109.554 -179.78 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.5 m95 52.75 -178.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.12 142.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -138.74 154.08 72.7 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt -46.57 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' B' ' 6' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.242 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.1 mptp? -64.33 -13.81 52.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.35 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 6.9 m -167.78 59.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -54.3 170.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.32 87.73 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.58 140.2 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.631 -0.923 . . . . 0.0 108.917 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -98.91 122.54 42.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' LYS . 49.4 mtp -69.22 153.48 43.6 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.476 0.655 . . . . 0.0 110.461 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -26.13 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.9 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.0 -15.19 6.27 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' C ' ' H ' ' A' ' 20' ' ' LYS . 5.9 mmmt -63.97 124.87 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.736 -1.449 . . . . 0.0 108.871 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -64.79 -1.94 2.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -67.39 -173.72 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.884 0.849 . . . . 0.0 109.897 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt -135.91 158.94 43.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.59 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.57 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt -84.22 -22.64 30.8 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -70.47 -38.22 74.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -65.65 -41.43 92.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.069 -1.02 . . . . 0.0 109.376 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.8 -46.09 89.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.299 -0.875 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.43 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.438 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 48.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.438 ' CD1' ' O ' ' B' ' 1' ' ' SER . 47.4 m95 -162.39 179.05 8.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -154.39 139.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.563 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.5 OUTLIER -98.42 159.3 30.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' B' ' 8' ' ' HIS . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.563 ' H ' ' HG ' ' B' ' 5' ' ' SER . 17.3 mt -47.27 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' B' ' 6' ' ' PRO . 71.1 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.693 ' C ' ' H ' ' A' ' 3' ' ' THR . 10.2 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.329 0.585 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -61.84 15.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.693 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.1 t -140.28 47.73 1.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.18 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -93.15 125.99 38.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.83 37.17 94.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.2 138.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.574 -0.956 . . . . 0.0 108.957 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 24' ' ' ARG . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -108.71 107.19 17.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.521 ' O ' ' C ' ' A' ' 16' ' ' LYS . 12.6 mmt -69.56 151.83 45.51 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.599 -0.688 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -2.79 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.18 0.27 0.8 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.635 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.1 mmmt -49.64 124.81 10.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.416 . . . . 0.0 108.934 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -61.71 -5.88 2.22 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.93 -174.0 5.02 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.922 0.868 . . . . 0.0 109.718 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt -136.35 157.52 46.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 36' ' ' VAL . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.482 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.547 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.615 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.535 ' CD ' HE22 ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.535 HE22 ' CD ' ' A' ' 80' ' ' GLU . 48.6 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.08 -21.85 53.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -71.14 -56.29 6.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.402 -0.811 . . . . 0.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -49.13 -37.78 23.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.361 -0.837 . . . . 0.0 109.662 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -58.98 -30.99 68.36 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.666 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.465 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 83.2 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 1' ' ' SER . 46.1 m95 -167.19 -179.76 4.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 137.94 8.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -110.02 151.37 42.43 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt -52.81 -175.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.664 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' THR . 2.2 tp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 2.3 mptp? 46.57 17.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.0 109.167 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 1' ' ' LEU . 15.0 m -161.21 59.06 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 109.087 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -131.64 111.06 11.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 43.92 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.41 140.18 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.615 -0.932 . . . . 0.0 109.288 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -92.74 127.29 38.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' C ' ' A' ' 16' ' ' LYS . 66.2 mtp -71.11 154.7 41.54 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -28.95 -68.46 0.07 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.196 0.522 . . . . 0.0 111.445 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.41 -11.21 1.55 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' LYS . 12.2 mmmt -62.83 128.11 34.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.929 -1.336 . . . . 0.0 108.76 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -7.3 0.71 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -67.61 -175.38 0.51 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.894 0.854 . . . . 0.0 110.14 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt -138.62 157.41 46.19 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.533 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 76' ' ' VAL . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.424 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.416 ' O ' ' OG ' ' A' ' 61' ' ' SER . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 60' ' ' LYS . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 55.3 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt -82.21 -25.55 34.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -27.38 69.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.0 109.89 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 100' ' ' LYS . 17.2 mtpp -53.79 -31.97 50.81 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -56.35 -6.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.413 -0.804 . . . . 0.0 109.29 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' H ' ' C ' ' A' ' 98' ' ' LYS . 15.9 ttmm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.308 0.575 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -68.74 -177.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.09 141.15 13.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.457 ' O ' ' CD2' ' B' ' 8' ' ' HIS . 0.2 OUTLIER -127.96 160.51 61.03 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -43.06 -45.32 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 5' ' ' SER . 15.1 p80 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 3' ' ' THR . 19.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.4 mptt -72.09 15.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.533 -0.73 . . . . 0.0 109.395 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -170.1 59.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 109.708 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -98.01 128.83 44.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.565 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.74 11.44 83.95 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.51 140.55 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -1.094 . . . . 0.0 109.215 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.522 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -104.42 119.74 39.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.506 ' O ' ' C ' ' A' ' 16' ' ' LYS . 68.1 mtp -69.97 152.33 44.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.862 -0.524 . . . . 0.0 110.249 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -10.87 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 123.35 0.66 . . . . 0.0 112.573 -178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.78 -9.73 1.48 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' LYS . 6.9 mmmt -52.86 124.69 14.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.276 . . . . 0.0 108.633 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -62.9 -4.42 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.53 -174.9 1.82 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 109.773 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -137.31 157.44 46.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 32' ' ' CYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.624 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.624 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' NZ ' ' O2P' ' B' ' 4' ' ' PTR . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.458 ' NE ' ' O2P' ' B' ' 4' ' ' PTR . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.501 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 47.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 92' ' ' ILE . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.16 -28.0 27.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -67.32 -40.4 85.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -68.07 -34.33 76.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.95 -46.33 78.52 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.2 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 32.2 m95 50.28 -172.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.29 135.41 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . 0.458 ' O2P' ' NE ' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -143.29 149.74 49.32 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -48.14 116.5 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.4 ' CD2' ' H ' ' B' ' 8' ' ' HIS . 11.8 p80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.542 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 3' ' ' THR . 1.6 mm? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 9.8 mptt -69.29 10.72 0.29 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.402 -0.811 . . . . 0.0 109.237 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.549 ' H ' ' C ' ' A' ' 1' ' ' LEU . 6.7 p -129.28 45.16 2.85 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.01 107.97 15.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.579 -0.701 . . . . 0.0 109.647 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.94 8.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t -128.27 140.24 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.619 -0.93 . . . . 0.0 109.105 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -107.26 98.87 8.45 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.3 mmt -71.94 152.81 42.25 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.159 0.98 . . . . 0.0 109.368 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.01 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.611 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -32.11 -29.95 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.999 -0.438 . . . . 0.0 112.262 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -112.06 123.46 50.3 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.201 -1.176 . . . . 0.0 110.177 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.638 HD21 ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -74.82 -1.68 23.28 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.638 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.8 OUTLIER -69.85 -173.25 0.6 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.875 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.47 157.34 20.41 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.504 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.504 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.527 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' O ' ' OG ' ' A' ' 75' ' ' SER . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.439 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 62' ' ' PHE . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 ' N ' ' HG ' ' A' ' 75' ' ' SER . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 82' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.436 HD11 HG23 ' A' ' 92' ' ' ILE . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.27 -23.36 43.66 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -66.95 -35.81 80.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.767 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.18 -39.59 65.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.174 -0.954 . . . . 0.0 109.502 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -61.13 -45.94 92.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 10.9 mptt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 109.25 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 32.1 m95 52.84 -173.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -149.9 137.21 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -101.52 155.75 36.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt -46.56 171.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.445 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.8 p80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.508 ' O ' ' N ' ' A' ' 3' ' ' THR . 23.3 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 47.59 15.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 1' ' ' LEU . 13.3 t -153.01 48.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.141 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.45 81.87 8.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 46.73 93.89 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.99 136.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -1.023 . . . . 0.0 109.367 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.93 122.43 42.84 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LYS . 45.9 mmm -69.63 151.56 45.77 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.741 -0.599 . . . . 0.0 109.563 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -5.45 -69.08 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 123.406 0.682 . . . . 0.0 112.673 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -137.08 -16.17 0.76 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' NZ ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -47.98 124.7 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 109.373 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -64.7 -3.93 3.73 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -72.34 -173.99 1.22 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.27 158.82 43.57 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.596 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.596 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.582 ' HG1' ' HG ' ' A' ' 75' ' ' SER . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.536 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.582 ' HG ' ' HG1' ' A' ' 63' ' ' THR . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 92' ' ' ILE . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.97 -21.78 58.95 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -62.55 -38.94 92.0 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -70.28 -52.68 21.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.236 -0.915 . . . . 0.0 109.148 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CD ' ' N ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -66.14 -18.15 65.16 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.393 -0.817 . . . . 0.0 109.404 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.541 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -72.22 -177.91 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.434 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -155.57 136.92 5.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p -135.44 153.22 77.68 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt -48.48 121.79 4.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' A' ' 1' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.0 mptp? 48.98 18.77 0.22 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.304 -0.873 . . . . 0.0 109.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.422 ' N ' ' C ' ' A' ' 1' ' ' LEU . 8.8 t -150.38 47.7 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.323 -0.861 . . . . 0.0 109.561 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -150.68 129.9 12.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.83 3.89 87.66 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.0 138.23 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -104.29 122.99 46.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 1.2 mmt -69.97 152.23 44.68 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -8.69 -71.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.07 -15.8 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.61 ' C ' ' H ' ' A' ' 20' ' ' LYS . 1.8 mmtp -50.34 125.94 13.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.927 -1.337 . . . . 0.0 109.256 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.73 -2.11 0.75 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.76 -174.51 0.32 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.651 0.738 . . . . 0.0 109.72 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mt -140.48 158.47 43.96 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 44' ' ' ILE . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' O ' ' OG ' ' A' ' 75' ' ' SER . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.521 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 62' ' ' PHE . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 56.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 92' ' ' ILE . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt -69.56 -24.45 63.71 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -46.07 64.12 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.148 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -55.52 -25.27 36.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.203 -0.935 . . . . 0.0 109.141 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -75.38 -46.3 33.87 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.349 -0.844 . . . . 0.0 109.353 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.385 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -66.33 177.24 1.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 109.395 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.38 138.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -106.12 153.73 40.07 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt -48.01 158.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.363 179.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 3' ' ' THR . 10.1 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -58.5 -7.39 0.91 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.295 -0.878 . . . . 0.0 108.925 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.0 m -164.45 44.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 5' ' ' GLY . 7.6 t80 58.07 87.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 110.799 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 4' ' ' TYR . . . 47.94 108.11 0.01 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.681 -0.637 . . . . 0.0 111.559 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t -128.42 132.62 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -1.039 . . . . 0.0 108.754 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 22' ' ' VAL . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -109.16 98.85 8.23 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.7 mmt -77.51 152.82 33.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.09 0.947 . . . . 0.0 109.453 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' HZ2' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -55.29 -87.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.206 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.564 ' H ' ' HZ2' ' A' ' 16' ' ' LYS . . . -30.27 -31.46 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -114.02 123.26 49.26 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.242 -1.152 . . . . 0.0 110.062 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -75.05 0.4 16.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -78.2 -173.56 3.28 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.583 -179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 157.2 17.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 44' ' ' ILE . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 48' ' ' SER . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.604 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.604 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.503 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 46.3 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt -66.75 -21.61 66.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 38.0 tttp -78.58 -60.94 2.17 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 100' ' ' LYS . 26.9 mttm -65.97 -52.28 50.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 110.783 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -6.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 110.141 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.405 ' H3 ' ' H ' ' B' ' 2' ' ' TRP . 97.5 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.325 0.583 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.405 ' H ' ' H3 ' ' B' ' 1' ' ' SER . 37.8 m95 -63.18 177.87 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -148.88 136.9 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 1.2 p -137.79 155.52 74.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.516 ' H ' ' HG ' ' B' ' 5' ' ' SER . 14.8 mt -47.55 116.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 11.2 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.482 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 3' ' ' THR . 16.3 mt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.384 0.612 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.0 mptp? -67.82 0.71 3.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 7.2 m -166.52 56.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.709 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.74 129.6 49.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.3 -9.24 55.51 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.74 139.29 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 109.309 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.61 113.71 27.38 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' C ' ' A' ' 16' ' ' LYS . 36.2 mmm -69.76 151.88 45.27 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 109.433 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -1.84 -72.87 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 C-N-CA 123.324 0.649 . . . . 0.0 112.675 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.23 -5.01 0.75 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.01 124.73 10.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.976 -1.308 . . . . 0.0 108.934 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.04 -6.81 2.09 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -74.64 -174.15 2.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.048 0.927 . . . . 0.0 109.904 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.11 158.52 43.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.503 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 28' ' ' ILE . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.581 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.581 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.544 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' NE2' ' OE2' ' A' ' 80' ' ' GLU . 48.9 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.85 -21.39 51.49 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 100' ' ' LYS . 26.7 tttt -80.77 -53.6 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -45.8 -42.97 12.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 110.344 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -75.4 -5.68 46.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.034 -1.041 . . . . 0.0 109.716 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 97' ' ' LYS . 75.8 tttt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.478 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.314 0.578 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -72.44 -170.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.21 137.41 13.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p -133.81 150.47 74.71 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt -49.42 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' B' ' 6' ' ' PRO . 74.0 m-70 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.0 mptt 46.77 15.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.287 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 1' ' ' LEU . 9.2 m -167.86 59.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -148.84 131.24 15.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.59 -9.11 30.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.29 140.13 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.305 -1.115 . . . . 0.0 109.4 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -114.73 108.7 17.13 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 18' ' ' LYS . 61.2 mmm -70.57 152.59 43.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.101 0.953 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.713 ' HZ1' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -60.89 -90.19 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.715 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.713 ' H ' ' HZ1' ' A' ' 16' ' ' LYS . . . -40.56 -35.05 0.78 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -96.82 123.72 40.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.17 -1.194 . . . . 0.0 109.959 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.95 0.38 15.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 18' ' ' LYS . 1.3 tppt? -67.89 -173.36 0.35 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.688 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.34 158.27 31.41 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 25' ' ' LEU . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.43 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.639 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.43 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.571 ' HG1' ' CA ' ' A' ' 81' ' ' GLY . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' CA ' ' HG1' ' A' ' 78' ' ' THR . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.9 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.408 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mt -78.2 -34.42 49.45 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 19.5 ptmt -69.37 -45.47 69.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.929 -1.107 . . . . 0.0 109.47 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 10.9 mptt -53.07 -42.46 65.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.176 -0.953 . . . . 0.0 108.706 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -71.79 -19.95 61.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.369 -0.832 . . . . 0.0 109.89 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.298 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.5 m95 -157.37 177.26 11.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -154.78 138.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.66 162.49 31.56 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 66.5 mt 38.82 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.523 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.0 p80 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.433 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.457 0.646 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -72.56 16.97 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.512 -0.743 . . . . 0.0 109.251 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.52 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.9 OUTLIER -160.4 59.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -77.15 93.34 3.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.852 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.75 55.13 32.51 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.3 139.01 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.53 -0.982 . . . . 0.0 109.041 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -106.42 100.22 9.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -69.48 150.56 47.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.243 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 12.53 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.274 0.63 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -153.31 6.09 0.4 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.562 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -47.87 125.03 8.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.916 -1.343 . . . . 0.0 109.188 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -60.43 -6.7 1.67 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -84.24 -173.07 4.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.984 0.897 . . . . 0.0 109.469 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -133.89 157.47 45.91 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.453 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' B' ' 4' ' ' PTR . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' N ' ' HG ' ' A' ' 61' ' ' SER . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 74' ' ' TYR . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 63' ' ' THR . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 60' ' ' LYS . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.95 -23.05 41.95 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -51.61 64.89 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.0 109.015 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.408 ' C ' ' H ' ' A' ' 100' ' ' LYS . 30.9 mmtp -70.09 -50.71 38.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -58.35 -5.97 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 120.985 -1.072 . . . . 0.0 109.613 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.448 ' H1 ' ' H ' ' B' ' 2' ' ' TRP . 17.4 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.448 ' H ' ' H1 ' ' B' ' 1' ' ' SER . 45.0 m95 -87.54 179.81 6.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.06 137.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . 0.419 ' OH ' ' NH1' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 164.5 20.65 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt 46.67 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.299 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.9 mptt -69.37 12.89 0.14 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.478 -0.763 . . . . 0.0 109.467 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -153.83 57.61 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.947 . . . . 0.0 109.346 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.33 128.67 35.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.78 44.43 31.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t -128.15 133.07 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.629 -0.924 . . . . 0.0 109.261 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' OE2' ' OH ' ' A' ' 74' ' ' TYR . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 99.15 7.97 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.739 ' H ' ' HZ3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.85 154.83 41.49 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 15.62 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.159 0.504 . . . . 0.0 112.015 -177.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -167.61 16.11 0.07 OUTLIER Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.778 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.739 ' HZ3' ' H ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -55.06 134.09 49.04 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.571 -1.546 . . . . 0.0 108.7 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 9.0 p30 -55.97 -10.46 0.8 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -83.96 -173.54 4.78 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.927 0.87 . . . . 0.0 109.73 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CA ' ' HZ1' ' A' ' 18' ' ' LYS . 1.2 mp -134.59 159.13 42.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.509 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.438 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.438 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt -80.5 -24.48 39.37 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -26.19 66.52 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.09 -51.78 23.21 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 109.524 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -70.01 -46.29 65.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.245 -0.909 . . . . 0.0 109.723 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.575 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.0 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' O ' ' B' ' 1' ' ' SER . 39.6 m95 -162.32 179.5 7.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.139 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.85 139.34 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.61 162.4 57.9 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt -46.64 118.33 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.479 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 3' ' ' THR . 30.3 mt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.431 0.634 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -71.46 14.19 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.187 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -151.21 49.35 0.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' VAL . 9.6 t80 -79.21 -179.23 6.61 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' N ' ' CD2' ' A' ' 4' ' ' TYR . . . -63.87 68.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' TYR . 66.1 t -105.62 139.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.96 . . . . 0.0 109.193 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -105.0 113.1 26.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.523 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.7 mmt -69.7 151.47 45.81 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 1.15 -69.49 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 123.357 0.663 . . . . 0.0 112.537 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -148.75 -4.37 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 20' ' ' LYS . 7.7 mmmt -50.08 124.88 10.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.976 -1.308 . . . . 0.0 109.039 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -60.8 -7.71 2.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.05 -174.15 0.75 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.649 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mt -139.49 157.39 45.91 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 44' ' ' ILE . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 51' ' ' ASN . 1.0 OUTLIER -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.619 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.619 ' N ' ' HG ' ' A' ' 61' ' ' SER . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' CD ' HE22 ' A' ' 83' ' ' GLN . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.529 HE22 ' CD ' ' A' ' 80' ' ' GLU . 31.0 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.49 -23.15 60.99 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -71.48 -60.61 2.14 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.909 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -54.41 -34.08 60.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.443 -0.785 . . . . 0.0 109.126 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' LYS . 10.7 mmmt -70.86 -30.8 67.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.216 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 36.9 m95 -80.11 -175.12 4.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.07 133.31 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -111.27 153.61 43.96 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.34 119.93 3.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.352 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 3' ' ' THR . 6.8 tp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -60.42 -1.01 0.3 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.397 -0.814 . . . . 0.0 109.146 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.541 ' H ' ' C ' ' A' ' 1' ' ' LEU . 7.4 m -81.43 -60.72 2.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 109.218 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.7 -77.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.39 0.614 . . . . 0.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -177.32 71.2 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t -127.67 140.53 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.683 -0.893 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 9.3 mptt -103.46 115.22 30.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.53 ' O ' ' C ' ' A' ' 16' ' ' LYS . 5.6 mmm -69.37 150.32 47.43 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 8.13 -75.21 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-O 121.492 0.663 . . . . 0.0 112.264 -178.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -145.37 -3.83 0.6 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -49.83 125.05 10.95 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.069 -1.253 . . . . 0.0 109.151 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.58 -7.32 2.1 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -68.85 -174.19 0.56 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.929 0.871 . . . . 0.0 109.621 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mt -140.75 157.96 44.66 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.589 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 62' ' ' PHE . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.547 ' N ' ' HG ' ' A' ' 61' ' ' SER . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.54 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 61' ' ' SER . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' HE22 ' A' ' 83' ' ' GLN . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.486 HE22 ' CD ' ' A' ' 80' ' ' GLU . 53.2 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 94' ' ' ILE . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.01 -34.42 61.92 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -31.16 71.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 109.452 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.8 -35.31 79.47 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.119 -0.988 . . . . 0.0 109.146 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 100' ' ' LYS . 18.7 ttmt -83.15 -6.83 59.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.4 -0.813 . . . . 0.0 109.248 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 99' ' ' LYS . 75.3 tttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.591 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.526 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.4 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' B' ' 1' ' ' SER . 56.0 m95 -161.35 -175.52 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.851 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.96 139.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.602 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.0 OUTLIER -140.15 164.11 39.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.517 ' O ' ' CG ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.602 ' H ' ' HG ' ' B' ' 5' ' ' SER . 19.2 mt -48.87 -12.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 18.7 m170 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.539 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.6 mptt -69.78 12.77 0.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.309 -0.87 . . . . 0.0 109.416 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.539 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.5 m -143.97 49.28 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.47 126.67 37.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.0 -13.93 16.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t -86.89 131.84 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 109.232 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.515 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -107.9 108.63 19.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' LYS . 6.3 mmt -69.23 151.21 46.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 3.62 -72.36 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 123.257 0.623 . . . . 0.0 112.521 -178.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.34 3.37 0.54 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.9 mmmt -47.92 125.35 8.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.113 -1.227 . . . . 0.0 109.605 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -60.74 -6.42 1.73 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -83.96 -174.3 5.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.949 0.881 . . . . 0.0 109.775 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -136.66 157.64 46.29 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.515 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.41 HG23 HD12 ' A' ' 44' ' ' ILE . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.469 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.525 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.45 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 3.7 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' LYS . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 94' ' ' ILE . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -84.02 -33.68 24.46 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -30.9 67.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.734 -1.229 . . . . 0.0 110.165 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -70.88 -42.7 69.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.996 -1.065 . . . . 0.0 109.586 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -77.04 -23.85 52.06 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.657 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.507 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 93.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 -153.79 -169.21 3.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -153.36 143.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.601 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.6 OUTLIER -141.66 158.49 62.8 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.601 ' H ' ' HG ' ' B' ' 5' ' ' SER . 17.0 mt -47.48 -12.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' PRO . 40.3 m170 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.851 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 3' ' ' THR . 16.3 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.339 0.59 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.0 mptt -62.58 3.58 0.2 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.357 -0.839 . . . . 0.0 109.51 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.3 m -94.87 34.73 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.946 . . . . 0.0 109.01 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' VAL . 3.2 m-85 -51.74 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.83 89.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' TYR . 75.5 t -128.08 139.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.963 . . . . 0.0 108.887 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -101.89 120.0 39.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.487 ' O ' ' C ' ' A' ' 16' ' ' LYS . 47.8 mtp -68.87 152.84 44.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.747 -0.595 . . . . 0.0 109.819 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -19.38 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 121.138 0.494 . . . . 0.0 112.05 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.82 -10.87 1.51 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' C ' ' H ' ' A' ' 20' ' ' LYS . 4.3 mmmt -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.912 -1.346 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -59.91 -7.24 1.6 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.56 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.91 -175.57 0.58 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.011 0.91 . . . . 0.0 110.073 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt -139.51 158.78 43.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.603 ' NE ' HE21 ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.603 HE21 ' NE ' ' A' ' 35' ' ' ARG . 7.3 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.666 HD21 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.666 ' N ' HD21 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' O ' ' N ' ' A' ' 78' ' ' THR . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.407 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.407 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.545 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mt -76.22 -30.1 57.83 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -29.82 48.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.911 -1.118 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.0 -53.27 27.2 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.84 -1.163 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.8 pttm -84.59 -13.13 52.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.707 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.551 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.412 ' O ' ' O ' ' B' ' 2' ' ' TRP . 5.8 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.412 ' O ' ' O ' ' B' ' 1' ' ' SER . 48.6 m95 51.08 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -156.1 137.61 5.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p -96.12 149.94 36.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.519 -0.738 . . . . 0.0 109.145 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt -49.68 90.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' B' ' 6' ' ' PRO . 17.5 p80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.517 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 1' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.508 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.3 mptt 45.5 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.426 -0.796 . . . . 0.0 109.667 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 1' ' ' LEU . 5.5 m -152.8 49.76 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.782 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' A' ' 6' ' ' VAL . 7.9 m-85 -80.96 -167.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.09 85.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' TYR . 82.9 t -122.9 140.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.675 -0.897 . . . . 0.0 109.256 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -107.75 106.09 16.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.3 mmm -71.23 151.99 43.76 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.07 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -54.73 -93.55 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.347 0.594 . . . . 0.0 111.06 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -37.38 -29.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.687 -0.633 . . . . 0.0 111.907 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 2.4 mptt -100.34 124.59 46.01 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.005 -1.291 . . . . 0.0 110.96 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -76.53 -5.01 45.77 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -171.98 0.25 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.67 157.54 33.61 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 28' ' ' ILE . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.537 ' HG1' ' H ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' H ' ' HG1' ' A' ' 29' ' ' THR . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.563 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.569 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.28 -23.57 40.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -37.65 83.68 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.519 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.34 -48.54 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.25 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' OXT' ' A' ' 100' ' ' LYS . 7.4 mtpm? -60.35 -42.14 95.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.298 -0.876 . . . . 0.0 109.737 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' OXT' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.489 ' O ' ' CG ' ' B' ' 2' ' ' TRP . 3.2 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.489 ' CG ' ' O ' ' B' ' 1' ' ' SER . 50.7 m95 -165.99 179.78 5.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -0.954 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.34 141.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.27 165.5 17.55 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 78.6 mt 39.78 75.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.534 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.472 ' O ' ' N ' ' A' ' 3' ' ' THR . 31.4 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 47.35 17.83 0.08 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.0 109.069 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' LEU . 8.8 t -146.68 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.696 . . . . 0.0 109.301 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.63 85.85 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.59 77.11 0.09 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.29 140.7 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.525 -0.985 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.532 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.23 103.32 11.99 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.513 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 153.25 43.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.488 -0.757 . . . . 0.0 109.271 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -23.42 -91.55 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 120.974 0.416 . . . . 0.0 111.665 -178.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.29 8.14 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -43.38 132.37 4.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.364 -1.08 . . . . 0.0 111.533 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -96.88 -12.97 22.81 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -173.15 2.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.478 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt -105.97 157.24 17.64 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.426 ' O ' ' OG ' ' A' ' 75' ' ' SER . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.435 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.435 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' CD ' HE21 ' A' ' 83' ' ' GLN . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.486 HE21 ' CD ' ' A' ' 80' ' ' GLU . 52.2 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.47 -28.52 41.53 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.88 -47.04 49.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.872 -1.142 . . . . 0.0 109.643 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 45.9 mtpt -54.15 -31.12 51.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.312 -0.868 . . . . 0.0 109.46 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -61.95 -32.47 72.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.439 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.3 m95 51.98 -173.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.23 139.19 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.701 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.1 OUTLIER -140.11 163.37 44.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.42 ' N ' ' HG ' ' B' ' 5' ' ' SER . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.701 ' H ' ' HG ' ' B' ' 5' ' ' SER . 25.3 mt -47.53 153.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.641 -179.858 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.3 mptt -63.95 1.74 0.62 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.32 -0.862 . . . . 0.0 109.143 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 1' ' ' LEU . 51.4 p -114.75 42.17 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.44 106.49 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.29 65.47 2.73 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -128.85 140.28 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.487 -1.007 . . . . 0.0 108.816 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.554 ' HZ3' ' CD2' ' A' ' 21' ' ' LEU . 9.5 mmmt -113.81 100.87 8.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 18' ' ' LYS . 16.6 mmt -70.64 151.99 44.37 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.304 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.32 -88.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.686 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -36.46 -28.93 0.02 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -101.02 124.37 46.63 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.165 -1.197 . . . . 0.0 110.609 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.12 -0.75 29.43 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -80.39 -171.41 3.02 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.69 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' CD2' ' HZ3' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -121.23 158.85 27.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HZ3' ' NH2' ' A' ' 54' ' ' ARG . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.551 ' NH2' ' HZ3' ' A' ' 53' ' ' LYS . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.486 ' HG ' ' H ' ' A' ' 62' ' ' PHE . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' H ' ' HG ' ' A' ' 61' ' ' SER . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.488 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 60' ' ' LYS . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 82' ' ' GLU . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.494 HE22 ' CD ' ' A' ' 80' ' ' GLU . 50.4 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.83 -21.64 60.06 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -80.31 -47.24 14.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 110.39 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -64.77 -44.74 89.05 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.121 -0.987 . . . . 0.0 110.142 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -79.17 -5.78 55.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.926 -1.109 . . . . 0.0 109.822 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.344 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 2' ' ' TRP . 67.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.431 ' O ' ' O ' ' B' ' 1' ' ' SER . 34.9 m95 50.17 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.086 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.22 135.64 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.659 ' HG ' ' H ' ' B' ' 7' ' ' LEU . 0.0 OUTLIER -127.24 164.63 34.48 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.659 ' H ' ' HG ' ' B' ' 5' ' ' SER . 30.0 mt -47.11 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.571 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.576 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' H ' HG22 ' A' ' 29' ' ' THR . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CA ' HD12 ' A' ' 49' ' ' LEU . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.416 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 84' ' ' ILE . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 91' ' ' TYR . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.449 ' CE2' HD11 ' A' ' 87' ' ' LEU . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 47.5 m95 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.592 0.71 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.432 HG21 ' SD ' ' A' ' 34' ' ' MET . 55.5 t . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 29' ' ' THR . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CA ' HD12 ' A' ' 49' ' ' LEU . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.432 ' SD ' HG21 ' A' ' 6' ' ' VAL . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' GLU . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.462 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.604 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.516 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 47.4 m95 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.675 0.75 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 78' ' ' THR . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HZ3' ' HB3' ' A' ' 14' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.579 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' OE1' ' NE2' ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.484 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 16.4 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 91' ' ' TYR . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 87' ' ' LEU . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 95' ' ' ILE . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 46.1 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.611 0.719 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' THR . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 50' ' ' THR . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.402 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.402 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 HG12 ' A' ' 11' ' ' VAL . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' N ' ' A' ' 82' ' ' GLU . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.0 m95 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 28' ' ' ILE . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 28' ' ' ILE . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' MET . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 26' ' ' LEU . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' HG22 ' A' ' 29' ' ' THR . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' CA ' HD12 ' A' ' 49' ' ' LEU . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.642 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.642 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 52' ' ' ILE . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 20.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' ILE . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 32.2 m95 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.703 0.763 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.547 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.554 HG22 HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 29' ' ' THR . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' A' ' 78' ' ' THR . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' CG ' ' HE ' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.409 ' H ' ' HA ' ' A' ' 61' ' ' SER . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 64.5 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 91' ' ' TYR . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' HD11 ' A' ' 87' ' ' LEU . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 32.1 m95 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.603 0.716 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.568 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.616 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.616 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 84' ' ' ILE . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.624 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 15.7 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 48.1 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.669 0.747 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' H ' ' H ' ' A' ' 26' ' ' LEU . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' PHE . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 28' ' ' ILE . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' HD11 ' A' ' 49' ' ' LEU . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 HG22 ' A' ' 44' ' ' ILE . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.563 HG22 HH21 ' A' ' 35' ' ' ARG . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.416 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 29' ' ' THR . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.615 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 20.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 44.7 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.621 0.724 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' THR . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 95' ' ' ILE . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.8 m95 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.551 0.691 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 78' ' ' THR . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.543 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.597 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.597 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 64' ' ' LEU . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 11' ' ' VAL . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 20.2 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 91' ' ' TYR . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 87' ' ' LEU . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 31.3 m95 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.67 0.747 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 78' ' ' THR . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 61' ' ' SER . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.541 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 15.7 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 91' ' ' TYR . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 87' ' ' LEU . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.491 HD11 ' H ' ' B' ' 7' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 42.5 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.638 0.732 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.491 ' H ' HD11 ' A' ' 96' ' ' LEU . 66.5 mt . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 78' ' ' THR . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 14' ' ' LYS . 4.9 mmmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.474 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' SER . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 64' ' ' LEU . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 11' ' ' VAL . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD11 ' CE2' ' A' ' 91' ' ' TYR . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' HD11 ' A' ' 87' ' ' LEU . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 45.0 m95 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.623 0.725 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 51' ' ' ASN . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 48' ' ' SER . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 70' ' ' GLN . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 95' ' ' ILE . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 39.6 m95 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.573 0.701 . . . . 0.0 109.139 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.578 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 28' ' ' ILE . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' THR . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 43' ' ' VAL . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.582 HH21 HG22 ' A' ' 44' ' ' ILE . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG22 ' CE ' ' A' ' 34' ' ' MET . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.582 HG22 HH21 ' A' ' 35' ' ' ARG . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.498 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.627 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.41 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 46.9 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 91' ' ' TYR . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 28' ' ' ILE . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 87' ' ' LEU . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 95' ' ' ILE . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 36.9 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.665 0.745 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 14' ' ' LYS . 9.3 mptt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 18.6 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 91' ' ' TYR . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.474 ' CE2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 56.0 m95 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.556 0.693 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 78' ' ' THR . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' HG22 ' A' ' 29' ' ' THR . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 HH21 HG22 ' A' ' 44' ' ' ILE . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 HH21 ' A' ' 35' ' ' ARG . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 5.0 tp60 -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE2' HD21 ' A' ' 64' ' ' LEU . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 62' ' ' PHE . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.433 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 77' ' ' GLN . 20.1 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 11' ' ' VAL . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' TYR . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE2' HD11 ' A' ' 87' ' ' LEU . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.588 0.709 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 78' ' ' THR . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 33' ' ' VAL . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CA ' HD12 ' A' ' 49' ' ' LEU . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.538 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 47.5 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 78' ' ' THR . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.618 HD11 ' CE2' ' A' ' 91' ' ' TYR . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.618 ' CE2' HD11 ' A' ' 87' ' ' LEU . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 95' ' ' ILE . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 48.6 m95 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 78' ' ' THR . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.577 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 52' ' ' ILE . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.401 ' HA ' HD22 ' B' ' 7' ' ' LEU . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' CB ' HG21 ' A' ' 78' ' ' THR . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 11' ' ' VAL . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 91' ' ' TYR . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 87' ' ' LEU . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 95' ' ' ILE . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 50.7 m95 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.707 0.765 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 50' ' ' THR . 78.6 mt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' H ' ' H ' ' A' ' 26' ' ' LEU . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.572 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' H ' ' H ' ' A' ' 9' ' ' PHE . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 52' ' ' ILE . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' C ' ' N ' ' A' ' 82' ' ' GLU . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 17.5 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 25.3 m95 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.622 0.725 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 78' ' ' THR . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.561 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HZ2' HD23 ' A' ' 21' ' ' LEU . 9.5 mmmt . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 65' ' ' ASP . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.636 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 53' ' ' LYS . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.448 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 11' ' ' VAL . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 82' ' ' GLU . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 18.1 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 34.9 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.633 0.73 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 1' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 10.6 mptt -70.02 11.86 0.27 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.403 -0.811 . . . . 0.0 109.278 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER -170.27 62.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.409 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -132.6 110.29 10.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.62 -0.99 68.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.88 129.37 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.433 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.576 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 106.02 15.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -68.96 151.57 46.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.44 -0.788 . . . . 0.0 109.338 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 5.0 -72.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 123.415 0.686 . . . . 0.0 112.299 -178.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.64 4.01 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 20' ' ' LYS . 14.2 mmmt -49.31 124.96 10.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -60.85 -8.64 3.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -79.7 -174.48 4.35 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.843 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt -138.7 158.21 44.66 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG21 ' SD ' ' A' ' 15' ' ' MET . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' H ' HG22 ' A' ' 29' ' ' THR . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CA ' HD12 ' A' ' 49' ' ' LEU . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.416 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 84' ' ' ILE . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 91' ' ' TYR . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.449 ' CE2' HD11 ' A' ' 87' ' ' LEU . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.62 -24.32 42.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -71.91 -37.67 70.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.587 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -80.79 -13.76 58.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.0 109.388 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.08 -15.81 49.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 110.098 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 109.554 -179.78 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 47.5 m95 52.75 -178.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.12 142.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -138.74 154.08 72.7 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt -46.57 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' B' ' 6' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.242 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.1 mptp? -64.33 -13.81 52.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.35 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.9 m -167.78 59.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -54.3 170.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.32 87.73 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' THR . 55.5 t -105.58 140.2 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.631 -0.923 . . . . 0.0 108.917 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -98.91 122.54 42.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' LYS . 49.4 mtp -69.22 153.48 43.6 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.476 0.655 . . . . 0.0 110.461 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -26.13 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.9 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.0 -15.19 6.27 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' LYS . 5.9 mmmt -63.97 124.87 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.736 -1.449 . . . . 0.0 108.871 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -64.79 -1.94 2.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -67.39 -173.72 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.884 0.849 . . . . 0.0 109.897 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt -135.91 158.94 43.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HE ' ' HA ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 29' ' ' THR . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CA ' HD12 ' A' ' 49' ' ' LEU . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.432 ' SD ' HG21 ' A' ' 6' ' ' VAL . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' GLU . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.462 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.604 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt -84.22 -22.64 30.8 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -70.47 -38.22 74.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -65.65 -41.43 92.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.069 -1.02 . . . . 0.0 109.376 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.8 -46.09 89.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.299 -0.875 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.43 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.438 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 48.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.516 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 47.4 m95 -162.39 179.05 8.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -154.39 139.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.42 159.3 30.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' B' ' 8' ' ' HIS . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.3 mt -47.27 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' B' ' 6' ' ' PRO . 71.1 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 3' ' ' THR . 10.2 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.329 0.585 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -61.84 15.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.1 t -140.28 47.73 1.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.18 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -93.15 125.99 38.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.83 37.17 94.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.2 138.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.574 -0.956 . . . . 0.0 108.957 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 78' ' ' THR . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HZ3' ' HB3' ' A' ' 14' ' ' LYS . 5.7 mmmm -108.71 107.19 17.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.521 ' O ' ' C ' ' A' ' 16' ' ' LYS . 12.6 mmt -69.56 151.83 45.51 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.599 -0.688 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -2.79 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.18 0.27 0.8 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.635 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.1 mmmt -49.64 124.81 10.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.416 . . . . 0.0 108.934 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -61.71 -5.88 2.22 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.93 -174.0 5.02 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.922 0.868 . . . . 0.0 109.718 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt -136.35 157.52 46.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.579 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' OE1' ' NE2' ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.484 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 16.4 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 91' ' ' TYR . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 87' ' ' LEU . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 95' ' ' ILE . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.08 -21.85 53.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -71.14 -56.29 6.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.402 -0.811 . . . . 0.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -49.13 -37.78 23.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.361 -0.837 . . . . 0.0 109.662 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -58.98 -30.99 68.36 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.666 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.465 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 83.2 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 1' ' ' SER . 46.1 m95 -167.19 -179.76 4.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 137.94 8.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -110.02 151.37 42.43 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt -52.81 -175.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.664 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' THR . 2.2 tp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 2.3 mptp? 46.57 17.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.0 109.167 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 1' ' ' LEU . 15.0 m -161.21 59.06 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 109.087 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -131.64 111.06 11.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 43.92 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.41 140.18 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.615 -0.932 . . . . 0.0 109.288 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' THR . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -92.74 127.29 38.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.519 ' CG ' HG23 ' A' ' 22' ' ' VAL . 66.2 mtp -71.11 154.7 41.54 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -28.95 -68.46 0.07 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.196 0.522 . . . . 0.0 111.445 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.41 -11.21 1.55 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' LYS . 12.2 mmmt -62.83 128.11 34.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.929 -1.336 . . . . 0.0 108.76 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -57.9 -7.3 0.71 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -67.61 -175.38 0.51 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.894 0.854 . . . . 0.0 110.14 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt -138.62 157.41 46.19 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' CG ' ' A' ' 15' ' ' MET . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 50' ' ' THR . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.402 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.402 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 HG12 ' A' ' 11' ' ' VAL . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' C ' ' N ' ' A' ' 82' ' ' GLU . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt -82.21 -25.55 34.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -27.38 69.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.0 109.89 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 100' ' ' LYS . 17.2 mtpp -53.79 -31.97 50.81 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -56.35 -6.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.413 -0.804 . . . . 0.0 109.29 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' LYS . 15.9 ttmm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.308 0.575 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.0 m95 -68.74 -177.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.09 141.15 13.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.457 ' O ' ' CD2' ' B' ' 8' ' ' HIS . 0.2 OUTLIER -127.96 160.51 61.03 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -43.06 -45.32 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 5' ' ' SER . 15.1 p80 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 3' ' ' THR . 19.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 10.4 mptt -72.09 15.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.533 -0.73 . . . . 0.0 109.395 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -170.1 59.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 109.708 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -98.01 128.83 44.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.565 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.74 11.44 83.95 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.51 140.55 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -1.094 . . . . 0.0 109.215 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 28' ' ' ILE . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -104.42 119.74 39.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.506 ' O ' ' C ' ' A' ' 16' ' ' LYS . 68.1 mtp -69.97 152.33 44.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.862 -0.524 . . . . 0.0 110.249 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -10.87 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 123.35 0.66 . . . . 0.0 112.573 -178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.78 -9.73 1.48 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 20' ' ' LYS . 6.9 mmmt -52.86 124.69 14.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.276 . . . . 0.0 108.633 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -4.42 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.53 -174.9 1.82 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 109.773 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -137.31 157.44 46.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 28' ' ' ILE . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' MET . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 26' ' ' LEU . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' HG22 ' A' ' 29' ' ' THR . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' CA ' HD12 ' A' ' 49' ' ' LEU . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.642 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.642 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 52' ' ' ILE . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' NZ ' ' O2P' ' B' ' 4' ' ' PTR . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.458 ' NE ' ' O2P' ' B' ' 4' ' ' PTR . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.416 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 20.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' ILE . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.16 -28.0 27.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -67.32 -40.4 85.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -68.07 -34.33 76.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.95 -46.33 78.52 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.2 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 32.2 m95 50.28 -172.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.29 135.41 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PTR . . . . . 0.458 ' O2P' ' NE ' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -143.29 149.74 49.32 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -48.14 116.5 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.542 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.793 HD22 ' N ' ' A' ' 1' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 9.8 mptt -69.29 10.72 0.29 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.402 -0.811 . . . . 0.0 109.237 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 1' ' ' LEU . 6.7 p -129.28 45.16 2.85 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.01 107.97 15.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.579 -0.701 . . . . 0.0 109.647 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.94 8.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t -128.27 140.24 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.619 -0.93 . . . . 0.0 109.105 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.547 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -107.26 98.87 8.45 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.3 mmt -71.94 152.81 42.25 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.159 0.98 . . . . 0.0 109.368 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.01 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.611 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -32.11 -29.95 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.999 -0.438 . . . . 0.0 112.262 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -112.06 123.46 50.3 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.201 -1.176 . . . . 0.0 110.177 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 5.4 p30 -74.82 -1.68 23.28 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -69.85 -173.25 0.6 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.875 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.47 157.34 20.41 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.554 HG22 HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 29' ' ' THR . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' A' ' 78' ' ' THR . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' CG ' ' HE ' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.409 ' H ' ' HA ' ' A' ' 61' ' ' SER . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 64.5 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 91' ' ' TYR . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' HD11 ' A' ' 87' ' ' LEU . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.27 -23.36 43.66 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -66.95 -35.81 80.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.767 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.18 -39.59 65.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.174 -0.954 . . . . 0.0 109.502 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -61.13 -45.94 92.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 10.9 mptt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 109.25 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 32.1 m95 52.84 -173.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -149.9 137.21 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -101.52 155.75 36.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt -46.56 171.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.445 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.8 p80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 3' ' ' THR . 23.3 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 47.59 15.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 1' ' ' LEU . 13.3 t -153.01 48.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.141 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.45 81.87 8.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 46.73 93.89 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.99 136.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -1.023 . . . . 0.0 109.367 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.568 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.93 122.43 42.84 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LYS . 45.9 mmm -69.63 151.56 45.77 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.741 -0.599 . . . . 0.0 109.563 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -5.45 -69.08 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 123.406 0.682 . . . . 0.0 112.673 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' H ' ' HE2' ' A' ' 18' ' ' LYS . . . -137.08 -16.17 0.76 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' N ' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -47.98 124.7 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 109.373 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -64.7 -3.93 3.73 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -72.34 -173.99 1.22 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.27 158.82 43.57 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.616 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.616 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 84' ' ' ILE . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.624 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 15.7 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.97 -21.78 58.95 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -62.55 -38.94 92.0 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -70.28 -52.68 21.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.236 -0.915 . . . . 0.0 109.148 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' N ' ' CD ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -66.14 -18.15 65.16 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.393 -0.817 . . . . 0.0 109.404 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.541 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 48.1 m95 -72.22 -177.91 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.434 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -155.57 136.92 5.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p -135.44 153.22 77.68 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt -48.48 121.79 4.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 1' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.0 mptp? 48.98 18.77 0.22 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.304 -0.873 . . . . 0.0 109.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 1' ' ' LEU . 8.8 t -150.38 47.7 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.323 -0.861 . . . . 0.0 109.561 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -150.68 129.9 12.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.83 3.89 87.66 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.0 138.23 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' H ' ' H ' ' A' ' 26' ' ' LEU . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -104.29 122.99 46.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 1.2 mmt -69.97 152.23 44.68 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -8.69 -71.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.07 -15.8 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 20' ' ' LYS . 1.8 mmtp -50.34 125.94 13.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.927 -1.337 . . . . 0.0 109.256 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.73 -2.11 0.75 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.76 -174.51 0.32 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.651 0.738 . . . . 0.0 109.72 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 20' ' ' LYS . 8.1 mt -140.48 158.47 43.96 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' PHE . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 28' ' ' ILE . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' HD11 ' A' ' 49' ' ' LEU . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 HG22 ' A' ' 44' ' ' ILE . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.563 HG22 HH21 ' A' ' 35' ' ' ARG . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.416 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 29' ' ' THR . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.615 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 20.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt -69.56 -24.45 63.71 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -46.07 64.12 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.148 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -55.52 -25.27 36.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.203 -0.935 . . . . 0.0 109.141 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -75.38 -46.3 33.87 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.349 -0.844 . . . . 0.0 109.353 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.385 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 44.7 m95 -66.33 177.24 1.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 109.395 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.38 138.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -106.12 153.73 40.07 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt -48.01 158.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.363 179.841 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 1' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -58.5 -7.39 0.91 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.295 -0.878 . . . . 0.0 108.925 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.0 m -164.45 44.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 5' ' ' GLY . 7.6 t80 58.07 87.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 110.799 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 4' ' ' TYR . . . 47.94 108.11 0.01 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.681 -0.637 . . . . 0.0 111.559 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t -128.42 132.62 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -1.039 . . . . 0.0 108.754 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -109.16 98.85 8.23 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.7 mmt -77.51 152.82 33.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.09 0.947 . . . . 0.0 109.453 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' HZ2' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -55.29 -87.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.206 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.675 ' H ' ' HZ2' ' A' ' 16' ' ' LYS . . . -30.27 -31.46 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -114.02 123.26 49.26 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.242 -1.152 . . . . 0.0 110.062 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -75.05 0.4 16.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -78.2 -173.56 3.28 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.583 -179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 157.2 17.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' THR . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 95' ' ' ILE . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt -66.75 -21.61 66.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 38.0 tttp -78.58 -60.94 2.17 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -65.97 -52.28 50.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 110.783 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -6.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 110.141 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.325 0.583 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.8 m95 -63.18 177.87 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -148.88 136.9 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -137.79 155.52 74.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.55 116.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 11.2 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.482 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.384 0.612 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.0 mptp? -67.82 0.71 3.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 7.2 m -166.52 56.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.709 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.74 129.6 49.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.3 -9.24 55.51 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.74 139.29 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 109.309 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 78' ' ' THR . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.543 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.61 113.71 27.38 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' C ' ' A' ' 16' ' ' LYS . 36.2 mmm -69.76 151.88 45.27 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 109.433 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -1.84 -72.87 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 C-N-CA 123.324 0.649 . . . . 0.0 112.675 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.23 -5.01 0.75 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.01 124.73 10.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.976 -1.308 . . . . 0.0 108.934 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.04 -6.81 2.09 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -74.64 -174.15 2.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.048 0.927 . . . . 0.0 109.904 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.11 158.52 43.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.597 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.597 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 64' ' ' LEU . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 11' ' ' VAL . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 82' ' ' GLU . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.464 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 20.2 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 91' ' ' TYR . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 87' ' ' LEU . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.85 -21.39 51.49 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' LYS . 26.7 tttt -80.77 -53.6 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -45.8 -42.97 12.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 110.344 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -75.4 -5.68 46.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.034 -1.041 . . . . 0.0 109.716 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 97' ' ' LYS . 75.8 tttt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.478 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.314 0.578 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 31.3 m95 -72.44 -170.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.21 137.41 13.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p -133.81 150.47 74.71 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt -49.42 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' B' ' 6' ' ' PRO . 74.0 m-70 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 11.0 mptt 46.77 15.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.287 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 1' ' ' LEU . 9.2 m -167.86 59.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -148.84 131.24 15.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.59 -9.11 30.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.29 140.13 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.305 -1.115 . . . . 0.0 109.4 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -114.73 108.7 17.13 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 18' ' ' LYS . 61.2 mmm -70.57 152.59 43.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.101 0.953 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HZ2' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -60.89 -90.19 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.715 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.669 ' H ' ' HZ2' ' A' ' 16' ' ' LYS . . . -40.56 -35.05 0.78 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -96.82 123.72 40.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.17 -1.194 . . . . 0.0 109.959 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.95 0.38 15.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 18' ' ' LYS . 1.3 tppt? -67.89 -173.36 0.35 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.688 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.34 158.27 31.41 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 78' ' ' THR . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.609 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 61' ' ' SER . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.541 ' OE1' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 15.7 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 91' ' ' TYR . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 87' ' ' LEU . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.491 HD11 ' H ' ' B' ' 7' ' ' LEU . 4.2 mt -78.2 -34.42 49.45 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 19.5 ptmt -69.37 -45.47 69.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.929 -1.107 . . . . 0.0 109.47 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 10.9 mptt -53.07 -42.46 65.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.176 -0.953 . . . . 0.0 108.706 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -71.79 -19.95 61.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.369 -0.832 . . . . 0.0 109.89 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.298 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 42.5 m95 -157.37 177.26 11.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -154.78 138.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.66 162.49 31.56 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.491 ' H ' HD11 ' A' ' 96' ' ' LEU . 66.5 mt 38.82 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.518 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.0 p80 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.433 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.457 0.646 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -72.56 16.97 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.512 -0.743 . . . . 0.0 109.251 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.9 OUTLIER -160.4 59.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -77.15 93.34 3.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.852 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.75 55.13 32.51 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.3 139.01 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.53 -0.982 . . . . 0.0 109.041 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 78' ' ' THR . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HZ3' ' HB3' ' A' ' 14' ' ' LYS . 4.9 mmmm -106.42 100.22 9.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -69.48 150.56 47.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.243 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 12.53 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.274 0.63 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -153.31 6.09 0.4 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -47.87 125.03 8.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.916 -1.343 . . . . 0.0 109.188 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -60.43 -6.7 1.67 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -84.24 -173.07 4.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.984 0.897 . . . . 0.0 109.469 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -133.89 157.47 45.91 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG21 ' SD ' ' A' ' 15' ' ' MET . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.474 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' B' ' 4' ' ' PTR . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' SER . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 64' ' ' LEU . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 11' ' ' VAL . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD11 ' CE2' ' A' ' 91' ' ' TYR . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' HD11 ' A' ' 87' ' ' LEU . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.95 -23.05 41.95 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -51.61 64.89 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.0 109.015 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -70.09 -50.71 38.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -58.35 -5.97 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 120.985 -1.072 . . . . 0.0 109.613 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 45.0 m95 -87.54 179.81 6.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.06 137.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PTR . . . . . 0.419 ' OH ' ' NH1' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 164.5 20.65 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt 46.67 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.299 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.607 HD22 ' N ' ' A' ' 1' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 10.9 mptt -69.37 12.89 0.14 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.478 -0.763 . . . . 0.0 109.467 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -153.83 57.61 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.947 . . . . 0.0 109.346 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.33 128.67 35.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.78 44.43 31.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t -128.15 133.07 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.629 -0.924 . . . . 0.0 109.261 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 99.15 7.97 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.87 ' H ' ' HZ2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.85 154.83 41.49 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 15.62 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.159 0.504 . . . . 0.0 112.015 -177.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -167.61 16.11 0.07 OUTLIER Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.778 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.87 ' HZ2' ' H ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -55.06 134.09 49.04 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.571 -1.546 . . . . 0.0 108.7 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 9.0 p30 -55.97 -10.46 0.8 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -83.96 -173.54 4.78 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.927 0.87 . . . . 0.0 109.73 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' C ' ' HZ1' ' A' ' 18' ' ' LYS . 1.2 mp -134.59 159.13 42.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 51' ' ' ASN . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 48' ' ' SER . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 70' ' ' GLN . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 95' ' ' ILE . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt -80.5 -24.48 39.37 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -26.19 66.52 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.09 -51.78 23.21 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 109.524 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -70.01 -46.29 65.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.245 -0.909 . . . . 0.0 109.723 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.575 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.0 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' O ' ' B' ' 1' ' ' SER . 39.6 m95 -162.32 179.5 7.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.139 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.85 139.34 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.61 162.4 57.9 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt -46.64 118.33 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.479 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 3' ' ' THR . 30.3 mt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.431 0.634 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -71.46 14.19 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.187 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -151.21 49.35 0.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' VAL . 9.6 t80 -79.21 -179.23 6.61 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' N ' ' CD2' ' A' ' 4' ' ' TYR . . . -63.87 68.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' TYR . 66.1 t -105.62 139.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.96 . . . . 0.0 109.193 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -105.0 113.1 26.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.523 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.7 mmt -69.7 151.47 45.81 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 1.15 -69.49 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 123.357 0.663 . . . . 0.0 112.537 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -148.75 -4.37 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 20' ' ' LYS . 7.7 mmmt -50.08 124.88 10.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.976 -1.308 . . . . 0.0 109.039 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -60.8 -7.71 2.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.05 -174.15 0.75 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.649 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 20' ' ' LYS . 5.0 mt -139.49 157.39 45.91 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 28' ' ' ILE . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' THR . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 43' ' ' VAL . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.582 HH21 HG22 ' A' ' 44' ' ' ILE . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG22 ' CE ' ' A' ' 34' ' ' MET . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.582 HG22 HH21 ' A' ' 35' ' ' ARG . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.498 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.627 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 82' ' ' GLU . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.41 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 46.9 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 91' ' ' TYR . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 28' ' ' ILE . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 87' ' ' LEU . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 95' ' ' ILE . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.49 -23.15 60.99 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -71.48 -60.61 2.14 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.909 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -54.41 -34.08 60.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.443 -0.785 . . . . 0.0 109.126 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' LYS . 10.7 mmmt -70.86 -30.8 67.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.216 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 36.9 m95 -80.11 -175.12 4.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.07 133.31 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -111.27 153.61 43.96 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.34 119.93 3.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.352 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 3' ' ' THR . 6.8 tp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -60.42 -1.01 0.3 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.397 -0.814 . . . . 0.0 109.146 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 5' ' ' GLY . 7.4 m -81.43 -60.72 2.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 109.218 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.7 -77.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.39 0.614 . . . . 0.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -177.32 71.2 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t -127.67 140.53 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.683 -0.893 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 9.3 mptt -103.46 115.22 30.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 17' ' ' GLY . 5.6 mmm -69.37 150.32 47.43 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 8.13 -75.21 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-O 121.492 0.663 . . . . 0.0 112.264 -178.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -145.37 -3.83 0.6 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -49.83 125.05 10.95 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.069 -1.253 . . . . 0.0 109.151 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.58 -7.32 2.1 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -68.85 -174.19 0.56 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.929 0.871 . . . . 0.0 109.621 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -140.75 157.96 44.66 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 82' ' ' GLU . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 18.6 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 91' ' ' TYR . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.474 ' CE2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.01 -34.42 61.92 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -31.16 71.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 109.452 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.8 -35.31 79.47 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.119 -0.988 . . . . 0.0 109.146 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 100' ' ' LYS . 18.7 ttmt -83.15 -6.83 59.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.4 -0.813 . . . . 0.0 109.248 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 99' ' ' LYS . 75.3 tttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.591 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.526 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.4 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' B' ' 1' ' ' SER . 56.0 m95 -161.35 -175.52 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.851 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.96 139.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 164.11 39.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.517 ' O ' ' CG ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -48.87 -12.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 18.7 m170 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 10.6 mptt -69.78 12.77 0.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.309 -0.87 . . . . 0.0 109.416 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.5 m -143.97 49.28 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.47 126.67 37.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.0 -13.93 16.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t -86.89 131.84 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 109.232 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 78' ' ' THR . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -107.9 108.63 19.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' LYS . 6.3 mmt -69.23 151.21 46.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 3.62 -72.36 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 123.257 0.623 . . . . 0.0 112.521 -178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.34 3.37 0.54 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.9 mmmt -47.92 125.35 8.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.113 -1.227 . . . . 0.0 109.605 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -60.74 -6.42 1.73 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -83.96 -174.3 5.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.949 0.881 . . . . 0.0 109.775 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -136.66 157.64 46.29 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' HG22 ' A' ' 29' ' ' THR . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 HH21 HG22 ' A' ' 44' ' ' ILE . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 HH21 ' A' ' 35' ' ' ARG . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 5.0 tp60 -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE2' HD21 ' A' ' 64' ' ' LEU . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 62' ' ' PHE . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.433 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 77' ' ' GLN . 20.1 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 11' ' ' VAL . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' TYR . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE2' HD11 ' A' ' 87' ' ' LEU . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -84.02 -33.68 24.46 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -30.9 67.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.734 -1.229 . . . . 0.0 110.165 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -70.88 -42.7 69.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.996 -1.065 . . . . 0.0 109.586 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -77.04 -23.85 52.06 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.657 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.507 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 93.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 -153.79 -169.21 3.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -153.36 143.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.66 158.49 62.8 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.48 -12.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' PRO . 7.5 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.851 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 3' ' ' THR . 16.3 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.339 0.59 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 11.0 mptt -62.58 3.58 0.2 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.357 -0.839 . . . . 0.0 109.51 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.3 m -94.87 34.73 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.946 . . . . 0.0 109.01 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' VAL . 3.2 m-85 -51.74 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.83 89.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' TYR . 75.5 t -128.08 139.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.963 . . . . 0.0 108.887 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 78' ' ' THR . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -101.89 120.0 39.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.487 ' O ' ' C ' ' A' ' 16' ' ' LYS . 47.8 mtp -68.87 152.84 44.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.747 -0.595 . . . . 0.0 109.819 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -19.38 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 121.138 0.494 . . . . 0.0 112.05 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.82 -10.87 1.51 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 20' ' ' LYS . 4.3 mmmt -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.912 -1.346 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -59.91 -7.24 1.6 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.91 -175.57 0.58 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.011 0.91 . . . . 0.0 110.073 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt -139.51 158.78 43.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 33' ' ' VAL . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CA ' HD12 ' A' ' 49' ' ' LEU . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.538 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.538 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 47.5 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 78' ' ' THR . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.618 HD11 ' CE2' ' A' ' 91' ' ' TYR . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.618 ' CE2' HD11 ' A' ' 87' ' ' LEU . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 95' ' ' ILE . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.543 HD23 ' NZ ' ' A' ' 99' ' ' LYS . 4.4 mt -76.22 -30.1 57.83 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -29.82 48.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.911 -1.118 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.0 -53.27 27.2 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.84 -1.163 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.543 ' NZ ' HD23 ' A' ' 96' ' ' LEU . 21.8 pttm -84.59 -13.13 52.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.707 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.551 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.412 ' O ' ' O ' ' B' ' 2' ' ' TRP . 5.8 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.412 ' O ' ' O ' ' B' ' 1' ' ' SER . 48.6 m95 51.08 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -156.1 137.61 5.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p -96.12 149.94 36.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.519 -0.738 . . . . 0.0 109.145 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt -49.68 90.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' B' ' 6' ' ' PRO . 53.7 p-80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.517 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 1' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.508 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 11.3 mptt 45.5 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.426 -0.796 . . . . 0.0 109.667 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 1' ' ' LEU . 5.5 m -152.8 49.76 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.782 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' A' ' 6' ' ' VAL . 7.9 m-85 -80.96 -167.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.09 85.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' TYR . 82.9 t -122.9 140.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.675 -0.897 . . . . 0.0 109.256 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 78' ' ' THR . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -107.75 106.09 16.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.3 mmm -71.23 151.99 43.76 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.07 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -54.73 -93.55 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.347 0.594 . . . . 0.0 111.06 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -37.38 -29.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.687 -0.633 . . . . 0.0 111.907 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 2.4 mptt -100.34 124.59 46.01 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.005 -1.291 . . . . 0.0 110.96 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -76.53 -5.01 45.77 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -171.98 0.25 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -123.67 157.54 33.61 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.577 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 52' ' ' ILE . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.401 ' HA ' HD22 ' B' ' 7' ' ' LEU . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' CB ' HG21 ' A' ' 78' ' ' THR . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 11' ' ' VAL . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 91' ' ' TYR . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 87' ' ' LEU . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 95' ' ' ILE . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.28 -23.57 40.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -37.65 83.68 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.519 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.34 -48.54 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.25 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' OXT' ' A' ' 100' ' ' LYS . 7.4 mtpm? -60.35 -42.14 95.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.298 -0.876 . . . . 0.0 109.737 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' OXT' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.489 ' O ' ' CG ' ' B' ' 2' ' ' TRP . 3.2 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.489 ' CG ' ' O ' ' B' ' 1' ' ' SER . 50.7 m95 -165.99 179.78 5.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -0.954 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.34 141.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.27 165.5 17.55 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 50' ' ' THR . 78.6 mt 39.78 75.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.534 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 3' ' ' THR . 31.4 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 47.35 17.83 0.08 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.0 109.069 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 1' ' ' LEU . 8.8 t -146.68 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.696 . . . . 0.0 109.301 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.63 85.85 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.59 77.11 0.09 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.29 140.7 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.525 -0.985 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.468 ' H ' ' H ' ' A' ' 26' ' ' LEU . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.572 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.23 103.32 11.99 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.513 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 153.25 43.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.488 -0.757 . . . . 0.0 109.271 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -23.42 -91.55 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 120.974 0.416 . . . . 0.0 111.665 -178.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.29 8.14 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -43.38 132.37 4.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.364 -1.08 . . . . 0.0 111.533 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -96.88 -12.97 22.81 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -173.15 2.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.478 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt -105.97 157.24 17.64 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' H ' ' H ' ' A' ' 9' ' ' PHE . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 52' ' ' ILE . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' C ' ' N ' ' A' ' 82' ' ' GLU . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 17.5 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.47 -28.52 41.53 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.88 -47.04 49.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.872 -1.142 . . . . 0.0 109.643 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 45.9 mtpt -54.15 -31.12 51.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.312 -0.868 . . . . 0.0 109.46 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -61.95 -32.47 72.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.439 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 25.3 m95 51.98 -173.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.23 139.19 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.11 163.37 44.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.53 153.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.641 -179.858 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 1' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 10.3 mptt -63.95 1.74 0.62 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.32 -0.862 . . . . 0.0 109.143 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 1' ' ' LEU . 51.4 p -114.75 42.17 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.44 106.49 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.29 65.47 2.73 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -128.85 140.28 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.487 -1.007 . . . . 0.0 108.816 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 78' ' ' THR . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HZ2' HD23 ' A' ' 21' ' ' LEU . 9.5 mmmt -113.81 100.87 8.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 18' ' ' LYS . 16.6 mmt -70.64 151.99 44.37 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.304 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.32 -88.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.686 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -36.46 -28.93 0.02 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -101.02 124.37 46.63 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.165 -1.197 . . . . 0.0 110.609 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.12 -0.75 29.43 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -80.39 -171.41 3.02 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.69 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -121.23 158.85 27.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ1' ' HE2' ' B' ' 4' ' ' PTR . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.636 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 53' ' ' LYS . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.448 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 11' ' ' VAL . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 82' ' ' GLU . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 18.1 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.83 -21.64 60.06 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -80.31 -47.24 14.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 110.39 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -64.77 -44.74 89.05 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.121 -0.987 . . . . 0.0 110.142 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -79.17 -5.78 55.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.926 -1.109 . . . . 0.0 109.822 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.344 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 2' ' ' TRP . 67.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 34.9 m95 50.17 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.086 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.22 135.64 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PTR . . . . . 0.457 ' HE2' ' HZ1' ' A' ' 53' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.24 164.63 34.48 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -47.11 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 m80 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.571 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.576 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' H ' HG22 ' A' ' 29' ' ' THR . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CA ' HD12 ' A' ' 49' ' ' LEU . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.461 ' OG ' ' NE2' ' A' ' 77' ' ' GLN . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 61' ' ' SER . 24.0 mm-40 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 84' ' ' ILE . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 91' ' ' TYR . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.449 ' CE2' HD11 ' A' ' 87' ' ' LEU . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 47.5 m95 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.592 0.71 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.432 HG21 ' SD ' ' A' ' 34' ' ' MET . 55.5 t . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 29' ' ' THR . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CA ' HD12 ' A' ' 49' ' ' LEU . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.432 ' SD ' HG21 ' A' ' 6' ' ' VAL . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' GLU . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.462 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.604 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.516 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 47.4 m95 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.675 0.75 . . . . 0.0 109.372 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 78' ' ' THR . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' HD22 ' A' ' 51' ' ' ASN . 1.1 m-80 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.579 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.54 ' CD ' HE22 ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.54 HE22 ' CD ' ' A' ' 80' ' ' GLU . 48.6 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 91' ' ' TYR . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 87' ' ' LEU . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.445 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 46.1 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.611 0.719 . . . . 0.0 109.269 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' THR . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 50' ' ' THR . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.402 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.402 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 HG12 ' A' ' 11' ' ' VAL . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 55.3 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.0 m95 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 28' ' ' ILE . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 28' ' ' ILE . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' MET . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 26' ' ' LEU . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' HG22 ' A' ' 29' ' ' THR . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' CA ' HD12 ' A' ' 49' ' ' LEU . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.642 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.642 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 52' ' ' ILE . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.501 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.501 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 47.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' ILE . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 32.2 m95 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.703 0.763 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.547 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.554 HG22 HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 29' ' ' THR . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' A' ' 78' ' ' THR . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' CG ' ' HE ' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.409 ' H ' ' HA ' ' A' ' 61' ' ' SER . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.401 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 12.3 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 91' ' ' TYR . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' HD11 ' A' ' 87' ' ' LEU . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 32.1 m95 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.603 0.716 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.568 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.616 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.616 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 84' ' ' ILE . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.595 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 54.6 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 48.1 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.669 0.747 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' H ' ' H ' ' A' ' 26' ' ' LEU . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' PHE . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 28' ' ' ILE . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' HD11 ' A' ' 49' ' ' LEU . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 HG22 ' A' ' 44' ' ' ILE . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.563 HG22 HH21 ' A' ' 35' ' ' ARG . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.416 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 29' ' ' THR . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.615 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 56.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 44.7 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.621 0.724 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.549 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD22 HE22 ' A' ' 77' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' THR . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.472 HE22 HD22 ' A' ' 21' ' ' LEU . 33.0 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.503 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.503 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 46.3 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 95' ' ' ILE . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.8 m95 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.551 0.691 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 78' ' ' THR . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.543 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.597 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.597 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 51' ' ' ASN . 1.2 m-80 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 64' ' ' LEU . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 11' ' ' VAL . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.537 ' OE2' ' NE2' ' A' ' 83' ' ' GLN . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.537 ' NE2' ' OE2' ' A' ' 80' ' ' GLU . 48.9 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 91' ' ' TYR . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 87' ' ' LEU . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 31.3 m95 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.67 0.747 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 78' ' ' THR . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.673 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 61' ' ' SER . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.9 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 91' ' ' TYR . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 87' ' ' LEU . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.491 HD11 ' H ' ' B' ' 7' ' ' LEU . 4.2 mt . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 42.5 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.638 0.732 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.491 ' H ' HD11 ' A' ' 96' ' ' LEU . 66.5 mt . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 78' ' ' THR . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 4.9 mmmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.474 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 54' ' ' ARG . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' SER . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 64' ' ' LEU . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 11' ' ' VAL . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.422 HD11 ' CE2' ' A' ' 91' ' ' TYR . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' HD11 ' A' ' 87' ' ' LEU . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 45.0 m95 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.623 0.725 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.497 1.921 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 51' ' ' ASN . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 48' ' ' SER . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 70' ' ' GLN . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 95' ' ' ILE . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 39.6 m95 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.573 0.701 . . . . 0.0 109.139 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.578 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 28' ' ' ILE . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' THR . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 43' ' ' VAL . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.582 HH21 HG22 ' A' ' 44' ' ' ILE . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.4 HG22 ' CE ' ' A' ' 34' ' ' MET . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.582 HG22 HH21 ' A' ' 35' ' ' ARG . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.627 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.536 ' CD ' HE22 ' A' ' 83' ' ' GLN . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.536 HE22 ' CD ' ' A' ' 80' ' ' GLU . 31.0 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 91' ' ' TYR . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 28' ' ' ILE . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 87' ' ' LEU . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 95' ' ' ILE . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 36.9 m95 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.665 0.745 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 9.3 mptt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.61 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.48 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.2 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 91' ' ' TYR . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.474 ' CE2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 56.0 m95 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.556 0.693 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 78' ' ' THR . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' HG22 ' A' ' 29' ' ' THR . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 HH21 HG22 ' A' ' 44' ' ' ILE . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 HH21 ' A' ' 35' ' ' ARG . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE2' HD21 ' A' ' 64' ' ' LEU . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 62' ' ' PHE . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.433 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.581 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 3.7 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 11' ' ' VAL . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' TYR . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE2' HD11 ' A' ' 87' ' ' LEU . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.588 0.709 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 78' ' ' THR . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 22' ' ' VAL . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 33' ' ' VAL . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CA ' HD12 ' A' ' 49' ' ' LEU . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.643 ' NE ' HE21 ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.643 HE21 ' NE ' ' A' ' 35' ' ' ARG . 7.3 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 78' ' ' THR . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.618 HD11 ' CE2' ' A' ' 91' ' ' TYR . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.618 ' CE2' HD11 ' A' ' 87' ' ' LEU . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 95' ' ' ILE . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 48.6 m95 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.9 t . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 78' ' ' THR . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? . . . . . 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.577 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 52' ' ' ILE . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.401 ' HA ' HD22 ' B' ' 7' ' ' LEU . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.4 ' CB ' HG21 ' A' ' 78' ' ' THR . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 11' ' ' VAL . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 91' ' ' TYR . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 87' ' ' LEU . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 95' ' ' ILE . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 50.7 m95 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.707 0.765 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 50' ' ' THR . 78.6 mt . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' H ' ' H ' ' A' ' 26' ' ' LEU . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.572 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' H ' ' H ' ' A' ' 9' ' ' PHE . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 52' ' ' ILE . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.511 ' CD ' HE21 ' A' ' 83' ' ' GLN . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.511 HE21 ' CD ' ' A' ' 80' ' ' GLU . 52.2 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 25.3 m95 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.622 0.725 . . . . 0.0 109.315 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 mt . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 78' ' ' THR . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.561 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HZ2' HD23 ' A' ' 21' ' ' LEU . 9.5 mmmt . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 65' ' ' ASP . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.636 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 53' ' ' LYS . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.448 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 11' ' ' VAL . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.4 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 34.9 m95 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.633 0.73 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 1' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.6 mptt -70.02 11.86 0.27 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.403 -0.811 . . . . 0.0 109.278 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER -170.27 62.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.885 . . . . 0.0 109.409 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -132.6 110.29 10.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.574 -0.704 . . . . 0.0 109.277 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.62 -0.99 68.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 t -88.88 129.37 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -1.155 . . . . 0.0 109.433 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.1 m -90.45 119.43 30.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 109.712 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 32.1 p90 -93.14 140.6 29.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.629 -0.669 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -124.17 130.24 52.2 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.43 103.76 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.017 -1.052 . . . . 0.0 109.333 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.07 152.71 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -107.5 145.36 33.2 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.576 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 60.3 mt-10 -114.22 161.04 18.33 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.354 0.597 . . . . 0.0 109.603 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.43 106.02 15.94 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -68.96 151.57 46.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.44 -0.788 . . . . 0.0 109.338 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 5.0 -72.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.685 0 C-N-CA 123.415 0.686 . . . . 0.0 112.299 -178.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.64 4.01 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 20' ' ' LYS . 14.2 mmmt -49.31 124.96 10.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -60.85 -8.64 3.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -79.7 -174.48 4.35 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.843 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.4 mt -138.7 158.21 44.66 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG21 ' SD ' ' A' ' 15' ' ' MET . 12.5 t -122.5 114.41 30.22 Favored Pre-proline 0 N--CA 1.504 2.248 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -57.73 147.83 77.99 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.046 1.164 . . . . 0.0 110.619 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.576 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -154.01 147.24 24.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 36' ' ' VAL . 53.3 mt -103.9 140.01 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.4 tp -122.37 108.22 12.97 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.46 121.72 5.52 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.54 111.4 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -94.46 171.05 9.05 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.0 109.521 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' H ' HG22 ' A' ' 29' ' ' THR . 14.1 ptpt -71.5 -18.21 62.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.9 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' CA ' HD12 ' A' ' 49' ' ' LEU . 24.3 mt-10 -136.79 13.05 3.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -169.93 161.91 9.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.875 -1.141 . . . . 0.0 110.44 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 47' ' ' TRP . 53.1 t -121.23 143.69 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 4.2 mtt -128.88 148.62 50.92 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.072 -1.018 . . . . 0.0 111.279 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.43 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 12.5 mtm180 -93.88 111.5 23.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LEU . 61.2 t -110.89 126.7 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.217 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 28.2 t0 -69.31 147.96 50.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.42 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -89.64 -19.7 24.57 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -75.64 -53.56 8.37 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.445 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -100.31 -4.53 29.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.643 -0.661 . . . . 0.0 110.452 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 52.86 22.74 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.682 -1.261 . . . . 0.0 109.255 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.82 162.51 12.87 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.383 -0.823 . . . . 0.0 109.1 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 38.4 t -80.85 120.92 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.458 -0.776 . . . . 0.0 108.931 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -96.41 -30.08 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.953 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 15.0 tp60 -150.01 166.07 30.79 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.952 -1.092 . . . . 0.0 110.579 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 61.6 mt-10 -136.64 141.53 43.2 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.8 m95 -139.32 153.65 47.77 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -92.75 141.74 28.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -0.868 . . . . 0.0 109.285 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.8 mt -66.39 -22.99 66.25 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.174 -0.953 . . . . 0.0 108.653 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 64.0 p -80.97 -5.16 57.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.352 -0.843 . . . . 0.0 109.658 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -90.1 -33.55 16.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.213 -0.929 . . . . 0.0 109.801 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.6 mt -57.78 121.74 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.162 -0.961 . . . . 0.0 109.597 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -89.11 -48.38 7.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.226 -0.921 . . . . 0.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -153.53 177.81 10.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.476 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.9 171.13 20.83 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 0.0 109.355 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.77 111.47 5.03 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.01 128.05 45.07 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.25 -0.906 . . . . 0.0 110.124 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.584 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.5 m -127.09 156.55 74.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.78 22.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.45 1.433 . . . . 0.0 110.968 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.584 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.8 pttp -145.6 -39.1 0.24 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.724 -1.235 . . . . 0.0 110.646 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.461 ' OG ' ' NE2' ' A' ' 77' ' ' GLN . 64.5 m -147.17 168.09 22.54 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.072 -1.018 . . . . 0.0 111.744 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -123.6 140.81 52.62 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -130.12 144.96 51.64 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.26 -0.9 . . . . 0.0 109.777 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.52 153.96 49.93 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.6 126.66 37.24 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.517 -0.74 . . . . 0.0 109.279 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -85.85 1.73 48.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.29 -9.97 62.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.9 87.62 5.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.37 -1.077 . . . . 0.0 109.602 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -47.22 -45.89 23.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 109.268 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -49.24 -50.67 37.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 109.46 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -61.7 -32.04 72.22 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.25 -0.906 . . . . 0.0 108.945 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.39 161.23 34.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 34.9 m-85 -75.23 168.34 20.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -1.164 . . . . 0.0 109.893 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' OH ' ' OE2' ' A' ' 13' ' ' GLU . 82.0 t80 -131.71 107.51 8.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.9 p -122.73 152.29 40.74 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.686 0.755 . . . . 0.0 110.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.12 167.58 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.461 ' NE2' ' OG ' ' A' ' 61' ' ' SER . 24.0 mm-40 -78.49 132.97 37.46 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.99 -1.069 . . . . 0.0 109.566 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.469 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 10.6 p -150.82 115.95 5.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.7 m -67.96 -21.37 65.08 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 50.3 mt-10 -115.97 31.07 6.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.299 0.571 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -48.58 -15.99 0.55 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' N ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -77.54 -57.7 3.68 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.706 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 54.5 mt-30 -53.25 -46.52 69.22 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 84' ' ' ILE . 29.1 mt -53.98 -31.21 20.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.11 -30.3 26.06 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -78.14 -37.75 45.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD11 ' CE2' ' A' ' 91' ' ' TYR . 32.2 tp -69.07 -40.13 78.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.1 mt -73.72 -53.97 16.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -56.4 -17.08 6.88 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 -37.91 8.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.449 ' CE2' HD11 ' A' ' 87' ' ' LEU . 24.6 m-85 -70.39 -32.8 70.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.828 -1.395 . . . . 0.0 109.141 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.0 mt -63.41 -24.82 36.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.972 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.25 -23.7 28.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.423 -0.798 . . . . 0.0 110.059 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.09 -26.41 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.335 -0.853 . . . . 0.0 110.547 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.8 pt -83.21 -34.12 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.056 -1.028 . . . . 0.0 108.845 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.62 -24.32 42.02 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -71.91 -37.67 70.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.587 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -80.79 -13.76 58.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.0 109.388 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.08 -15.81 49.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.251 -0.906 . . . . 0.0 110.098 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.041 -1.037 . . . . 0.0 109.554 -179.78 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.283 0.563 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.553 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 47.5 m95 52.75 -178.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -149.12 142.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -138.74 154.08 72.7 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.3 Cg_endo -60.72 -27.19 84.41 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.01 1.14 . . . . 0.0 110.022 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.8 mt -46.57 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' B' ' 6' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.242 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 1' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.1 mptp? -64.33 -13.81 52.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.502 -0.749 . . . . 0.0 109.35 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 6' ' ' VAL . 6.9 m -167.78 59.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 109.558 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -54.3 170.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.677 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.32 87.73 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' THR . 55.5 t -105.58 140.2 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.631 -0.923 . . . . 0.0 108.917 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -80.56 112.75 18.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 110.278 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -93.46 144.7 25.1 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -127.56 129.31 47.1 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -77.41 119.8 21.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.051 -1.031 . . . . 0.0 109.563 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.88 153.56 38.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -107.06 134.64 49.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.337 -0.852 . . . . 0.0 108.785 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -105.64 161.05 14.72 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -98.91 122.54 42.29 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.74 0.781 . . . . 0.0 108.938 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' LYS . 49.4 mtp -69.22 153.48 43.6 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.476 0.655 . . . . 0.0 110.461 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -26.13 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.9 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.0 -15.19 6.27 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' C ' ' H ' ' A' ' 20' ' ' LYS . 5.9 mmmt -63.97 124.87 22.69 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.736 -1.449 . . . . 0.0 108.871 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -64.79 -1.94 2.24 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -67.39 -173.72 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.884 0.849 . . . . 0.0 109.897 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.3 mt -135.91 158.94 43.16 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 22' ' ' VAL . 1.8 t -127.38 114.64 21.37 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.344 -0.847 . . . . 0.0 109.628 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -57.38 147.64 76.38 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.858 1.039 . . . . 0.0 109.821 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -153.72 146.99 24.74 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 42.3 mt -105.12 140.11 38.78 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.76 107.79 12.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.323 -0.861 . . . . 0.0 110.376 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.6 123.44 6.12 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -102.71 111.39 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.376 -1.073 . . . . 0.0 108.55 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.6 m -95.48 170.71 9.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.117 -0.99 . . . . 0.0 108.86 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' H ' HG22 ' A' ' 29' ' ' THR . 12.1 pttt -78.05 -1.52 32.71 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.18 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' CA ' HD12 ' A' ' 49' ' ' LEU . 32.7 mt-10 -146.11 6.43 1.01 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.36 -0.837 . . . . 0.0 110.279 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.0 160.68 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.894 -1.129 . . . . 0.0 110.67 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.7 t -107.45 134.36 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.432 ' SD ' HG21 ' A' ' 6' ' ' VAL . 8.0 mtp -102.42 136.51 42.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 110.663 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.54 121.72 35.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' GLU . 12.0 t -136.06 124.93 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 0.0 110.525 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 90.1 m-20 -67.12 148.79 51.4 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -89.21 -24.3 22.17 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -71.08 -52.26 20.46 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.382 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.0 p -99.26 -5.92 28.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.67 -0.644 . . . . 0.0 110.278 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 51.75 23.6 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.65 -1.281 . . . . 0.0 108.816 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -100.93 162.75 12.68 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.3 t -86.56 127.96 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -102.91 -31.35 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 0.0 110.166 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 46.5 tt0 -169.9 166.12 9.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.888 -1.133 . . . . 0.0 110.559 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.8 mt-10 -134.61 160.06 39.28 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.711 -0.618 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 90.4 m95 -139.34 153.45 47.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.557 -0.715 . . . . 0.0 109.181 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.9 p -85.51 142.15 29.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.196 -0.94 . . . . 0.0 109.053 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.462 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.4 mt -68.08 -24.87 65.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.157 -0.965 . . . . 0.0 108.788 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.9 p -80.24 -6.05 57.21 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.262 -0.899 . . . . 0.0 109.615 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.66 -30.53 19.1 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 97.5 mt -58.84 120.21 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.29 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -86.53 -50.41 6.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 109.22 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' NE ' ' OD2' ' A' ' 65' ' ' ASP . 14.4 ptt180 -153.59 179.22 9.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.237 -0.914 . . . . 0.0 109.51 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.404 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 21.8 p90 -157.7 170.03 23.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.96 106.05 3.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.62 142.12 31.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 110.839 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -144.86 158.78 52.2 Favored Pre-proline 0 N--CA 1.488 1.428 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.82 29.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 121.513 1.475 . . . . 0.0 111.119 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 58' ' ' SER . 20.5 pttm -150.64 -41.27 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.529 -1.357 . . . . 0.0 110.671 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' CG ' ' A' ' 60' ' ' LYS . 75.1 m -145.9 168.08 21.71 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.127 -0.983 . . . . 0.0 111.233 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -127.56 140.65 51.98 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -132.49 144.14 50.24 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.154 -0.966 . . . . 0.0 110.031 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -136.32 156.91 47.97 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.478 ' OD2' ' NE ' ' A' ' 54' ' ' ARG . 16.8 m-20 -130.04 125.09 34.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.516 -0.74 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -93.51 -1.73 55.22 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.7 -6.95 75.87 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.76 85.58 7.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -1.17 . . . . 0.0 109.705 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -47.92 -43.7 29.22 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.177 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.604 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -49.62 -61.33 2.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.059 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -60.15 -30.11 69.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 108.783 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 173.62 48.08 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -71.97 168.24 18.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -1.163 . . . . 0.0 109.557 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -131.43 107.29 8.81 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 p -124.48 156.14 37.75 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.23 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.5 m -150.81 167.21 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.35 141.21 37.13 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.6 p -150.56 125.77 10.01 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.7 m -64.85 -29.75 70.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 82' ' ' GLU . 44.8 mm-40 -105.75 -70.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.713 0.768 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.81 -31.39 0.62 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 80' ' ' GLU . 19.2 tt0 -71.95 -57.49 4.26 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.322 -1.105 . . . . 0.0 108.948 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.498 ' NE2' ' OE1' ' A' ' 80' ' ' GLU . 49.8 mt-30 -50.09 -48.53 53.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.4 mt -53.6 -31.74 19.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.21 -30.13 26.0 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 82' ' ' GLU . 10.5 tp60 -76.92 -38.82 52.7 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.56 -38.53 77.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 mt -75.77 -50.97 21.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -60.32 -17.52 43.48 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.43 -30.19 28.19 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -81.03 -31.06 34.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.751 -1.44 . . . . 0.0 109.387 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.3 mt -68.04 -27.6 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.321 -0.862 . . . . 0.0 110.258 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.7 -20.71 30.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.946 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 89.3 mt -86.47 -23.79 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.5 pt -84.17 -34.43 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.055 -1.028 . . . . 0.0 108.937 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.3 mt -84.22 -22.64 30.8 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.784 -0.573 . . . . 0.0 109.831 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -70.47 -38.22 74.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.021 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -65.65 -41.43 92.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.069 -1.02 . . . . 0.0 109.376 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.8 -46.09 89.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.299 -0.875 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.43 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.438 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 48.3 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.516 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 47.4 m95 -162.39 179.05 8.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -154.39 139.23 9.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.42 159.3 30.89 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' B' ' 8' ' ' HIS . 3.8 Cg_endo -62.45 -24.71 75.65 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 121.089 1.193 . . . . 0.0 109.735 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.3 mt -47.27 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.136 -0.978 . . . . 0.0 109.347 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' B' ' 6' ' ' PRO . 71.1 m-70 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.062 -0.971 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.665 ' C ' ' H ' ' A' ' 3' ' ' THR . 10.2 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.329 0.585 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -61.84 15.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 109.478 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.665 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.1 t -140.28 47.73 1.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.233 -0.917 . . . . 0.0 109.18 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -93.15 125.99 38.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.83 37.17 94.28 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.2 138.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.574 -0.956 . . . . 0.0 108.957 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 t -95.39 99.71 11.59 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.215 -0.928 . . . . 0.0 109.985 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 24.3 p90 -82.26 120.09 24.93 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -102.84 131.54 49.65 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.279 -0.888 . . . . 0.0 108.913 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.28 103.87 8.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.017 -1.052 . . . . 0.0 108.944 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 78' ' ' THR . 17.6 m -115.37 152.99 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -108.92 150.68 27.35 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.368 -0.832 . . . . 0.0 108.834 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.2 mt-10 -119.56 160.95 21.44 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.44 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 5.7 mmmm -108.71 107.19 17.54 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.521 ' O ' ' C ' ' A' ' 16' ' ' LYS . 12.6 mmt -69.56 151.83 45.51 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.599 -0.688 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -2.79 -72.19 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.18 0.27 0.8 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.635 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.1 mmmt -49.64 124.81 10.23 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.794 -1.416 . . . . 0.0 108.934 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -61.71 -5.88 2.22 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -82.93 -174.0 5.02 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.922 0.868 . . . . 0.0 109.718 -179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.0 mt -136.35 157.52 46.59 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.5 112.57 37.21 Favored Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.228 -0.92 . . . . 0.0 109.204 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.91 149.46 78.53 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.927 1.085 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 12.4 tpp180 -153.87 150.82 28.8 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 55.4 mt -108.84 140.64 42.02 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 tp -126.19 108.52 11.39 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.455 -0.778 . . . . 0.0 109.72 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -88.44 124.51 7.25 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 28' ' ' ILE . 2.4 mp -101.85 111.48 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.407 -1.055 . . . . 0.0 108.524 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 m -94.92 168.78 10.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.071 -1.018 . . . . 0.0 109.096 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' LYS . 9.0 ptpp? -73.51 -15.14 61.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.99 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -129.03 2.91 5.27 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.547 -0.721 . . . . 0.0 110.583 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.504 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 160.31 3.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.777 -1.202 . . . . 0.0 110.828 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.4 t -103.92 133.52 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 mtp -103.25 140.57 37.21 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.076 -1.015 . . . . 0.0 111.422 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.561 HH21 ' CG2' ' A' ' 44' ' ' ILE . 4.5 mtm180 -92.35 127.64 37.91 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -136.31 126.41 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.299 -0.875 . . . . 0.0 110.493 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.31 148.6 43.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -88.12 -19.56 26.84 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -75.29 -53.64 8.44 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.488 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.7 p -99.28 -5.28 30.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 110.31 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt 50.64 21.39 0.88 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.661 -1.274 . . . . 0.0 109.171 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -100.9 163.97 12.05 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.546 -0.722 . . . . 0.0 109.495 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.3 t -85.98 124.42 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.621 -0.674 . . . . 0.0 109.199 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.561 ' CG2' HH21 ' A' ' 35' ' ' ARG . 19.0 mm -101.18 -25.14 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.353 -0.842 . . . . 0.0 110.243 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -170.3 165.74 8.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.948 -1.095 . . . . 0.0 110.118 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -139.22 161.46 37.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.507 0.67 . . . . 0.0 109.859 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 7.0 m0 -139.04 152.44 47.58 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 t -83.86 137.23 33.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.39 -26.12 68.32 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 108.749 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.9 p -80.06 -6.69 58.09 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' N ' HD22 ' A' ' 51' ' ' ASN . 1.1 m-80 -89.63 -34.24 16.36 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.143 -0.973 . . . . 0.0 109.506 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 85.6 mt -55.4 126.5 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.173 -0.954 . . . . 0.0 109.433 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -92.11 -49.64 6.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.769 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -152.98 176.91 11.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -157.87 169.96 23.43 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.422 -0.799 . . . . 0.0 109.614 178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.25 120.52 8.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.55 113.14 25.35 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.183 -0.948 . . . . 0.0 110.366 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 162.03 28.05 Favored Pre-proline 0 N--CA 1.485 1.304 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.83 3.22 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.215 1.277 . . . . 0.0 110.148 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.0 pttt -153.07 -20.23 0.15 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.413 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 p -129.02 164.3 23.52 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.276 -0.89 . . . . 0.0 111.404 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -132.82 140.09 47.8 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.6 m -133.2 144.77 50.04 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.133 -0.98 . . . . 0.0 109.792 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.55 155.87 48.75 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.23 135.28 47.96 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.414 -0.804 . . . . 0.0 110.467 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.23 -8.32 21.39 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.7 -14.85 58.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 108.736 -1.745 . . . . 0.0 108.736 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' GLY . 2.6 m-20 -75.06 99.36 3.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -1.091 . . . . 0.0 109.325 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -42.03 -25.28 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.183 -0.948 . . . . 0.0 110.99 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.579 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 5.8 pt20 -88.4 -66.14 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.954 -1.092 . . . . 0.0 111.291 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 9.1 t70 -97.31 -4.78 38.01 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.055 . . . . 0.0 109.953 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' ASP . . . -40.72 -68.8 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -70.62 119.39 14.7 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.431 -1.041 . . . . 0.0 111.032 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -132.87 107.4 8.3 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.8 p -125.21 159.03 32.56 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.018 0.913 . . . . 0.0 111.07 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 m -152.6 172.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -78.63 130.73 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.046 -1.034 . . . . 0.0 109.563 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 60' ' ' LYS . 22.4 p -145.11 124.13 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.485 -0.76 . . . . 0.0 109.344 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.6 m -73.81 -21.03 60.28 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.54 ' CD ' HE22 ' A' ' 83' ' ' GLN . 53.7 mt-10 -123.82 37.12 4.48 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.399 0.619 . . . . 0.0 109.523 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.94 -11.26 0.91 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 80' ' ' GLU . 7.8 tt0 -78.88 -57.71 3.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -1.091 . . . . 0.0 108.877 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.54 HE22 ' CD ' ' A' ' 80' ' ' GLU . 48.6 mt-30 -53.44 -45.6 69.52 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.445 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 28.3 mt -54.58 -31.52 23.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.12 -28.86 27.18 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -80.52 -38.75 29.15 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.42 HD11 ' CE2' ' A' ' 91' ' ' TYR . 43.4 tp -68.55 -38.34 80.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.3 mm -70.6 -53.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.79 -17.03 13.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.56 -0.712 . . . . 0.0 109.196 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.11 -28.96 26.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.42 ' CE2' HD11 ' A' ' 87' ' ' LEU . 29.0 m-85 -85.29 -15.98 41.6 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.458 . . . . 0.0 109.915 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.32 -28.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.582 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -84.54 -19.67 32.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.165 -0.96 . . . . 0.0 110.178 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 80.7 mt -86.59 -23.09 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.915 . . . . 0.0 110.234 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.445 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.9 pt -83.55 -33.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.188 -0.945 . . . . 0.0 108.86 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.08 -21.85 53.74 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -71.14 -56.29 6.41 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.402 -0.811 . . . . 0.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -49.13 -37.78 23.02 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.361 -0.837 . . . . 0.0 109.662 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -58.98 -30.99 68.36 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.666 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.465 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.533 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 83.2 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 1' ' ' SER . 46.1 m95 -167.19 -179.76 4.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 137.94 8.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -110.02 151.37 42.43 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.434 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.7 Cg_endo -60.45 -15.48 36.16 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 120.907 1.071 . . . . 0.0 109.839 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 6' ' ' PRO . 13.2 mt -52.81 -175.14 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.179 -0.95 . . . . 0.0 109.487 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.664 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' THR . 2.2 tp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 2.3 mptp? 46.57 17.93 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.905 . . . . 0.0 109.167 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 1' ' ' LEU . 15.0 m -161.21 59.06 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 109.087 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -131.64 111.06 11.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.554 -0.716 . . . . 0.0 109.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 43.92 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.41 140.18 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.615 -0.932 . . . . 0.0 109.288 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.2 t -96.46 107.06 19.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.7 120.71 27.44 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -102.4 131.68 48.89 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -76.62 104.49 7.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.123 -0.986 . . . . 0.0 109.884 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.448 HG12 HG22 ' A' ' 78' ' ' THR . 12.7 m -112.13 157.88 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -114.39 155.75 25.73 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.198 -0.939 . . . . 0.0 109.689 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.555 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 42.0 mp0 -124.93 160.98 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -92.74 127.29 38.19 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.476 1.131 . . . . 0.0 110.793 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.519 ' CG ' HG23 ' A' ' 22' ' ' VAL . 66.2 mtp -71.11 154.7 41.54 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.459 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -28.95 -68.46 0.07 Allowed 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 121.196 0.522 . . . . 0.0 111.445 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.41 -11.21 1.55 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 20' ' ' LYS . 12.2 mmmt -62.83 128.11 34.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.929 -1.336 . . . . 0.0 108.76 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.9 -7.3 0.71 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -67.61 -175.38 0.51 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.894 0.854 . . . . 0.0 110.14 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.6 mt -138.62 157.41 46.19 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.519 HG23 ' CG ' ' A' ' 15' ' ' MET . 1.9 t -111.47 113.12 53.84 Favored Pre-proline 0 N--CA 1.507 2.383 0 O-C-N 121.084 -1.01 . . . . 0.0 109.292 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -59.13 147.94 88.07 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 120.865 1.043 . . . . 0.0 110.183 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -154.01 148.21 25.85 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.07 140.58 41.04 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.34 108.74 13.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.356 -0.84 . . . . 0.0 110.274 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -83.52 123.17 6.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.7 mp -101.07 111.61 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.377 -1.072 . . . . 0.0 108.323 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.491 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 1.0 OUTLIER -95.53 174.71 6.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.004 -1.06 . . . . 0.0 108.938 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 10.1 pttp -80.42 -6.66 58.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.614 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -139.51 3.95 2.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.433 -0.792 . . . . 0.0 109.972 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.05 160.14 4.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.701 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.29 133.29 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.1 mmm -102.03 136.52 41.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.048 -1.032 . . . . 0.0 110.336 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 7.3 mtm180 -93.09 123.25 36.22 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -133.19 129.68 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.374 -0.829 . . . . 0.0 110.286 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -74.72 148.78 40.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.716 -0.615 . . . . 0.0 109.439 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.42 -21.79 22.86 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -73.72 -51.96 14.85 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.534 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 66.6 p -101.12 -4.96 26.33 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.644 -0.66 . . . . 0.0 110.278 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.521 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 8.0 mtmp? 51.57 23.9 2.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.668 -1.27 . . . . 0.0 109.061 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -105.02 163.07 12.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.527 -0.733 . . . . 0.0 109.037 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.7 t -84.51 126.37 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.3 mm -100.96 -28.6 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 35' ' ' ARG . 33.9 tt0 -170.12 166.13 9.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.931 -1.105 . . . . 0.0 110.423 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -135.29 158.72 43.65 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.474 0.654 . . . . 0.0 109.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.503 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 72.9 m95 -139.88 153.64 47.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.772 . . . . 0.0 109.113 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -86.91 136.44 32.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.0 109.174 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.29 -38.79 91.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.045 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.507 ' O ' HG22 ' A' ' 50' ' ' THR . 85.3 m -65.9 -5.39 9.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.342 -0.849 . . . . 0.0 109.39 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -87.84 -38.14 15.94 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 109.804 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.5 mt -53.77 116.93 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -81.79 -48.24 11.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.39 -0.818 . . . . 0.0 109.217 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -154.0 178.41 9.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.403 -0.811 . . . . 0.0 109.087 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -157.62 170.88 21.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.727 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -147.4 114.66 6.25 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.29 28.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.194 -0.941 . . . . 0.0 110.25 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -99.56 158.59 31.9 Favored Pre-proline 0 N--CA 1.487 1.396 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -59.19 7.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.321 1.347 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.3 pttt -147.26 -23.11 0.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.689 -1.257 . . . . 0.0 111.446 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -139.41 164.27 30.3 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.111 -0.993 . . . . 0.0 111.639 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -125.41 140.51 52.73 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.402 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 16.4 m -132.68 138.81 47.41 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.163 -0.961 . . . . 0.0 109.637 -179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -130.72 156.43 44.95 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.45 121.36 25.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.489 -0.757 . . . . 0.0 109.531 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 65.8 m-85 -89.82 -2.05 58.13 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.48 -2.95 84.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -83.41 92.8 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -1.172 . . . . 0.0 109.645 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -48.05 -38.62 17.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.97 -73.51 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.482 0.658 . . . . 0.0 109.633 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -55.12 -30.91 60.74 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.563 -0.711 . . . . 0.0 109.457 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.76 -171.02 55.08 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.53 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 33.7 m-85 -76.5 164.49 25.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -1.091 . . . . 0.0 110.025 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -131.79 107.84 9.04 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.402 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 20.2 t -130.05 157.31 42.72 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 110.272 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.93 172.37 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -78.02 138.95 39.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.996 -1.065 . . . . 0.0 109.473 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.448 HG22 HG12 ' A' ' 11' ' ' VAL . 64.5 p -150.19 118.06 6.25 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.494 -0.753 . . . . 0.0 109.288 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.5 m -67.79 -18.41 64.84 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 30.9 mt-10 -132.97 39.04 3.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.805 -0.559 . . . . 0.0 109.71 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.37 -15.63 0.76 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 80' ' ' GLU . 11.9 tt0 -74.09 -57.93 3.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.445 -1.032 . . . . 0.0 109.081 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 55.3 mt-30 -52.85 -45.27 67.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 mt -55.16 -29.97 23.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.11 -26.86 28.61 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -80.98 -38.69 27.19 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.38 -0.825 . . . . 0.0 109.229 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.04 -40.57 75.08 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.4 mt -72.27 -52.53 23.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.2 -17.34 2.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.34 -28.84 18.73 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -80.43 -35.14 35.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.874 -1.368 . . . . 0.0 109.178 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.1 mt -58.89 -22.99 22.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.653 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.62 -22.54 29.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.426 -0.796 . . . . 0.0 110.017 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.9 mt -86.63 -21.93 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.246 -0.909 . . . . 0.0 110.407 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 30' ' ' LYS . 15.6 pt -84.29 -24.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.98 -1.075 . . . . 0.0 108.693 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.2 mt -82.21 -25.55 34.11 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.745 -0.597 . . . . 0.0 110.001 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -27.38 69.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.167 -0.958 . . . . 0.0 109.89 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 100' ' ' LYS . 17.2 mtpp -53.79 -31.97 50.81 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -56.35 -6.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.413 -0.804 . . . . 0.0 109.29 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 98' ' ' LYS . 15.9 ttmm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.308 0.575 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.0 m95 -68.74 -177.38 0.97 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.078 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -153.09 141.15 13.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.457 ' O ' ' CD2' ' B' ' 8' ' ' HIS . 0.2 OUTLIER -127.96 160.51 61.03 Favored Pre-proline 0 N--CA 1.499 2.018 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -65.43 -14.24 43.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 121.314 1.343 . . . . 0.0 109.91 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -43.06 -45.32 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 0.0 110.337 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.457 ' CD2' ' O ' ' B' ' 5' ' ' SER . 15.1 p80 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.112 -0.993 . . . . 0.0 109.709 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 3' ' ' THR . 19.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.4 mptt -72.09 15.19 0.17 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.533 -0.73 . . . . 0.0 109.395 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.3 OUTLIER -170.1 59.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 0.0 109.708 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -98.01 128.83 44.8 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.42 -0.8 . . . . 0.0 109.565 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 80.74 11.44 83.95 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.5 t -95.51 140.55 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.34 -1.094 . . . . 0.0 109.215 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 m -84.36 111.62 19.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.043 -1.036 . . . . 0.0 110.006 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.54 144.83 25.72 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' HD13 ' A' ' 28' ' ' ILE . 22.2 m-85 -127.19 134.07 50.19 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 tp -77.43 107.91 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.129 -0.982 . . . . 0.0 110.14 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.6 m -120.84 150.76 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -107.6 140.98 39.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.147 -0.971 . . . . 0.0 109.349 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 68.0 mt-10 -112.05 160.79 17.16 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -104.42 119.74 39.66 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.856 0.836 . . . . 0.0 109.779 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.506 ' O ' ' C ' ' A' ' 16' ' ' LYS . 68.1 mtp -69.97 152.33 44.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.862 -0.524 . . . . 0.0 110.249 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -10.87 -73.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 123.35 0.66 . . . . 0.0 112.573 -178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.78 -9.73 1.48 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 20' ' ' LYS . 6.9 mmmt -52.86 124.69 14.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.031 -1.276 . . . . 0.0 108.633 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -62.9 -4.42 2.15 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.53 -174.9 1.82 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.812 0.815 . . . . 0.0 109.773 -179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 12.8 mt -137.31 157.44 46.61 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.6 t -121.46 114.85 31.45 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 121.438 -0.789 . . . . 0.0 109.18 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -57.84 150.79 60.77 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 120.606 0.87 . . . . 0.0 109.893 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.65 145.93 23.88 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -104.63 134.03 48.48 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 28' ' ' ILE . 38.0 tp -115.22 108.46 16.63 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.681 0.753 . . . . 0.0 110.206 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' MET . . . -80.6 121.14 5.35 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.499 HD12 ' O ' ' A' ' 26' ' ' LEU . 3.8 mp -103.96 111.32 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.0 m -96.18 170.48 9.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.251 -0.906 . . . . 0.0 109.41 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' H ' HG22 ' A' ' 29' ' ' THR . 8.9 pttp -74.64 -9.04 58.18 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 109.243 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' CA ' HD12 ' A' ' 49' ' ' LEU . 50.5 mt-10 -139.56 6.77 2.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.482 -0.761 . . . . 0.0 110.534 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -171.99 163.55 6.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.664 -1.273 . . . . 0.0 110.773 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -113.4 130.98 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 27' ' ' GLY . 2.6 mtt -104.01 141.27 36.49 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.992 -1.068 . . . . 0.0 111.362 -178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.642 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.6 mtm180 -92.98 126.99 38.33 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.49 126.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.872 . . . . 0.0 110.367 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.2 t0 -69.09 148.46 49.97 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.9 tm-20 -89.02 -20.49 24.32 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -76.55 -52.9 8.86 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.459 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 31.4 p -102.51 -1.56 30.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.658 -0.652 . . . . 0.0 110.874 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt 49.75 18.83 0.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.601 -1.312 . . . . 0.0 109.358 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -92.7 162.76 14.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.229 -0.919 . . . . 0.0 108.831 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -90.32 124.02 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.31 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.642 ' CG2' HH21 ' A' ' 35' ' ' ARG . 17.7 mm -101.07 -23.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.377 -0.827 . . . . 0.0 110.277 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.5 tt0 -170.28 165.84 8.85 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.881 -1.137 . . . . 0.0 110.856 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 40.3 mt-10 -140.23 158.86 43.38 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.585 0.707 . . . . 0.0 110.006 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.2 m0 -140.22 154.3 46.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.599 -0.688 . . . . 0.0 109.491 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -86.95 142.23 28.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.23 -0.919 . . . . 0.0 109.077 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.2 mt -70.09 -29.76 66.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.945 . . . . 0.0 109.18 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.5 p -73.47 -5.17 38.3 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.46 -33.15 14.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 52' ' ' ILE . 18.1 mt -56.94 114.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.039 -1.038 . . . . 0.0 109.362 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' NZ ' ' O2P' ' B' ' 4' ' ' PTR . 44.1 tttm -85.58 -49.79 7.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.458 ' NE ' ' O2P' ' B' ' 4' ' ' PTR . 8.8 ptt180 -149.75 177.31 9.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.188 -0.945 . . . . 0.0 109.797 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -158.23 170.57 21.96 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.458 -0.777 . . . . 0.0 109.617 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.49 118.67 7.26 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.99 104.13 16.15 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.163 -0.961 . . . . 0.0 109.847 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -87.02 160.57 49.07 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -60.58 3.09 0.3 Allowed 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.271 1.314 . . . . 0.0 110.055 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -148.47 -11.15 0.35 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.874 -1.141 . . . . 0.0 111.603 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -147.79 163.32 37.09 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.749 -1.219 . . . . 0.0 111.594 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -125.41 141.16 52.22 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 m -132.85 149.5 52.25 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.203 -0.935 . . . . 0.0 109.861 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.86 156.64 44.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.467 -0.771 . . . . 0.0 109.098 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -130.42 132.77 45.89 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.585 -0.697 . . . . 0.0 109.267 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -98.49 -0.15 43.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.355 -0.84 . . . . 0.0 108.734 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.93 -9.02 40.3 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.2 89.57 6.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -1.051 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -44.81 -46.98 10.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -50.86 -46.34 60.22 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.455 -0.778 . . . . 0.0 109.952 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -72.24 -44.55 62.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.169 -0.957 . . . . 0.0 109.671 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.59 -176.34 47.92 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -79.83 159.3 26.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -1.118 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -132.09 106.65 8.13 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 26.0 p -123.49 161.4 24.94 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.818 0.818 . . . . 0.0 110.724 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 m -151.42 171.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -78.57 138.64 38.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.552 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.0 p -150.1 121.22 7.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.9 m -68.47 -18.83 64.49 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.501 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 4.1 pt-20 -149.71 52.11 0.93 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.338 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.81 -9.22 1.66 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.8 tt0 -60.57 -57.08 14.22 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.309 -1.112 . . . . 0.0 108.93 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.501 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 47.3 mt-30 -51.51 -48.68 62.87 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.5 mt -52.42 -31.2 15.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.52 -28.98 26.31 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -79.61 -37.57 35.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.43 -0.794 . . . . 0.0 109.077 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.3 tp -70.4 -40.25 74.02 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.1 mt -74.27 -48.1 38.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.04 -17.33 57.02 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 108.736 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.57 -27.98 28.26 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -81.95 -16.06 51.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.805 -1.409 . . . . 0.0 109.281 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.65 -28.49 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.42 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -84.77 -20.85 30.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.173 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.6 mt -86.28 -24.53 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' ILE . 12.6 pt -84.21 -33.08 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.067 -1.021 . . . . 0.0 109.271 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.16 -28.0 27.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.76 -0.588 . . . . 0.0 110.091 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -67.32 -40.4 85.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.13 -0.981 . . . . 0.0 109.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -68.07 -34.33 76.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.922 . . . . 0.0 109.541 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.95 -46.33 78.52 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.2 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.535 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 32.2 m95 50.28 -172.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.918 . . . . 0.0 109.505 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.29 135.41 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . 0.458 ' O2P' ' NE ' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -143.29 149.74 49.32 Favored Pre-proline 0 N--CA 1.494 1.758 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.18 -23.75 74.86 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.007 1.138 . . . . 0.0 110.485 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -48.14 116.5 1.56 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.993 -1.067 . . . . 0.0 109.75 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' B' ' 8' ' ' HIS . 11.8 p80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.542 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 1' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 9.8 mptt -69.29 10.72 0.29 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.402 -0.811 . . . . 0.0 109.237 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 1' ' ' LEU . 6.7 p -129.28 45.16 2.85 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -82.01 107.97 15.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.579 -0.701 . . . . 0.0 109.647 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.94 8.14 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.8 t -128.27 140.24 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.619 -0.93 . . . . 0.0 109.105 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 t -83.39 99.78 10.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 109.872 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -87.98 120.81 29.68 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.24 0.543 . . . . 0.0 109.657 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -103.81 134.5 47.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.35 -0.844 . . . . 0.0 109.01 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -83.05 107.89 15.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.973 -1.079 . . . . 0.0 109.449 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 m -118.09 152.63 20.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -107.5 141.89 38.24 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.547 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 27.2 mt-10 -118.15 160.76 20.99 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -107.26 98.87 8.45 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.3 mmt -71.94 152.81 42.25 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.159 0.98 . . . . 0.0 109.368 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -55.01 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.611 -178.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -32.11 -29.95 0.01 OUTLIER Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.999 -0.438 . . . . 0.0 112.262 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -112.06 123.46 50.3 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.201 -1.176 . . . . 0.0 110.177 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -74.82 -1.68 23.28 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.672 ' N ' HD22 ' A' ' 19' ' ' ASN . 0.8 OUTLIER -69.85 -173.25 0.6 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.875 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mt -111.47 157.34 20.41 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 13' ' ' GLU . 47.8 t -129.86 113.55 17.59 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.535 -0.728 . . . . 0.0 109.293 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -57.49 146.64 82.78 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 121.068 1.179 . . . . 0.0 110.62 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.0 tpp180 -153.95 144.89 22.69 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 36' ' ' VAL . 75.8 mt -102.64 140.41 36.95 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.1 tp -125.8 108.82 11.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.305 -0.872 . . . . 0.0 110.256 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.54 8.02 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 mm -111.34 126.93 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.929 . . . . 0.0 108.717 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.446 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.28 166.46 21.15 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -74.05 -15.5 61.07 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.769 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -104.04 -22.61 13.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.507 -0.746 . . . . 0.0 110.999 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.73 167.64 4.44 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.471 -1.393 . . . . 0.0 110.914 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.4 t -101.99 131.06 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.9 mtt -102.76 140.63 36.79 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.935 -1.103 . . . . 0.0 111.289 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.554 HH21 HG22 ' A' ' 44' ' ' ILE . 5.9 mtm180 -93.04 128.6 38.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.2 t -136.56 125.04 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.385 -178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -70.16 148.67 48.4 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -89.36 -21.64 23.0 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -76.76 -50.34 13.79 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.345 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.7 m -100.23 -6.57 25.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.632 -0.668 . . . . 0.0 110.421 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 41' ' ' LYS . 4.9 mtpm? 50.29 23.71 1.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.698 -1.251 . . . . 0.0 109.419 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 163.13 12.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 0.0 109.055 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -84.29 124.98 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.481 -0.762 . . . . 0.0 109.345 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.554 HG22 HH21 ' A' ' 35' ' ' ARG . 19.7 mm -101.81 -26.06 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 110.293 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.419 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.8 tt0 -170.58 165.85 8.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.898 -1.126 . . . . 0.0 110.622 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.1 mt-10 -138.64 158.46 44.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.5 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.6 m0 -139.46 148.67 43.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.367 -0.833 . . . . 0.0 109.645 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 m -82.86 139.14 33.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 0.0 109.225 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 ' O ' ' A' ' 29' ' ' THR . 6.0 mt -65.17 -31.22 72.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.3 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.9 p -76.12 -8.04 56.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.883 . . . . 0.0 110.032 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -90.52 -8.32 50.63 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.009 . . . . 0.0 109.699 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 99.2 mt -74.14 125.53 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.078 -1.014 . . . . 0.0 110.092 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.65 -51.29 7.87 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -170.8 173.71 5.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -0.803 . . . . 0.0 108.919 179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.417 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 23.2 p90 -148.35 172.71 13.97 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.084 -1.01 . . . . 0.0 110.382 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -145.79 105.52 3.98 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.79 142.11 31.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.348 -0.845 . . . . 0.0 110.796 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -142.56 158.97 59.16 Favored Pre-proline 0 N--CA 1.486 1.361 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.39 -1.17 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.304 1.336 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 58' ' ' SER . 25.5 mmtp -107.43 -61.98 1.48 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.496 -0.752 . . . . 0.0 110.606 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' A' ' 78' ' ' THR . 10.9 p -138.68 171.61 14.1 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.959 0.885 . . . . 0.0 111.46 -177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.42 139.97 51.17 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 75' ' ' SER . 18.8 m -135.98 124.41 23.44 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -114.25 155.39 26.23 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' CG ' ' HE ' ' A' ' 54' ' ' ARG . 0.6 OUTLIER -130.62 133.1 45.87 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.638 -0.664 . . . . 0.0 109.891 -179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -103.09 -0.47 30.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 -3.21 87.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.1 p30 -84.02 79.06 9.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.165 -1.197 . . . . 0.0 109.723 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -49.34 -45.37 45.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.155 -0.966 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 11.1 pt20 -55.93 -55.44 32.65 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.517 -0.74 . . . . 0.0 109.814 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 9.7 t70 -62.11 -33.75 75.04 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.236 -0.915 . . . . 0.0 109.096 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.72 170.39 38.77 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.529 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 50.7 m-85 -79.11 173.63 12.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.354 -1.086 . . . . 0.0 109.746 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -131.98 107.68 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 63' ' ' THR . 32.1 t -130.42 157.83 41.54 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.711 0.767 . . . . 0.0 109.907 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.9 m -150.57 171.13 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -78.34 136.23 37.66 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.962 -1.087 . . . . 0.0 109.341 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.409 ' H ' ' HA ' ' A' ' 61' ' ' SER . 33.0 p -149.53 114.14 5.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.596 -0.69 . . . . 0.0 109.329 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 52.8 m -66.84 -18.17 65.25 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.492 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 1.6 pm0 -136.02 43.72 2.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.44 0.638 . . . . 0.0 109.471 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.23 -8.67 1.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.5 tt0 -71.28 -58.1 3.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.419 -1.048 . . . . 0.0 109.016 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.401 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 12.3 mt-30 -53.15 -47.04 69.05 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mt -54.33 -29.47 19.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.08 -30.36 26.07 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -78.72 -38.72 38.27 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.4 HD11 ' CE2' ' A' ' 91' ' ' TYR . 53.4 tp -67.88 -38.76 83.45 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 mm -73.61 -53.16 18.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.21 -17.56 42.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.08 -25.14 32.44 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CE2' HD11 ' A' ' 87' ' ' LEU . 10.6 m-85 -84.21 -26.78 28.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.867 -1.373 . . . . 0.0 109.162 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 83.7 mt -74.31 -22.92 18.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.377 -0.827 . . . . 0.0 110.368 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -84.82 -20.44 30.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.22 -0.925 . . . . 0.0 109.931 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.0 mt -86.23 -24.57 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.243 -0.911 . . . . 0.0 110.312 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 95' ' ' ILE . 11.1 pt -82.66 -34.67 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 0.0 108.598 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.27 -23.36 43.66 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -66.95 -35.81 80.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.767 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.18 -39.59 65.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.174 -0.954 . . . . 0.0 109.502 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -61.13 -45.94 92.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.307 -0.871 . . . . 0.0 109.646 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' N ' ' CD ' ' A' ' 100' ' ' LYS . 10.9 mptt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.098 -1.001 . . . . 0.0 109.25 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 32.1 m95 52.84 -173.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.417 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -149.9 137.21 13.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -101.52 155.75 36.0 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' B' ' 7' ' ' LEU . 2.1 Cg_endo -60.25 -19.73 58.91 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.011 1.14 . . . . 0.0 109.462 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' B' ' 6' ' ' PRO . 16.6 mt -46.56 171.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.9 . . . . 0.0 109.574 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.445 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.8 p80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.547 ' O ' HG22 ' A' ' 3' ' ' THR . 23.3 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 47.59 15.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.228 -0.92 . . . . 0.0 109.356 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 1' ' ' LEU . 13.3 t -153.01 48.42 0.71 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.447 -0.783 . . . . 0.0 109.141 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.45 81.87 8.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.451 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.69 46.73 93.89 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.99 136.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.46 -1.023 . . . . 0.0 109.367 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 m -89.13 100.14 12.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -83.89 120.76 26.47 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.773 -0.58 . . . . 0.0 109.844 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -105.33 136.34 45.04 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 tt -82.49 126.04 31.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.963 -1.086 . . . . 0.0 109.15 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' ARG . 19.7 m -137.93 154.1 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -107.23 148.87 28.39 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.372 -0.83 . . . . 0.0 108.787 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.568 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 23.4 mt-10 -126.39 160.06 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -99.93 122.43 42.84 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.746 0.784 . . . . 0.0 108.986 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.516 ' O ' ' C ' ' A' ' 16' ' ' LYS . 45.9 mmm -69.63 151.56 45.77 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.741 -0.599 . . . . 0.0 109.563 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -5.45 -69.08 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 C-N-CA 123.406 0.682 . . . . 0.0 112.673 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' H ' ' HE2' ' A' ' 18' ' ' LYS . . . -137.08 -16.17 0.76 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' NZ ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -47.98 124.7 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 109.373 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -64.7 -3.93 3.73 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -72.34 -173.99 1.22 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.678 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.27 158.82 43.57 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.5 115.71 21.23 Favored Pre-proline 0 N--CA 1.503 2.179 0 O-C-N 121.516 -0.74 . . . . 0.0 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -56.74 150.1 55.67 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 120.902 1.068 . . . . 0.0 110.149 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.8 tpp180 -153.93 146.89 24.47 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' VAL . 69.4 mt -102.24 141.16 35.51 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.7 tp -126.15 109.18 12.06 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.293 -0.88 . . . . 0.0 110.561 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.7 129.99 9.73 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.61 111.85 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.704 -0.88 . . . . 0.0 108.832 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.493 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.1 m -101.94 163.96 11.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 0.0 108.635 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -75.63 -15.08 60.38 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -114.66 -7.77 12.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.711 -0.618 . . . . 0.0 110.25 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.37 171.05 4.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.687 -1.258 . . . . 0.0 110.902 -179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.3 t -120.36 148.21 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.493 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -134.65 151.34 50.97 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.739 -1.226 . . . . 0.0 111.704 -178.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.616 HH21 ' CG2' ' A' ' 44' ' ' ILE . 3.8 mtm180 -92.49 124.67 36.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.2 t -124.34 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.649 -0.657 . . . . 0.0 109.301 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 27.8 t0 -70.7 147.85 48.64 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.276 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.4 tm-20 -90.08 -20.88 22.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -74.77 -53.42 9.21 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.0 p -99.39 -3.49 33.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.561 -0.712 . . . . 0.0 110.282 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt 50.54 28.84 3.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.798 -1.189 . . . . 0.0 109.422 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 163.05 14.16 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.538 -0.726 . . . . 0.0 109.171 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.24 124.35 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.616 ' CG2' HH21 ' A' ' 35' ' ' ARG . 16.1 mm -98.48 -28.33 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 0.0 110.484 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 35.9 tt0 -156.2 166.22 34.08 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.801 -1.187 . . . . 0.0 111.15 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.4 mt-10 -134.88 148.36 50.08 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.04 148.41 43.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 m -83.81 136.71 34.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.973 . . . . 0.0 108.978 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.74 -24.18 67.67 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.16 -0.962 . . . . 0.0 109.107 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.2 p -82.2 -3.65 55.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.849 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -92.46 -21.58 20.08 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.147 -0.971 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -64.56 123.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 109.428 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -93.29 -50.99 5.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.353 -0.842 . . . . 0.0 109.592 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -152.62 175.64 12.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.507 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 21.3 p90 -157.55 170.68 21.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.0 109.688 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.51 110.81 4.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.91 106.83 19.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.276 -0.89 . . . . 0.0 109.826 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -93.99 161.26 30.38 Favored Pre-proline 0 N--CA 1.486 1.372 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -58.95 2.22 0.24 Allowed 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.467 1.445 . . . . 0.0 110.475 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.4 pttp -146.9 -27.26 0.4 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.901 -1.124 . . . . 0.0 111.159 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.1 p -124.31 167.83 13.8 Favored 'General case' 0 N--CA 1.504 2.273 0 CA-C-O 121.948 0.88 . . . . 0.0 111.304 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' CE2' HG21 ' A' ' 84' ' ' ILE . 23.7 t80 -141.94 139.61 32.55 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -140.37 149.12 42.27 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.898 -1.126 . . . . 0.0 110.982 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 154.83 49.05 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -131.31 124.24 30.03 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.558 -0.714 . . . . 0.0 109.655 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -93.35 -1.29 56.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 108.683 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.36 -4.43 63.47 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -91.05 93.26 9.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.346 -1.091 . . . . 0.0 109.719 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -47.92 -45.57 30.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.29 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -48.42 -61.66 1.9 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 108.978 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -60.14 -31.42 70.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.296 -0.878 . . . . 0.0 108.815 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.81 170.87 22.48 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.5 m-85 -70.91 163.6 27.1 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.25 -1.147 . . . . 0.0 109.515 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -131.76 108.02 9.17 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.8 t -127.5 154.1 45.52 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.847 0.832 . . . . 0.0 110.166 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.1 m -152.36 172.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -78.16 141.27 38.81 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.044 -1.035 . . . . 0.0 109.522 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 52.2 p -151.64 115.82 5.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.494 -0.754 . . . . 0.0 109.379 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 22.7 m -66.28 -21.87 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.595 ' H ' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -136.82 43.53 2.4 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.61 0.719 . . . . 0.0 109.49 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -45.07 -16.97 0.08 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 80' ' ' GLU . 13.2 tt0 -63.31 -57.25 11.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.454 -1.027 . . . . 0.0 108.952 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 54.6 mt-30 -50.3 -46.85 55.68 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.443 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.3 mm -54.46 -34.92 29.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.03 -26.76 28.86 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.07 -35.62 31.52 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.214 -0.929 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.5 tp -72.95 -36.72 67.22 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.8 mt -78.96 -46.43 23.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.15 -17.3 39.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.89 . . . . 0.0 109.117 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.93 -25.48 31.85 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.755 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -84.45 -21.77 30.57 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.428 . . . . 0.0 109.511 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.1 mt -72.78 -24.19 21.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 110.218 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -84.77 -19.82 32.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 109.817 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.57 -25.79 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.392 -0.817 . . . . 0.0 110.274 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.1 pt -83.29 -35.97 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.947 . . . . 0.0 108.947 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mt -74.97 -21.78 58.95 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -62.55 -38.94 92.0 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.472 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -70.28 -52.68 21.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.236 -0.915 . . . . 0.0 109.148 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CD ' ' N ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -66.14 -18.15 65.16 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.393 -0.817 . . . . 0.0 109.404 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.541 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 48.1 m95 -72.22 -177.91 2.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.434 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -155.57 136.92 5.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.4 p -135.44 153.22 77.68 Favored Pre-proline 0 N--CA 1.497 1.891 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.73 -25.67 69.49 Favored 'Trans proline' 0 C--N 1.322 -0.839 0 N-CA-C 109.441 -1.023 . . . . 0.0 109.441 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 mt -48.48 121.79 4.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.303 -1.419 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 1' ' ' LEU . 8.9 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.541 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.0 mptp? 48.98 18.77 0.22 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.304 -0.873 . . . . 0.0 109.318 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 1' ' ' LEU . 8.8 t -150.38 47.7 0.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.323 -0.861 . . . . 0.0 109.561 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -150.68 129.9 12.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.83 3.89 87.66 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.0 138.23 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -88.88 108.29 19.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.144 -0.972 . . . . 0.0 109.985 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 109.375 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' H ' ' H ' ' A' ' 26' ' ' LEU . 28.3 m-85 -138.09 135.41 35.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.6 tp -77.39 103.98 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -115.45 150.44 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 11.3 mttp -107.53 145.88 32.57 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.342 -0.848 . . . . 0.0 108.808 -179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 22' ' ' VAL . 18.1 mm-40 -114.49 162.08 17.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -104.29 122.99 46.57 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.577 -0.702 . . . . 0.0 109.829 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.525 ' O ' ' C ' ' A' ' 16' ' ' LYS . 1.2 mmt -69.97 152.23 44.68 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -8.69 -71.5 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.07 -15.8 0.78 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 20' ' ' LYS . 1.8 mmtp -50.34 125.94 13.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.927 -1.337 . . . . 0.0 109.256 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.73 -2.11 0.75 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -66.76 -174.51 0.32 Allowed 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.651 0.738 . . . . 0.0 109.72 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 20' ' ' LYS . 8.1 mt -140.48 158.47 43.96 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.2 t -126.69 116.09 22.65 Favored Pre-proline 0 N--CA 1.504 2.274 0 O-C-N 121.395 -0.815 . . . . 0.0 109.43 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -56.99 146.94 77.61 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.924 1.082 . . . . 0.0 110.424 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' NH1' ' HG2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -154.36 152.16 29.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' N ' ' O ' ' A' ' 36' ' ' VAL . 46.0 mt -106.6 140.78 38.94 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' H ' ' H ' ' A' ' 9' ' ' PHE . 12.7 tp -125.07 109.38 12.86 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.443 -0.786 . . . . 0.0 110.18 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.73 131.03 10.46 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 28' ' ' ILE . 3.9 mp -113.09 111.59 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.43 ' O ' HD11 ' A' ' 49' ' ' LEU . 1.8 m -92.62 168.65 11.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.994 -1.066 . . . . 0.0 109.366 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.0 pttp -75.41 -4.99 42.64 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -143.22 6.82 1.54 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 110.112 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.79 161.24 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.871 -1.143 . . . . 0.0 110.81 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 47' ' ' TRP . 87.6 t -117.03 149.22 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 7.8 ptp -141.46 152.24 44.06 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.676 -1.265 . . . . 0.0 111.518 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.563 HH21 HG22 ' A' ' 44' ' ' ILE . 30.9 mtm180 -91.53 136.88 32.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 25' ' ' LEU . 40.4 t -136.47 126.33 39.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.504 -0.748 . . . . 0.0 109.104 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -72.07 148.02 46.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 109.158 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.29 -21.38 23.21 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -73.64 -52.26 13.95 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.7 m -103.2 -4.62 24.12 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.682 -0.636 . . . . 0.0 110.596 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt 53.26 21.93 2.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.598 -1.314 . . . . 0.0 109.168 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -96.98 163.48 12.94 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.404 -0.81 . . . . 0.0 108.989 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -86.25 126.45 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.422 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.563 HG22 HH21 ' A' ' 35' ' ' ARG . 19.2 mm -100.4 -27.08 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.428 -0.795 . . . . 0.0 110.171 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.416 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 37.2 tt0 -156.23 166.26 33.97 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.74 -1.225 . . . . 0.0 111.052 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -140.01 140.7 36.28 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.502 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -140.01 154.04 47.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.192 -0.942 . . . . 0.0 109.537 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.6 p -87.9 142.27 27.93 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 29' ' ' THR . 4.8 mt -66.42 -26.88 67.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.128 -0.982 . . . . 0.0 109.239 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 p -75.27 -4.2 37.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 109.413 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -88.83 -26.94 21.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.0 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.9 mt -67.74 126.0 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.072 -1.017 . . . . 0.0 109.846 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -89.66 -49.16 6.82 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -152.65 176.74 11.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.31 -0.868 . . . . 0.0 109.346 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.9 p90 -157.88 171.36 20.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.68 121.93 9.59 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.18 112.15 24.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.104 -0.997 . . . . 0.0 110.188 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -89.16 162.41 37.61 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -60.66 3.1 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.15 1.233 . . . . 0.0 109.988 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 58' ' ' SER . 21.9 pttm -155.14 -8.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.901 -1.125 . . . . 0.0 111.428 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 m -142.32 167.38 22.25 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.05 -1.031 . . . . 0.0 111.606 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -130.94 140.63 50.19 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.9 m -132.23 140.76 48.78 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.185 -0.947 . . . . 0.0 109.532 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.56 155.8 48.98 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -130.8 132.87 45.51 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.608 -0.683 . . . . 0.0 109.488 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -99.05 -1.44 39.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 0.0 108.776 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.21 -6.75 49.12 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -90.13 100.77 13.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.345 -1.091 . . . . 0.0 109.461 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -46.48 -49.4 18.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.394 -0.817 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.615 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -48.6 -60.37 2.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -0.775 . . . . 0.0 109.194 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -58.63 -33.93 70.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.355 -0.84 . . . . 0.0 109.034 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.96 176.81 8.23 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 28.1 m-85 -72.26 157.88 36.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -1.171 . . . . 0.0 109.831 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -131.9 108.46 9.41 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.3 t -129.97 155.41 46.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.848 0.832 . . . . 0.0 110.236 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.2 m -151.19 172.26 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.514 ' OE1' ' N ' ' A' ' 77' ' ' GLN . 1.0 OUTLIER -78.09 146.73 35.03 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.958 -1.089 . . . . 0.0 110.471 -179.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 78.7 p -151.47 126.84 9.98 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -64.37 -29.48 70.55 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.088 -1.008 . . . . 0.0 108.709 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 82' ' ' GLU . 72.8 mm-40 -98.82 -65.58 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.584 0.707 . . . . 0.0 109.566 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.0 -31.06 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 80' ' ' GLU . 16.5 tt0 -77.68 -57.83 3.6 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -1.133 . . . . 0.0 108.828 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 56.6 mt-30 -51.5 -42.28 61.59 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.4 mm -51.86 -34.47 16.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.04 -34.41 24.27 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.77 -38.7 53.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.282 -0.886 . . . . 0.0 109.254 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.1 tp -67.97 -39.72 83.29 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.27 -50.03 20.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -59.94 -17.19 35.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 0.0 109.047 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.35 -29.57 32.94 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -85.57 -28.69 24.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.795 -1.415 . . . . 0.0 110.013 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -65.52 -25.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 110.617 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.43 -20.79 31.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 72.4 mt -87.07 -23.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 0.0 110.558 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.3 pt -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 108.936 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.2 mt -69.56 -24.45 63.71 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -46.07 64.12 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.148 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -55.52 -25.27 36.55 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.203 -0.935 . . . . 0.0 109.141 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -75.38 -46.3 33.87 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.349 -0.844 . . . . 0.0 109.353 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.385 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 44.7 m95 -66.33 177.24 1.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.887 . . . . 0.0 109.395 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.38 138.3 8.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.2 p -106.12 153.73 40.07 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.2 -22.99 59.64 Favored 'Trans proline' 0 C--N 1.321 -0.874 0 C-N-CA 120.888 1.059 . . . . 0.0 109.449 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt -48.01 158.49 0.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.363 179.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 1' ' ' LEU . 10.1 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -58.5 -7.39 0.91 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.295 -0.878 . . . . 0.0 108.925 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.0 m -164.45 44.85 0.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.701 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 5' ' ' GLY . 7.6 t80 58.07 87.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.422 -0.799 . . . . 0.0 110.799 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 4' ' ' TYR . . . 47.94 108.11 0.01 OUTLIER Glycine 0 N--CA 1.497 2.735 0 O-C-N 121.681 -0.637 . . . . 0.0 111.559 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.3 t -128.42 132.62 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.434 -1.039 . . . . 0.0 108.754 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -79.89 98.79 7.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.008 -1.057 . . . . 0.0 109.48 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.6 121.23 33.82 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -102.08 133.91 46.17 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.12 104.11 8.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 110.128 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.1 m -112.55 152.42 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -108.17 154.92 21.05 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.188 -0.945 . . . . 0.0 109.086 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 85.7 mt-10 -131.33 160.8 33.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 20' ' ' LYS . 0.1 OUTLIER -109.16 98.85 8.23 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 18' ' ' LYS . 2.7 mmt -77.51 152.82 33.93 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 122.09 0.947 . . . . 0.0 109.453 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' HZ2' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -55.29 -87.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.206 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.675 ' H ' ' HZ2' ' A' ' 16' ' ' LYS . . . -30.27 -31.46 0.01 OUTLIER Glycine 0 N--CA 1.497 2.741 0 N-CA-C 112.208 -0.357 . . . . 0.0 112.208 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -114.02 123.26 49.26 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.242 -1.152 . . . . 0.0 110.062 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -75.05 0.4 16.14 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -78.2 -173.56 3.28 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.583 -179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD22 HE22 ' A' ' 77' ' ' GLN . 1.0 OUTLIER -106.15 157.2 17.73 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 13' ' ' GLU . 54.4 t -126.86 114.04 22.24 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.517 -0.739 . . . . 0.0 109.05 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.97 147.86 71.65 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.892 1.062 . . . . 0.0 111.153 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.9 tpp180 -153.54 146.9 24.83 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' VAL . 80.2 mt -103.63 140.24 37.84 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.4 tp -120.2 107.92 13.59 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.428 -0.795 . . . . 0.0 109.964 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.29 126.17 7.51 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.8 mm -116.36 111.48 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 30' ' ' LYS . 1.5 m -99.71 170.06 8.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.144 -0.972 . . . . 0.0 109.579 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' THR . 14.3 ptpt -72.87 -16.69 61.58 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.391 -0.818 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -134.58 10.51 3.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.448 -0.782 . . . . 0.0 110.204 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -170.35 162.48 8.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.801 -1.187 . . . . 0.0 110.733 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 47' ' ' TRP . 48.9 t -117.83 147.73 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.8 mtt -135.33 149.04 49.64 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.936 -1.102 . . . . 0.0 111.075 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 15.4 mtm180 -93.33 130.26 39.14 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 25' ' ' LEU . 44.6 t -132.54 124.64 51.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -74.39 147.21 42.31 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.296 -0.877 . . . . 0.0 108.644 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -89.69 -22.74 22.09 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -69.11 -51.88 34.03 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.177 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 p -102.28 -2.59 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.696 -0.627 . . . . 0.0 110.135 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' O ' ' NZ ' ' A' ' 2' ' ' LYS . 44.4 mtpt 50.24 24.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.779 -1.201 . . . . 0.0 109.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 163.73 12.28 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.454 -0.779 . . . . 0.0 109.445 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.8 t -84.9 128.01 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.42 -26.9 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.492 -0.755 . . . . 0.0 110.319 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.448 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 21.6 tp60 -153.74 165.54 35.68 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.806 -1.184 . . . . 0.0 111.085 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 21.2 mt-10 -140.11 136.85 33.98 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.505 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 5.2 m0 -139.7 154.28 47.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.084 -1.01 . . . . 0.0 109.844 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 p -86.57 145.69 26.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.537 -0.727 . . . . 0.0 109.248 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mt -65.69 -31.42 72.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.113 -0.992 . . . . 0.0 108.831 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.1 p -68.86 -4.38 16.15 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.311 -0.868 . . . . 0.0 109.192 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -87.75 -32.06 19.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.433 -0.792 . . . . 0.0 109.621 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.17 121.7 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.915 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -89.66 -51.07 5.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.253 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -151.84 178.08 9.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.244 -0.91 . . . . 0.0 109.638 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 p90 -157.9 170.34 22.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.412 -0.805 . . . . 0.0 109.54 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.33 108.51 4.09 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.41 131.02 45.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.252 -0.905 . . . . 0.0 110.329 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.572 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -128.49 158.83 70.53 Favored Pre-proline 0 N--CA 1.49 1.54 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -61.08 23.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.226 0 C-N-CA 121.373 1.382 . . . . 0.0 111.016 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 58' ' ' SER . 16.3 pttm -149.7 -35.93 0.17 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.524 -1.36 . . . . 0.0 110.952 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.7 t -145.31 161.38 39.75 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.046 -1.034 . . . . 0.0 111.499 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -121.44 140.37 52.24 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.4 m -130.96 144.01 51.15 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.196 -0.94 . . . . 0.0 109.865 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.33 158.03 45.39 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -130.59 123.79 30.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.589 -0.694 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -93.28 -0.39 56.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 108.615 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.46 -3.1 43.12 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -86.04 93.03 8.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -1.024 . . . . 0.0 109.775 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -46.81 -44.53 19.34 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.309 -0.869 . . . . 0.0 109.435 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.411 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 2.8 pt20 -51.43 -55.1 20.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.438 -0.789 . . . . 0.0 109.812 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.411 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 8.0 t70 -69.79 -39.71 76.43 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.198 -0.939 . . . . 0.0 109.349 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.38 -177.0 54.53 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.19 159.76 33.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -1.121 . . . . 0.0 109.794 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -131.8 107.63 8.89 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 77.8 p -124.46 156.21 37.6 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.784 0.802 . . . . 0.0 110.599 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.8 m -152.45 172.44 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.472 HE22 HD22 ' A' ' 21' ' ' LEU . 33.0 mt-30 -78.33 140.68 38.77 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.16 -0.962 . . . . 0.0 110.018 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 80.6 p -151.33 124.62 8.82 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 38.7 m -71.67 -20.59 61.92 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.384 -0.823 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.503 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 7.2 pt-20 -149.22 52.7 0.96 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.465 -0.772 . . . . 0.0 109.312 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.9 -5.04 0.83 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.6 tt0 -62.94 -57.39 10.92 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.248 -1.148 . . . . 0.0 109.018 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.503 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 46.3 mt-30 -50.44 -45.21 55.77 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mt -52.95 -32.26 17.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.42 -27.45 27.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.563 -0.711 . . . . 0.0 109.368 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -83.55 -34.86 25.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.322 -0.861 . . . . 0.0 109.036 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 43.0 tp -71.67 -39.83 70.04 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.68 -50.68 22.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.56 -17.25 20.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.13 -28.08 29.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -85.23 -16.13 41.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.439 . . . . 0.0 109.6 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.6 mt -82.32 -28.25 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.53 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -84.68 -19.32 33.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.968 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.6 mt -86.91 -27.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 110.363 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 95' ' ' ILE . 7.1 pt -83.51 -41.0 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.149 -0.969 . . . . 0.0 108.994 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 mt -66.75 -21.61 66.06 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.346 0.593 . . . . 0.0 109.749 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 100' ' ' LYS . 38.0 tttp -78.58 -60.94 2.17 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.259 -0.901 . . . . 0.0 110.164 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -65.97 -52.28 50.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.297 -0.877 . . . . 0.0 110.783 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -6.21 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 110.141 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 0.0 109.692 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.325 0.583 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 37.8 m95 -63.18 177.87 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.407 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -148.88 136.9 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -137.79 155.52 74.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -61.77 -23.77 76.6 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 121.012 1.141 . . . . 0.0 110.101 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 mt -47.55 116.85 1.57 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 11.2 p80 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.482 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.384 0.612 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 3.0 mptp? -67.82 0.71 3.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.411 -0.806 . . . . 0.0 109.256 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 2' ' ' LYS . 7.2 m -166.52 56.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.709 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -102.74 129.6 49.43 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.385 -0.822 . . . . 0.0 109.326 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.3 -9.24 55.51 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.74 139.29 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -1.115 . . . . 0.0 109.309 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 p -86.85 102.94 14.78 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.173 -0.954 . . . . 0.0 109.795 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 p90 -86.14 126.51 34.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.82 -0.55 . . . . 0.0 109.907 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -108.46 128.74 55.05 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.369 -0.832 . . . . 0.0 108.994 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.92 115.47 17.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.985 -1.072 . . . . 0.0 109.063 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 78' ' ' THR . 13.1 m -126.57 152.19 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.61 144.06 35.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.426 -0.796 . . . . 0.0 108.935 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.543 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 69.7 mt-10 -116.81 160.68 20.45 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.61 113.71 27.38 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.712 0.768 . . . . 0.0 108.973 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' C ' ' A' ' 16' ' ' LYS . 36.2 mmm -69.76 151.88 45.27 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.731 -0.605 . . . . 0.0 109.433 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -1.84 -72.87 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 C-N-CA 123.324 0.649 . . . . 0.0 112.675 -178.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -143.23 -5.01 0.75 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -50.01 124.73 10.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.976 -1.308 . . . . 0.0 108.934 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.04 -6.81 2.09 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -74.64 -174.15 2.02 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.048 0.927 . . . . 0.0 109.904 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -140.11 158.52 43.93 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.51 112.6 31.0 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -58.53 149.37 75.82 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.868 1.045 . . . . 0.0 109.966 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.2 tpp180 -153.52 144.47 22.81 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -102.28 140.09 37.03 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.6 tp -125.98 107.9 10.89 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.313 -0.867 . . . . 0.0 109.964 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 34' ' ' MET . . . -90.2 127.62 8.86 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.5 mm -104.23 112.1 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.533 -0.981 . . . . 0.0 108.594 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.496 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.6 OUTLIER -90.62 169.34 11.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.924 -1.11 . . . . 0.0 109.052 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -70.69 -18.17 62.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.251 -0.906 . . . . 0.0 109.69 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.15 9.02 4.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.579 -0.701 . . . . 0.0 110.449 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -172.34 161.59 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 110.935 -179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.6 t -115.47 143.06 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.496 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -121.22 149.32 43.02 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.944 -1.098 . . . . 0.0 111.662 -178.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.597 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.1 mtm180 -92.73 115.44 28.11 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.1 t -120.57 118.78 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.689 -0.632 . . . . 0.0 109.546 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 26.6 t0 -67.66 148.31 51.52 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.5 tm-20 -89.18 -21.35 23.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -72.11 -50.81 25.06 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.419 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 p -105.5 -2.83 23.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.786 -0.571 . . . . 0.0 110.692 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt 50.73 23.27 1.33 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.511 -1.368 . . . . 0.0 108.767 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.1 156.71 17.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 0.0 109.143 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.4 t -82.69 122.55 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.597 ' CG2' HH21 ' A' ' 35' ' ' ARG . 14.2 mm -98.13 -28.16 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.461 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 42.0 tt0 -161.52 165.99 27.75 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.744 -1.222 . . . . 0.0 110.932 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 29.5 mt-10 -132.61 151.25 52.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.457 0.646 . . . . 0.0 109.966 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 8.8 m0 -139.29 153.85 47.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.4 -0.812 . . . . 0.0 109.146 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -86.53 142.37 28.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.99 . . . . 0.0 109.069 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.37 -26.37 65.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.078 -1.014 . . . . 0.0 109.025 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -77.22 -4.89 47.06 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.308 -0.87 . . . . 0.0 109.633 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.417 HD22 ' N ' ' A' ' 51' ' ' ASN . 1.2 m-80 -88.02 -33.5 18.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.193 -0.942 . . . . 0.0 109.708 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.4 mt -56.26 126.12 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -0.97 . . . . 0.0 109.369 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -96.21 -50.44 4.81 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.335 -0.853 . . . . 0.0 109.79 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -150.47 176.75 10.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.116 -0.99 . . . . 0.0 109.61 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 18.8 p90 -158.4 171.4 20.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.509 -0.744 . . . . 0.0 109.708 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.421 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.06 118.77 7.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.06 107.07 19.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.205 -0.934 . . . . 0.0 109.995 -179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 60' ' ' LYS . 2.2 m -93.69 155.35 40.62 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.59 3.22 0.15 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.178 1.252 . . . . 0.0 110.301 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 58' ' ' SER . 35.3 pttt -146.9 -15.63 0.41 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.898 -1.126 . . . . 0.0 111.271 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.3 p -142.89 162.9 34.23 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.033 -1.042 . . . . 0.0 111.779 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -129.18 141.03 51.28 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.8 m -135.49 149.08 49.43 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.12 -0.988 . . . . 0.0 110.171 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pp -143.86 154.0 42.92 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -128.91 125.53 37.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.583 -0.698 . . . . 0.0 109.899 -178.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CZ ' HD13 ' A' ' 64' ' ' LEU . 62.4 m-85 -93.54 0.57 56.7 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.76 -3.21 87.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 p30 -74.61 100.86 4.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.358 -1.084 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -66.68 -37.84 85.57 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.386 -0.821 . . . . 0.0 109.427 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' ' N ' ' A' ' 71' ' ' ASP . 1.6 pp0? -70.27 -50.28 41.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.475 -0.766 . . . . 0.0 110.469 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' N ' ' CD ' ' A' ' 70' ' ' GLN . 6.6 t70 -64.75 -38.65 91.72 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.096 -1.002 . . . . 0.0 109.588 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.67 -178.33 35.07 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.4 m-85 -81.8 176.51 9.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -1.149 . . . . 0.0 110.069 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -131.77 107.99 9.15 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.5 t -126.45 148.76 49.61 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.729 0.776 . . . . 0.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.8 m -151.99 171.3 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -79.21 140.75 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.115 -0.991 . . . . 0.0 109.685 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 11' ' ' VAL . 77.7 p -151.37 121.39 7.15 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 28.1 m -64.87 -29.1 70.03 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.342 -0.849 . . . . 0.0 108.868 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.537 ' OE2' ' NE2' ' A' ' 83' ' ' GLN . 4.6 mm-40 -104.84 -70.62 0.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.554 0.693 . . . . 0.0 109.248 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.87 -35.68 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 80' ' ' GLU . 10.3 tt0 -66.53 -57.26 7.66 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.308 -1.113 . . . . 0.0 108.835 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.537 ' NE2' ' OE2' ' A' ' 80' ' ' GLU . 48.9 mt-30 -50.33 -47.74 55.71 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.2 mt -53.27 -31.42 18.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.44 -25.45 28.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -82.16 -38.48 24.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 91' ' ' TYR . 42.7 tp -69.67 -43.1 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.93 -49.19 65.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.93 -17.17 22.02 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -89.19 -31.0 12.45 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 87' ' ' LEU . 22.6 m-85 -81.36 -22.32 38.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.767 -1.431 . . . . 0.0 109.237 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.8 mt -75.59 -24.56 17.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 110.35 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -84.21 -19.31 34.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.192 -0.942 . . . . 0.0 109.898 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.73 -23.61 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -0.925 . . . . 0.0 110.386 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.74 -31.33 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.85 -21.39 51.49 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.674 -0.641 . . . . 0.0 109.913 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' LYS . 26.7 tttt -80.77 -53.6 6.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.853 . . . . 0.0 110.513 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -45.8 -42.97 12.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 110.344 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -75.4 -5.68 46.16 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.034 -1.041 . . . . 0.0 109.716 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 97' ' ' LYS . 75.8 tttt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.478 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.314 0.578 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 31.3 m95 -72.44 -170.68 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.267 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.21 137.41 13.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 26.8 p -133.81 150.47 74.71 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -58.39 -19.43 43.41 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 120.841 1.028 . . . . 0.0 109.897 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.2 mt -49.42 97.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.483 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' B' ' 6' ' ' PRO . 74.0 m-70 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.471 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.0 mptt 46.77 15.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.287 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 1' ' ' LEU . 9.2 m -167.86 59.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -148.84 131.24 15.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.271 -0.893 . . . . 0.0 109.527 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.59 -9.11 30.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.29 140.13 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.305 -1.115 . . . . 0.0 109.4 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 m -87.82 104.34 16.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 110.001 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 1.5 p90 -86.16 120.93 28.06 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -102.2 127.54 49.1 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.02 104.22 8.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.4 m -111.5 154.22 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -107.52 137.44 45.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.245 -0.91 . . . . 0.0 109.422 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 50.4 mt-10 -104.1 161.07 14.32 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.506 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -114.73 108.7 17.13 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 18' ' ' LYS . 61.2 mmm -70.57 152.59 43.78 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.101 0.953 . . . . 0.0 109.953 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.669 ' HZ2' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -60.89 -90.19 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.715 -179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.669 ' H ' ' HZ2' ' A' ' 16' ' ' LYS . . . -40.56 -35.05 0.78 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -96.82 123.72 40.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.17 -1.194 . . . . 0.0 109.959 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -74.95 0.38 15.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 18' ' ' LYS . 1.3 tppt? -67.89 -173.36 0.35 Allowed 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.688 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.9 mt -123.34 158.27 31.41 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 13' ' ' GLU . 2.5 t -128.73 115.32 19.3 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.512 -0.743 . . . . 0.0 109.025 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -56.51 148.14 65.06 Favored 'Trans proline' 0 N--CA 1.479 0.666 0 C-N-CA 120.982 1.122 . . . . 0.0 110.934 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.3 tpp180 -153.35 141.25 20.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -99.75 140.62 33.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -127.86 108.58 10.83 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.322 -0.861 . . . . 0.0 110.332 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.31 124.76 6.6 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.0 mm -103.92 111.27 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.454 -1.027 . . . . 0.0 108.725 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 m -111.07 163.99 13.29 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -73.36 -23.66 60.24 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.306 -0.871 . . . . 0.0 109.556 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -99.12 -18.04 17.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.363 -0.835 . . . . 0.0 110.555 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.8 165.35 4.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.552 -1.343 . . . . 0.0 111.001 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 80.0 t -99.35 133.7 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.9 mtp -102.27 135.3 44.12 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.957 -1.089 . . . . 0.0 110.944 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.5 mtm180 -93.96 116.14 28.56 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -125.32 126.81 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.902 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 30.5 t0 -70.22 147.76 49.4 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 8.8 tm-20 -89.5 -22.55 22.39 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -77.75 -49.4 14.46 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.047 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -96.79 -7.67 33.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.669 -0.644 . . . . 0.0 110.112 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? 49.95 22.49 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.827 -1.171 . . . . 0.0 109.29 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.74 161.79 14.77 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.483 -0.761 . . . . 0.0 109.171 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.59 124.04 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.463 -0.773 . . . . 0.0 108.971 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 mm -98.16 -31.39 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.898 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.1 tt0 -170.56 165.3 8.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.2 mt-10 -132.81 160.32 37.24 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.581 ' CE3' ' CZ ' ' A' ' 66' ' ' PHE . 61.3 m95 -139.53 143.21 37.31 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.375 -0.828 . . . . 0.0 109.701 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 m -76.26 131.54 39.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 109.237 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -60.11 -34.96 74.21 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.872 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 p -69.1 -3.71 14.4 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.63 -34.65 17.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.379 -0.826 . . . . 0.0 109.891 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.74 116.95 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.92 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -83.3 -51.29 7.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 108.925 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -150.05 178.85 8.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.401 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 24.2 p90 -157.81 170.57 22.05 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.427 -0.795 . . . . 0.0 109.183 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -148.23 113.07 5.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.93 117.93 34.56 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 110.361 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.562 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.7 m -103.02 156.58 35.14 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.39 8.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.301 1.334 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 58' ' ' SER . 14.9 pttp -145.93 -32.59 0.35 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.677 -1.264 . . . . 0.0 111.185 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' A' ' 78' ' ' THR . 92.7 p -131.36 166.65 20.79 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-O 122.141 0.972 . . . . 0.0 111.732 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.87 140.78 52.09 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -133.4 133.69 42.71 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.254 -0.904 . . . . 0.0 109.25 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -124.81 155.11 39.92 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.32 130.46 44.5 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.561 -0.712 . . . . 0.0 109.722 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.581 ' CZ ' ' CE3' ' A' ' 47' ' ' TRP . 68.7 m-85 -97.15 -2.6 42.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.41 -6.04 65.92 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.42 88.0 7.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.332 -1.099 . . . . 0.0 109.672 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -46.31 -43.08 15.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 109.361 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.673 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -53.11 -58.79 5.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.535 -0.728 . . . . 0.0 109.487 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.28 -36.25 79.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.224 -0.922 . . . . 0.0 109.323 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.54 175.43 50.27 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.527 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 46.2 m-85 -76.1 165.95 24.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.877 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -132.14 107.85 8.89 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -127.32 154.91 44.36 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.826 0.822 . . . . 0.0 110.4 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -152.3 172.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -78.4 134.38 37.41 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.112 -0.992 . . . . 0.0 109.23 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.427 ' H ' ' HA ' ' A' ' 61' ' ' SER . 25.9 p -151.15 120.74 6.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 0.0 109.256 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.2 m -74.6 -20.4 59.93 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 56.1 mt-10 -113.38 27.4 9.61 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.272 0.558 . . . . 0.0 109.533 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -46.61 -17.76 0.29 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.3 tt0 -79.78 -57.58 3.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.456 -1.026 . . . . 0.0 108.643 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.9 mt-30 -52.42 -47.36 66.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 41.7 mt -54.39 -27.86 17.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -83.69 -30.82 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -79.19 -37.4 38.36 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 91' ' ' TYR . 41.6 tp -70.21 -41.89 73.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.8 mm -68.89 -52.5 33.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.58 -17.58 34.05 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.96 -26.02 32.79 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 87' ' ' LEU . 16.4 m-85 -83.77 -26.5 29.59 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.775 -1.427 . . . . 0.0 109.278 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.6 mt -72.11 -25.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.238 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -84.59 -20.96 30.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.379 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.0 mt -86.72 -25.31 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.203 -0.936 . . . . 0.0 110.465 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 95' ' ' ILE . 12.4 pt -84.23 -29.61 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.11 -0.994 . . . . 0.0 109.596 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.491 HD11 ' H ' ' B' ' 7' ' ' LEU . 4.2 mt -78.2 -34.42 49.45 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.617 -0.677 . . . . 0.0 110.599 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.461 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 19.5 ptmt -69.37 -45.47 69.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.929 -1.107 . . . . 0.0 109.47 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 10.9 mptt -53.07 -42.46 65.86 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.176 -0.953 . . . . 0.0 108.706 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -71.79 -19.95 61.93 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.369 -0.832 . . . . 0.0 109.89 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.298 -179.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 66.7 m . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 42.5 m95 -157.37 177.26 11.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 109.2 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 2.1 p -154.78 138.8 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.66 162.49 31.56 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -62.34 -88.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 121.092 1.195 . . . . 0.0 109.236 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.491 ' H ' HD11 ' A' ' 96' ' ' LEU . 66.5 mt 38.82 88.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.518 ' ND1' ' OXT' ' B' ' 8' ' ' HIS . 7.0 p80 . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.433 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.457 0.646 . . . . 0.0 109.292 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER -72.56 16.97 0.12 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.512 -0.743 . . . . 0.0 109.251 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 1' ' ' LEU . 0.9 OUTLIER -160.4 59.45 0.34 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -77.15 93.34 3.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 0.0 109.852 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.75 55.13 32.51 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.3 139.01 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.53 -0.982 . . . . 0.0 109.041 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -89.09 114.88 26.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.075 -1.016 . . . . 0.0 109.991 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.29 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 31.8 m-85 -142.89 124.91 15.24 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.17 103.73 7.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 0.0 109.623 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.502 HG12 HG22 ' A' ' 78' ' ' THR . 15.5 m -115.81 152.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mttt -107.69 147.14 31.13 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 55.8 mt-10 -119.63 160.99 21.42 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.508 0.67 . . . . 0.0 109.489 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 4.9 mmmm -106.42 100.22 9.76 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -69.48 150.56 47.06 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.243 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 12.53 -77.22 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 123.274 0.63 . . . . 0.0 112.136 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -153.31 6.09 0.4 Allowed Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -47.87 125.03 8.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.916 -1.343 . . . . 0.0 109.188 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -60.43 -6.7 1.67 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -84.24 -173.07 4.51 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.984 0.897 . . . . 0.0 109.469 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -133.89 157.47 45.91 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.447 HG21 ' SD ' ' A' ' 15' ' ' MET . 42.6 t -120.92 112.82 33.3 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.282 -0.886 . . . . 0.0 109.707 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -58.47 149.55 74.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.0 1.133 . . . . 0.0 110.421 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 9.9 tpp180 -153.98 146.26 23.86 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.1 mt -105.08 140.52 38.13 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 20.9 tp -124.98 107.88 11.28 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.33 -0.856 . . . . 0.0 109.895 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.99 121.31 5.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.7 mm -97.91 111.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.193 -1.181 . . . . 0.0 108.574 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' CYS . 1.1 m -94.48 167.96 11.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.99 . . . . 0.0 109.146 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -73.69 -8.61 56.67 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -138.84 6.22 2.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.428 -0.795 . . . . 0.0 110.263 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.07 160.56 4.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.755 -1.216 . . . . 0.0 110.722 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 98.8 t -105.83 131.21 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 8.6 mtp -102.69 137.8 40.42 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.982 -1.074 . . . . 0.0 110.919 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HE ' ' CB ' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.43 120.06 33.26 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.5 t -127.68 128.05 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.763 . . . . 0.0 110.056 -178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 12.4 t0 -68.96 148.73 49.72 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.8 tm-20 -87.91 -19.97 26.6 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -77.01 -51.32 11.3 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.582 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -102.09 -4.78 25.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.1 mtmm 50.96 20.13 0.75 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.492 -1.38 . . . . 0.0 109.286 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -100.75 156.89 17.08 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.372 -0.83 . . . . 0.0 108.943 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.5 t -76.73 126.31 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.514 -0.741 . . . . 0.0 109.493 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.38 -22.38 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.516 -0.74 . . . . 0.0 109.942 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.474 ' CB ' ' HE ' ' A' ' 35' ' ' ARG . 6.2 tp60 -169.58 165.72 10.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.101 -0.999 . . . . 0.0 110.094 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 16.1 mt-10 -142.14 158.03 44.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.548 -0.72 . . . . 0.0 109.659 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.497 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 10.0 m0 -139.1 153.48 48.03 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.486 -0.759 . . . . 0.0 109.068 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 m -85.7 139.8 31.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 109.629 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -28.71 68.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 109.102 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.4 m -80.28 -3.92 51.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.348 -0.845 . . . . 0.0 109.96 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -97.48 -6.04 34.67 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 0.0 109.9 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.9 mt -79.5 123.31 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.044 -1.035 . . . . 0.0 109.797 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -83.02 -51.46 7.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.868 . . . . 0.0 109.002 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' B' ' 4' ' ' PTR . 0.0 OUTLIER -165.83 172.51 11.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -147.32 172.93 13.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 0.0 109.743 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -143.93 116.87 8.82 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.57 108.44 21.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.369 -0.832 . . . . 0.0 109.72 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -90.68 160.63 38.28 Favored Pre-proline 0 N--CA 1.486 1.36 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.85 -6.96 1.97 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.256 1.304 . . . . 0.0 110.121 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 78' ' ' THR . 4.9 ptpt -139.31 -32.55 0.65 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.165 -0.959 . . . . 0.0 111.057 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' SER . 13.5 t -121.01 167.61 12.41 Favored 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 122.056 0.931 . . . . 0.0 111.242 -178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.497 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 11.0 t80 -150.22 137.64 19.72 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.6 t -141.8 149.65 40.64 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.023 -1.048 . . . . 0.0 110.816 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' CD2' ' CE2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -115.31 163.5 15.6 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -130.74 119.96 23.12 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.521 -0.737 . . . . 0.0 109.791 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 64' ' ' LEU . 74.5 m-85 -96.64 -0.59 48.29 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.41 0.66 90.06 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.9 p30 -74.64 87.8 2.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.375 -1.073 . . . . 0.0 109.756 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -51.92 -41.59 62.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 108.589 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -60.93 -71.06 0.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.701 -0.625 . . . . 0.0 109.557 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -56.86 -30.92 64.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.395 -0.815 . . . . 0.0 109.339 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.81 -175.86 54.76 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -73.89 177.42 5.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.413 -1.051 . . . . 0.0 109.999 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -131.02 107.28 8.97 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.3 t -121.03 148.63 43.87 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.709 0.766 . . . . 0.0 110.945 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.4 m -152.19 166.63 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -79.31 131.34 36.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 0.0 109.813 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.502 HG22 HG12 ' A' ' 11' ' ' VAL . 30.1 p -147.29 121.28 9.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.3 m -74.32 -25.43 59.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 54.8 mt-10 -108.24 30.29 6.55 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.578 0.704 . . . . 0.0 109.135 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -44.78 -22.36 0.42 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 80' ' ' GLU . 10.5 tt0 -76.75 -57.61 3.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.37 -1.076 . . . . 0.0 109.331 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.0 mt-30 -52.02 -47.46 64.97 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.9 mt -53.9 -33.14 23.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.56 -22.23 30.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.289 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -82.66 -37.6 24.62 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.326 -0.859 . . . . 0.0 109.205 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.422 HD11 ' CE2' ' A' ' 91' ' ' TYR . 31.1 tp -72.48 -40.57 66.83 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 56.1 mt -70.76 -47.93 60.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.69 -17.23 54.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.148 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.64 -24.42 35.97 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' HD11 ' A' ' 87' ' ' LEU . 21.3 m-85 -83.83 -24.71 30.83 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.799 -1.412 . . . . 0.0 109.349 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.01 -25.41 27.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 110.135 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -84.64 -19.82 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 0.0 110.059 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.6 mt -86.65 -23.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.52 -34.61 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.883 . . . . 0.0 108.902 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.0 mt -79.95 -23.05 41.95 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.742 -0.599 . . . . 0.0 109.518 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.47 -51.61 64.89 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.0 109.015 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -70.09 -50.71 38.08 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -58.35 -5.97 0.59 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.314 -0.866 . . . . 0.0 110.437 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 120.985 -1.072 . . . . 0.0 109.613 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.59 ' CE3' ' HB2' ' A' ' 56' ' ' ALA . 45.0 m95 -87.54 179.81 6.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.333 -0.854 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.06 137.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . 0.419 ' OH ' ' NH1' ' A' ' 54' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 164.5 20.65 Favored Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' B' ' 7' ' ' LEU . 4.9 Cg_endo -61.16 -90.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.146 1.23 . . . . 0.0 109.586 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' B' ' 6' ' ' PRO . 61.9 mt 46.67 -174.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.075 -1.015 . . . . 0.0 109.9 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.299 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.607 ' N ' HD22 ' A' ' 1' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.544 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.9 mptt -69.37 12.89 0.14 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.478 -0.763 . . . . 0.0 109.467 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -153.83 57.61 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.184 -0.947 . . . . 0.0 109.346 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -87.33 128.67 35.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.474 -0.766 . . . . 0.0 109.589 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.78 44.43 31.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 88.6 t -128.15 133.07 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.629 -0.924 . . . . 0.0 109.261 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 106.43 14.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.667 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -90.56 155.26 19.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.686 -0.634 . . . . 0.0 109.355 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -140.46 133.48 29.34 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.8 tp -76.58 109.25 10.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.979 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.7 m -124.31 152.69 30.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -106.87 144.01 34.13 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.255 -0.903 . . . . 0.0 108.783 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -113.9 161.35 17.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.53 99.15 7.97 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.87 ' H ' ' HZ2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -70.85 154.83 41.49 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 15.62 -77.73 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.732 0 CA-C-O 121.159 0.504 . . . . 0.0 112.015 -177.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -167.61 16.11 0.07 OUTLIER Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.778 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.87 ' HZ2' ' H ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -55.06 134.09 49.04 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.571 -1.546 . . . . 0.0 108.7 179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 9.0 p30 -55.97 -10.46 0.8 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -83.96 -173.54 4.78 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.927 0.87 . . . . 0.0 109.73 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' C ' ' HZ1' ' A' ' 18' ' ' LYS . 1.2 mp -134.59 159.13 42.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.4 t -115.57 112.99 42.97 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.247 -0.908 . . . . 0.0 109.45 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.01 148.74 75.17 Favored 'Trans proline' 0 N--CA 1.48 0.691 0 C-N-CA 121.078 1.185 . . . . 0.0 110.301 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -154.97 149.02 25.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.846 . . . . 0.0 109.205 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.99 128.68 54.57 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.37 108.72 20.21 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.352 -0.842 . . . . 0.0 110.374 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.13 141.84 22.67 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.14 111.39 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' CYS . 2.5 p -100.81 168.98 9.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.316 -0.865 . . . . 0.0 108.981 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 30' ' ' LYS . 13.5 ptpt -72.11 -11.21 60.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.35 -0.844 . . . . 0.0 110.171 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -130.87 6.73 4.68 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.418 -0.801 . . . . 0.0 110.616 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -172.35 172.79 4.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.643 -1.286 . . . . 0.0 111.162 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.77 142.42 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.4 mtt -133.62 147.97 51.52 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.778 -1.202 . . . . 0.0 111.631 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HE ' ' HB2' ' A' ' 45' ' ' GLN . 13.9 mtm180 -94.17 121.89 36.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.88 124.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -64.29 148.09 51.01 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 0.0 109.146 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -89.97 -21.66 22.32 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -74.9 -52.49 11.13 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.604 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.4 p -102.09 -2.86 28.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.649 -0.657 . . . . 0.0 110.433 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt 52.79 20.81 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.574 -1.329 . . . . 0.0 108.607 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.16 163.79 12.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.338 -0.852 . . . . 0.0 109.508 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.12 130.99 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.712 -0.617 . . . . 0.0 109.673 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.8 mm -110.29 -29.38 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.572 -0.705 . . . . 0.0 110.117 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.4 tp60 -148.51 165.81 30.09 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.869 -1.144 . . . . 0.0 110.614 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 23.2 mt-10 -145.02 137.65 26.2 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.518 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 6.5 m0 -139.28 153.26 47.76 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.217 -0.927 . . . . 0.0 109.493 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.408 ' HG ' ' CG ' ' A' ' 51' ' ' ASN . 2.1 p -87.81 146.22 25.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.343 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.66 -27.55 64.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.23 -0.919 . . . . 0.0 109.036 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.3 p -74.94 -9.52 58.62 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.262 -0.898 . . . . 0.0 109.65 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 48' ' ' SER . 3.7 m-20 -88.87 -20.73 24.23 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.176 -0.952 . . . . 0.0 109.721 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.63 120.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.049 -1.032 . . . . 0.0 109.435 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -86.39 -49.76 7.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 109.388 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -156.29 177.66 11.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.26 170.41 22.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.882 . . . . 0.0 109.673 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.18 114.28 5.83 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.81 121.21 40.95 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.195 -0.941 . . . . 0.0 110.157 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.3 m -111.7 157.05 40.5 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -60.05 22.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 121.301 1.334 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 58' ' ' SER . 13.2 pttp -153.91 -35.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.549 -1.345 . . . . 0.0 110.834 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.1 p -139.2 164.37 29.99 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.045 0.926 . . . . 0.0 111.642 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -122.32 140.83 52.2 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -132.2 137.09 47.46 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.172 -0.955 . . . . 0.0 109.421 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -129.6 159.62 35.8 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -130.09 132.79 46.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -104.71 -2.8 24.46 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.57 -1.63 76.54 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -89.22 90.39 8.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.306 -1.114 . . . . 0.0 109.84 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -48.17 -39.38 20.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.045 -1.034 . . . . 0.0 109.012 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 70' ' ' GLN . 7.8 mm100 -51.87 -68.46 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -61.19 -29.96 70.13 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.6 -178.48 38.94 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -70.66 164.99 23.84 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.329 -1.101 . . . . 0.0 109.609 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -131.89 108.2 9.24 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -129.9 154.47 47.28 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.39 -0.819 . . . . 0.0 110.096 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.95 172.18 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -78.21 133.22 37.77 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.403 ' OG1' ' CA ' ' A' ' 81' ' ' GLY . 5.5 p -150.29 127.91 11.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.467 -0.771 . . . . 0.0 109.365 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 95.5 m -78.59 -21.38 48.68 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 69.8 mt-10 -116.18 30.94 7.03 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.327 0.584 . . . . 0.0 109.533 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' CA ' ' OG1' ' A' ' 78' ' ' THR . . . -49.7 -15.05 0.78 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 80' ' ' GLU . 21.3 tt0 -79.04 -57.67 3.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.396 -1.061 . . . . 0.0 108.822 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.483 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 51.0 mt-30 -53.35 -46.81 69.7 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mt -54.11 -28.37 17.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.09 -30.45 25.97 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -81.21 -36.7 29.72 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.403 -0.811 . . . . 0.0 109.018 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.52 -42.06 79.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.01 -52.03 21.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.99 -17.2 15.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.366 -0.834 . . . . 0.0 108.937 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.27 -25.59 33.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -84.68 -28.32 26.46 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.815 -1.403 . . . . 0.0 109.435 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 85.9 mt -65.11 -25.61 37.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.351 -0.843 . . . . 0.0 110.213 -179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -85.08 -21.22 29.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.907 . . . . 0.0 110.084 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.2 mt -86.92 -21.57 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 110.419 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 95' ' ' ILE . 13.7 pt -83.36 -32.96 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.143 -0.973 . . . . 0.0 109.022 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.8 mt -80.5 -24.48 39.37 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.299 0.571 . . . . 0.0 109.492 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.17 -26.19 66.52 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -71.09 -51.78 23.21 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.156 -0.965 . . . . 0.0 109.524 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -70.01 -46.29 65.42 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.245 -0.909 . . . . 0.0 109.723 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.575 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.0 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.521 ' CD1' ' O ' ' B' ' 1' ' ' SER . 39.6 m95 -162.32 179.5 7.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 109.139 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.85 139.34 15.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.61 162.4 57.9 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.28 -25.22 80.16 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.091 1.194 . . . . 0.0 109.495 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 27.3 mt -46.64 118.33 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.517 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 13.2 p80 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.479 -179.903 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 3' ' ' THR . 30.3 mt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.431 0.634 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.6 OUTLIER -71.46 14.19 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.409 -0.807 . . . . 0.0 109.187 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 1' ' ' LEU . 1.2 t -151.21 49.35 0.84 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 109.559 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 6' ' ' VAL . 9.6 t80 -79.21 -179.23 6.61 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' N ' ' CD2' ' A' ' 4' ' ' TYR . . . -63.87 68.7 0.05 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' N ' ' O ' ' A' ' 4' ' ' TYR . 66.1 t -105.62 139.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.96 . . . . 0.0 109.193 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 m -84.52 117.06 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -97.36 120.91 38.59 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -102.7 135.35 44.51 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt -79.66 120.65 24.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.122 -0.986 . . . . 0.0 109.313 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 24' ' ' ARG . 16.7 m -130.13 154.41 40.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -108.16 154.99 20.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.808 . . . . 0.0 108.827 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.578 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 53.9 mt-10 -126.87 160.86 29.7 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -105.0 113.1 26.5 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.523 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.7 mmt -69.7 151.47 45.81 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.523 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 1.15 -69.49 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.673 0 C-N-CA 123.357 0.663 . . . . 0.0 112.537 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -148.75 -4.37 0.29 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 20' ' ' LYS . 7.7 mmmt -50.08 124.88 10.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.976 -1.308 . . . . 0.0 109.039 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -60.8 -7.71 2.52 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -70.05 -174.15 0.75 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.649 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 20' ' ' LYS . 5.0 mt -139.49 157.39 45.91 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.91 112.6 28.67 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.331 -0.856 . . . . 0.0 109.047 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -58.1 148.86 75.29 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.986 1.124 . . . . 0.0 110.302 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.578 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.7 tpp180 -153.87 146.52 24.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.6 mt -102.4 139.12 38.42 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' O ' HD13 ' A' ' 28' ' ' ILE . 12.7 tp -124.08 109.22 13.22 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.285 -0.884 . . . . 0.0 110.391 -177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.92 130.33 9.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.11 111.43 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' LYS . 2.3 m -103.31 172.18 6.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 29' ' ' THR . 13.6 pttt -77.19 -13.89 59.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.374 -0.829 . . . . 0.0 109.335 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -125.35 -0.28 7.65 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.67 -0.644 . . . . 0.0 110.643 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.59 162.71 4.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.693 -1.254 . . . . 0.0 110.851 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' TRP . 73.8 t -121.17 148.23 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.4 ' CE ' HG22 ' A' ' 43' ' ' VAL . 9.5 ptm -141.34 151.31 43.45 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.748 -1.22 . . . . 0.0 111.533 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 HH21 HG22 ' A' ' 44' ' ' ILE . 14.2 mtm180 -92.71 135.95 33.66 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.2 t -136.42 123.43 32.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 24.3 t0 -71.04 147.55 48.45 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 109.052 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 12.2 tm-20 -90.38 -24.82 20.69 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -68.47 -52.17 35.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.441 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.9 p -102.13 -2.52 29.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.659 -0.65 . . . . 0.0 110.276 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt 50.98 25.58 2.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.698 -1.251 . . . . 0.0 108.874 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -103.67 163.87 12.04 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.557 -0.714 . . . . 0.0 109.393 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG22 ' CE ' ' A' ' 34' ' ' MET . 82.7 t -85.7 124.33 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.534 -0.729 . . . . 0.0 109.42 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.582 HG22 HH21 ' A' ' 35' ' ' ARG . 19.6 mm -101.1 -26.07 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.382 -0.824 . . . . 0.0 110.362 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HB2' ' HE ' ' A' ' 35' ' ' ARG . 13.1 tp60 -154.5 165.83 35.21 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.703 -1.248 . . . . 0.0 110.926 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 19.7 mt-10 -139.56 141.18 37.24 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.478 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 87.9 m95 -140.1 153.72 46.81 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.02 -1.05 . . . . 0.0 110.248 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -86.89 140.39 29.69 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -66.06 -26.64 67.59 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.77 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.6 p -79.08 -3.93 47.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 0.0 109.817 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -88.79 -30.09 19.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 109.714 -179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.0 mt -54.44 116.72 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.36 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -87.53 -49.39 7.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.934 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -152.94 175.78 12.56 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.09 -1.006 . . . . 0.0 109.434 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 11.9 p90 -157.71 171.14 20.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.755 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.04 109.64 4.42 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.44 109.65 22.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.121 -0.987 . . . . 0.0 110.016 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -96.89 159.16 32.15 Favored Pre-proline 0 N--CA 1.486 1.348 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -59.01 3.64 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.486 1.457 . . . . 0.0 110.618 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 58' ' ' SER . 22.4 pttm -146.91 -13.45 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.853 -1.154 . . . . 0.0 111.497 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.6 t -145.19 160.8 40.89 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.937 -1.102 . . . . 0.0 111.442 -178.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -129.34 140.39 51.4 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.1 m -137.15 144.36 42.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.078 -1.014 . . . . 0.0 109.751 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -137.23 155.0 50.04 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -129.79 124.73 34.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.649 -0.657 . . . . 0.0 109.299 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 47' ' ' TRP . 66.7 m-85 -85.91 2.18 47.05 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.68 -11.02 67.62 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.947 -1.661 . . . . 0.0 108.947 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -87.42 75.92 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -1.147 . . . . 0.0 109.681 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -46.6 -40.06 12.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.971 . . . . 0.0 109.185 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.627 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -54.57 -54.34 42.65 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.588 -0.695 . . . . 0.0 109.342 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -60.42 -33.47 72.56 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.244 -0.91 . . . . 0.0 109.075 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.1 165.28 31.27 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.531 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 41.4 m-85 -81.85 176.05 9.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.413 -1.051 . . . . 0.0 110.011 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -131.87 108.31 9.32 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.0 m -123.37 147.7 46.8 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.664 0.745 . . . . 0.0 110.522 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.0 m -151.08 171.32 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -79.13 140.59 37.76 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.901 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -152.06 109.78 3.64 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 84.4 m -64.7 -16.91 63.58 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.536 ' CD ' HE22 ' A' ' 83' ' ' GLN . 7.4 pt-20 -144.88 46.27 1.35 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.51 0.671 . . . . 0.0 109.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.34 -6.69 2.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 80' ' ' GLU . 11.3 tt0 -66.7 -57.4 7.21 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.385 -1.068 . . . . 0.0 108.869 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.536 HE22 ' CD ' ' A' ' 80' ' ' GLU . 31.0 mt-30 -52.1 -44.37 64.37 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -54.57 -33.02 26.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 89' ' ' ALA . . . -84.13 -30.4 25.95 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -76.34 -36.49 58.2 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.374 -0.828 . . . . 0.0 108.784 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 91' ' ' TYR . 21.5 tp -69.86 -39.25 76.47 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 28' ' ' ILE . 3.2 mm -80.04 -45.69 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 85' ' ' ALA . . . -57.41 -17.24 11.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.207 -0.933 . . . . 0.0 108.485 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.72 -30.75 14.34 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 87' ' ' LEU . 28.0 m-85 -78.23 -27.16 47.64 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.78 -1.424 . . . . 0.0 109.111 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 95.9 mt -69.36 -26.01 30.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.246 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.91 -21.52 29.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.794 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.28 -27.96 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.866 . . . . 0.0 110.73 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 95' ' ' ILE . 7.6 pt -83.13 -37.7 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.023 -1.048 . . . . 0.0 109.089 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.49 -23.15 60.99 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -71.48 -60.61 2.14 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.378 -0.826 . . . . 0.0 108.909 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -54.41 -34.08 60.64 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.443 -0.785 . . . . 0.0 109.126 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 100' ' ' LYS . 10.7 mmmt -70.86 -30.8 67.3 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.414 -0.804 . . . . 0.0 109.331 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.216 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 43.5 t . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 36.9 m95 -80.11 -175.12 4.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 109.322 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 p -148.07 133.31 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -111.27 153.61 43.96 Favored Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.78 -23.48 58.71 Favored 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.002 1.135 . . . . 0.0 109.589 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.34 119.93 3.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.265 -0.897 . . . . 0.0 109.551 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.352 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 3' ' ' THR . 6.8 tp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -60.42 -1.01 0.3 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.397 -0.814 . . . . 0.0 109.146 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 5' ' ' GLY . 7.4 m -81.43 -60.72 2.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 109.218 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.7 -77.4 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.39 0.614 . . . . 0.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -177.32 71.2 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 39.0 t -127.67 140.53 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.683 -0.893 . . . . 0.0 109.437 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 m -83.08 113.95 20.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.885 . . . . 0.0 109.816 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CE2' ' O ' ' A' ' 6' ' ' VAL . 9.8 m-85 -92.94 123.63 36.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.719 -0.613 . . . . 0.0 109.652 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -102.63 129.94 49.37 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.383 -0.823 . . . . 0.0 109.331 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 tt -77.99 118.48 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.022 -1.048 . . . . 0.0 108.792 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 24' ' ' ARG . 12.0 m -130.89 153.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -107.16 146.12 31.71 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.563 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 32.9 mt-10 -122.14 160.81 24.32 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.446 0.641 . . . . 0.0 109.525 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' CD ' ' N ' ' A' ' 14' ' ' LYS . 9.3 mptt -103.46 115.22 30.13 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.53 ' O ' ' C ' ' A' ' 16' ' ' LYS . 5.6 mmm -69.37 150.32 47.43 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 8.13 -75.21 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 CA-C-O 121.492 0.663 . . . . 0.0 112.264 -178.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -145.37 -3.83 0.6 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -49.83 125.05 10.95 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.069 -1.253 . . . . 0.0 109.151 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.58 -7.32 2.1 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -68.85 -174.19 0.56 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.929 0.871 . . . . 0.0 109.621 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -140.75 157.96 44.66 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -128.61 114.39 19.39 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -56.95 148.14 69.71 Favored 'Trans proline' 0 N--CA 1.479 0.669 0 C-N-CA 121.036 1.157 . . . . 0.0 110.148 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 11.6 tpp180 -153.77 146.36 24.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.219 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 36' ' ' VAL . 33.8 mt -103.33 140.69 37.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.1 tp -128.98 108.38 10.36 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.398 -0.814 . . . . 0.0 110.275 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.36 126.82 7.7 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.3 mm -104.38 111.34 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.479 -1.012 . . . . 0.0 108.791 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.4 m -108.47 163.46 13.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -73.51 -20.84 60.57 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.24 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.24 -18.78 15.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.549 -0.72 . . . . 0.0 110.558 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.7 OUTLIER -173.79 166.98 4.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.667 -1.271 . . . . 0.0 110.824 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.63 134.34 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 6.5 mtp -101.95 137.44 40.23 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.879 -1.138 . . . . 0.0 111.126 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 6.1 mtm180 -93.42 119.35 32.42 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 25' ' ' LEU . 35.7 t -128.57 127.29 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.491 -0.756 . . . . 0.0 110.441 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 36.0 t0 -72.29 148.54 45.31 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 4.8 tm-20 -89.29 -20.04 24.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.27 -52.85 9.87 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.643 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.7 p -100.88 -1.42 34.7 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.641 -0.662 . . . . 0.0 110.312 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 48.74 23.82 0.72 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.832 -1.167 . . . . 0.0 109.355 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.04 162.42 12.9 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.386 -0.821 . . . . 0.0 109.176 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.7 t -83.66 123.5 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.39 -30.39 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.084 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 44.2 tt0 -171.47 165.9 6.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.002 -1.061 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 33.3 mt-10 -132.53 159.96 37.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 80.4 m95 -139.22 141.68 37.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.36 -0.837 . . . . 0.0 109.824 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.5 t -71.81 134.73 46.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.693 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.42 -20.74 64.79 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.9 p -82.98 -10.15 58.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 109.387 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.58 -23.03 32.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.0 116.44 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.536 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -84.62 -48.99 8.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -152.32 177.38 10.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.117 -0.989 . . . . 0.0 109.384 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.5 p90 -158.51 169.69 23.87 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.617 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.85 117.63 6.65 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.19 125.23 44.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.15 -0.969 . . . . 0.0 110.351 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 60' ' ' LYS . 3.6 m -119.5 154.19 54.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -60.73 16.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.282 1.321 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.561 ' H ' ' C ' ' A' ' 58' ' ' SER . 34.9 pttt -145.98 -36.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.718 -1.239 . . . . 0.0 110.901 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.0 t -141.6 162.39 35.6 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.139 -0.976 . . . . 0.0 111.436 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -119.69 140.79 50.11 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.2 m -128.44 139.73 52.2 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.238 -0.914 . . . . 0.0 109.345 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 2.5 pp -138.3 147.57 43.72 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -117.57 125.17 50.34 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.31 0.576 . . . . 0.0 110.226 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' CD1' ' A' ' 64' ' ' LEU . 56.2 m-85 -90.96 -0.74 57.82 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.43 -5.48 80.77 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.12 78.99 7.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.319 -1.107 . . . . 0.0 109.634 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -46.51 -36.56 6.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.354 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.61 ' CD ' ' H ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -58.49 -59.59 5.12 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.546 -0.721 . . . . 0.0 109.49 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.28 -33.76 76.21 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.196 -0.94 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.46 -176.35 36.77 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -75.43 171.89 13.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.336 -1.096 . . . . 0.0 109.975 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.87 107.93 9.06 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 86.1 p -128.88 145.06 51.32 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.807 0.813 . . . . 0.0 110.458 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.67 171.26 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -78.1 138.45 38.74 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.926 -1.109 . . . . 0.0 109.498 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 70.3 p -150.86 112.47 4.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.531 -0.731 . . . . 0.0 109.372 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 97.3 m -64.79 -20.27 66.28 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 37.6 mt-10 -126.21 37.27 4.36 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.346 0.594 . . . . 0.0 109.59 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.51 -13.79 0.84 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' GLU . 20.2 tt0 -77.7 -58.16 3.42 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.482 -1.011 . . . . 0.0 108.898 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.48 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 53.2 mt-30 -53.49 -46.71 70.11 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.1 mt -55.06 -29.22 21.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.86 -29.32 27.34 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -79.34 -37.19 38.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 91' ' ' TYR . 46.9 tp -70.13 -41.43 73.93 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.48 -50.84 52.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.2 -17.24 52.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.9 -28.32 23.9 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.474 ' CE2' HD11 ' A' ' 87' ' ' LEU . 17.2 m-85 -82.58 -16.23 49.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.74 -1.447 . . . . 0.0 109.365 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 98.6 mt -82.0 -28.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.107 -0.995 . . . . 0.0 110.362 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.68 -18.91 33.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -0.995 . . . . 0.0 109.729 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 88.9 mt -86.54 -27.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.327 -0.858 . . . . 0.0 110.442 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 95' ' ' ILE . 9.3 pt -84.22 -34.19 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.166 -0.959 . . . . 0.0 109.572 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mt -75.01 -34.42 61.92 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.75 -0.594 . . . . 0.0 110.474 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -31.16 71.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.828 -1.17 . . . . 0.0 109.452 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -62.8 -35.31 79.47 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.119 -0.988 . . . . 0.0 109.146 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 100' ' ' LYS . 18.7 ttmt -83.15 -6.83 59.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.4 -0.813 . . . . 0.0 109.248 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 99' ' ' LYS . 75.3 tttt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.591 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.526 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 11.4 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.526 ' CD1' ' O ' ' B' ' 1' ' ' SER . 56.0 m95 -161.35 -175.52 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.851 . . . . 0.0 109.301 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.96 139.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.15 164.11 39.55 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.517 ' O ' ' CG ' ' B' ' 8' ' ' HIS . 1.2 Cg_endo -59.87 -18.33 48.86 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 C-N-CA 121.285 1.323 . . . . 0.0 109.797 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 19.2 mt -48.87 -12.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.143 -0.973 . . . . 0.0 109.482 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 18.7 m170 . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 3' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.644 0.735 . . . . 0.0 109.376 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.6 mptt -69.78 12.77 0.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.309 -0.87 . . . . 0.0 109.416 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 1' ' ' LEU . 4.5 m -143.97 49.28 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 109.425 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.47 126.67 37.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.451 -0.78 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.0 -13.93 16.74 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.2 t -86.89 131.84 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.17 -1.194 . . . . 0.0 109.232 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.6 m -83.59 111.94 19.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.052 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 8' ' ' PHE . 16.4 p90 -90.73 120.67 31.97 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.644 -0.66 . . . . 0.0 109.498 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -102.55 133.49 47.45 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.164 -0.96 . . . . 0.0 108.814 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.83 106.99 14.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.002 . . . . 0.0 109.468 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG12 HG22 ' A' ' 78' ' ' THR . 11.0 m -118.41 152.2 20.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' NE2' ' A' ' 77' ' ' GLN . 20.7 mttp -107.87 156.65 18.93 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.554 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 76.8 mt-10 -127.43 160.73 30.55 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -107.9 108.63 19.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.529 ' O ' ' C ' ' A' ' 16' ' ' LYS . 6.3 mmt -69.23 151.21 46.58 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 3.62 -72.36 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 123.257 0.623 . . . . 0.0 112.521 -178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 15' ' ' MET . . . -150.34 3.37 0.54 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 20' ' ' LYS . 10.9 mmmt -47.92 125.35 8.77 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.113 -1.227 . . . . 0.0 109.605 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -60.74 -6.42 1.73 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -83.96 -174.3 5.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.949 0.881 . . . . 0.0 109.775 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.9 mt -136.66 157.64 46.29 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 t -117.9 112.27 38.55 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.22 -0.925 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -58.86 149.26 79.46 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.904 1.07 . . . . 0.0 110.045 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.5 tpp180 -153.91 141.84 20.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.411 -0.806 . . . . 0.0 108.847 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 36' ' ' VAL . 81.0 mt -99.6 140.92 33.08 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.9 tp -124.58 108.05 11.67 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.295 -0.878 . . . . 0.0 110.004 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.71 129.1 9.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.3 mm -113.7 114.46 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.49 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 2.3 m -96.23 170.82 8.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.091 -1.005 . . . . 0.0 109.435 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' H ' HG22 ' A' ' 29' ' ' THR . 14.9 pttt -80.54 2.04 27.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.373 -0.829 . . . . 0.0 109.234 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -145.77 5.26 1.02 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.406 -0.809 . . . . 0.0 109.832 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -173.25 160.83 4.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.897 -1.127 . . . . 0.0 110.808 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 47' ' ' TRP . 74.0 t -116.17 146.66 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -139.08 152.01 47.18 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.814 -1.179 . . . . 0.0 111.288 -178.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 HH21 HG22 ' A' ' 44' ' ' ILE . 13.2 mtm180 -91.74 132.74 36.18 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 25' ' ' LEU . 42.5 t -129.47 120.32 50.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 38' ' ' GLU . 32.3 t0 -69.08 147.41 51.53 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 13.7 tm-20 -90.02 -20.46 23.22 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -74.11 -53.79 9.18 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.384 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 60.1 p -99.25 -2.71 35.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 0.0 110.131 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' NZ ' ' CB ' ' A' ' 41' ' ' LYS . 5.8 mtpm? 49.97 27.19 2.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.775 -1.203 . . . . 0.0 109.353 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.52 163.28 13.36 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.514 -0.741 . . . . 0.0 109.28 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.4 t -82.8 124.58 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.534 HG22 HH21 ' A' ' 35' ' ' ARG . 20.2 mm -102.11 -26.3 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 110.693 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.463 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -149.97 165.3 33.07 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.741 -1.224 . . . . 0.0 110.935 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' H ' ' HG3' ' A' ' 45' ' ' GLN . 22.1 mt-10 -142.11 138.14 31.45 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.509 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.8 m0 -139.27 153.97 47.89 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.172 -0.955 . . . . 0.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.5 m -87.66 143.81 26.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.332 -0.855 . . . . 0.0 108.953 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mt -66.03 -23.32 66.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.022 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.9 p -79.85 -3.68 48.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.288 -0.882 . . . . 0.0 109.723 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -90.78 -19.69 23.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.226 -0.921 . . . . 0.0 109.912 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.27 125.96 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 109.814 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.82 -51.86 5.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.223 -0.923 . . . . 0.0 109.224 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' NH1' ' CH2' ' B' ' 2' ' ' TRP . 2.5 ppt_? -155.97 163.22 39.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.396 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.405 ' CD1' ' CG1' ' B' ' 3' ' ' VAL . 36.8 p90 -139.9 172.43 12.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' CE3' ' B' ' 2' ' ' TRP . . . -147.08 116.34 6.97 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 0.0 109.757 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 60' ' ' LYS . 1.1 m -93.7 156.46 39.52 Favored Pre-proline 0 N--CA 1.485 1.287 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -58.07 0.4 0.33 Allowed 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 121.289 1.326 . . . . 0.0 110.201 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.7 pttp -144.66 -21.59 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.084 -1.01 . . . . 0.0 110.827 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.9 m -130.79 172.27 12.19 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.213 1.006 . . . . 0.0 111.592 -178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE2' HD21 ' A' ' 64' ' ' LEU . 53.1 t80 -137.97 140.65 40.34 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.0 m -139.98 141.67 36.37 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.819 -1.176 . . . . 0.0 111.564 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.579 HD21 ' CE2' ' A' ' 62' ' ' PHE . 55.0 mt -122.79 160.57 25.72 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -133.27 132.84 41.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.65 -0.657 . . . . 0.0 109.36 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.23 -0.14 30.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.78 -6.84 23.65 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.38 94.74 8.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -1.12 . . . . 0.0 109.626 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -47.0 -47.27 22.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 0.0 109.54 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.433 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 8.0 pt20 -49.58 -54.42 18.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.449 -0.782 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 10.1 t70 -63.37 -34.73 78.36 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 108.829 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.52 173.35 44.65 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.489 ' CE1' ' NH2' ' A' ' 54' ' ' ARG . 44.9 m-85 -77.25 173.29 12.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.349 -1.089 . . . . 0.0 109.807 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -131.04 107.27 8.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.3 p -125.78 146.22 49.88 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.821 0.819 . . . . 0.0 111.209 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.1 170.75 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.581 ' NE2' ' H ' ' A' ' 77' ' ' GLN . 3.7 mp0 -79.29 136.31 37.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.085 -1.009 . . . . 0.0 109.981 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.551 HG22 HG12 ' A' ' 11' ' ' VAL . 79.9 p -148.05 127.28 12.97 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.436 -0.79 . . . . 0.0 109.177 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 88.5 m -70.11 -28.91 65.77 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 82' ' ' GLU . 15.1 mp0 -99.52 -71.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.727 . . . . 0.0 109.6 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.87 -41.96 0.27 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 80' ' ' GLU . 8.0 tt0 -66.65 -57.46 7.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.355 -1.085 . . . . 0.0 109.017 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.417 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 55.8 mt-30 -50.04 -48.94 52.54 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 38.6 mt -55.41 -28.27 22.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.23 26.28 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.28 -36.93 33.77 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD11 ' CE2' ' A' ' 91' ' ' TYR . 39.8 tp -69.73 -40.85 75.97 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.451 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 3.2 mm -68.85 -53.21 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -17.11 22.94 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -85.4 -30.36 25.01 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE2' HD11 ' A' ' 87' ' ' LEU . 27.7 m-85 -84.9 -19.38 32.38 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.75 -1.441 . . . . 0.0 109.683 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.92 -25.79 15.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.359 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -84.78 -19.13 33.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.905 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.5 -27.01 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 110.273 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.39 -28.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.931 . . . . 0.0 109.894 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -84.02 -33.68 24.46 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.594 -0.691 . . . . 0.0 110.999 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.38 -30.9 67.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.734 -1.229 . . . . 0.0 110.165 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -70.88 -42.7 69.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.996 -1.065 . . . . 0.0 109.586 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -77.04 -23.85 52.06 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.657 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 56.4 tttm . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.507 179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' B' ' 2' ' ' TRP . 93.1 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.644 ' CH2' ' NH1' ' A' ' 54' ' ' ARG . 18.8 m95 -153.79 -169.21 3.21 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 109.248 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.405 ' CG1' ' CD1' ' A' ' 55' ' ' TRP . 1.7 p -153.36 143.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.66 158.49 62.8 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' B' ' 8' ' ' HIS . 2.7 Cg_endo -61.31 -26.33 81.64 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.063 1.175 . . . . 0.0 109.759 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 17.0 mt -47.48 -12.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.77 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' B' ' 6' ' ' PRO . 40.3 m170 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.851 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 3' ' ' THR . 16.3 mt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.339 0.59 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.0 mptt -62.58 3.58 0.2 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.357 -0.839 . . . . 0.0 109.51 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' LEU . 3.3 m -94.87 34.73 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.946 . . . . 0.0 109.01 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' VAL . 3.2 m-85 -51.74 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.83 89.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' TYR . 75.5 t -128.08 139.08 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.963 . . . . 0.0 108.887 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -83.18 99.29 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.033 . . . . 0.0 109.89 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -86.94 143.36 27.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.764 -0.585 . . . . 0.0 109.475 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -125.99 135.27 51.63 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.0 106.16 9.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.976 . . . . 0.0 109.524 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG12 HG22 ' A' ' 78' ' ' THR . 5.8 m -118.29 145.23 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -106.97 138.8 42.45 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 35.0 mt-10 -103.83 160.51 14.73 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -101.89 120.0 39.69 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.758 0.79 . . . . 0.0 109.133 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.487 ' O ' ' C ' ' A' ' 16' ' ' LYS . 47.8 mtp -68.87 152.84 44.78 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.747 -0.595 . . . . 0.0 109.819 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -19.38 -71.3 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 121.138 0.494 . . . . 0.0 112.05 -179.016 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.82 -10.87 1.51 Allowed Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 20' ' ' LYS . 4.3 mmmt -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.912 -1.346 . . . . 0.0 108.64 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -59.91 -7.24 1.6 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -67.91 -175.57 0.58 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 122.011 0.91 . . . . 0.0 110.073 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 17.2 mt -139.51 158.78 43.55 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 22' ' ' VAL . 2.0 t -122.5 113.52 30.6 Favored Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.291 -0.881 . . . . 0.0 109.228 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -58.02 148.07 78.99 Favored 'Trans proline' 0 N--CA 1.481 0.773 0 C-N-CA 121.298 1.332 . . . . 0.0 110.864 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.567 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.1 tpp180 -155.12 147.77 24.26 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 36' ' ' VAL . 78.1 mt -104.52 141.12 36.95 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.403 HD11 ' CG1' ' A' ' 33' ' ' VAL . 14.5 tp -124.7 108.2 11.76 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 121.76 0.79 . . . . 0.0 110.042 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.36 128.94 9.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.7 mm -112.02 112.26 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.499 ' OG1' ' SD ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -90.32 -179.42 5.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.0 109.581 -179.343 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -80.29 -10.36 59.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.394 -0.816 . . . . 0.0 109.526 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CA ' HD12 ' A' ' 49' ' ' LEU . 36.6 mt-10 -145.92 10.76 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.206 -0.934 . . . . 0.0 110.076 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.5 OUTLIER -164.7 160.72 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.937 -1.102 . . . . 0.0 110.455 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' TRP . 70.5 t -120.87 143.35 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.499 ' SD ' ' OG1' ' A' ' 29' ' ' THR . 0.0 OUTLIER -133.45 152.95 51.97 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.838 -1.164 . . . . 0.0 111.463 -178.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.643 ' NE ' HE21 ' A' ' 45' ' ' GLN . 46.9 mtm180 -91.71 132.51 36.32 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' LEU . 33.4 t -133.9 125.59 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.515 -0.74 . . . . 0.0 109.723 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.67 147.92 45.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 0.0 109.313 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -90.22 -22.82 21.46 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -72.04 -51.37 22.03 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.509 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.6 p -102.6 -3.38 26.79 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.0 110.442 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.6 mtmm 51.88 23.53 2.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.678 -1.264 . . . . 0.0 109.024 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.91 163.52 12.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.429 -0.795 . . . . 0.0 109.063 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.1 t -88.05 123.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 109.19 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.9 mm -95.42 -27.41 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.306 -0.871 . . . . 0.0 110.202 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.643 HE21 ' NE ' ' A' ' 35' ' ' ARG . 7.3 tt0 -159.58 165.75 32.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.674 -1.266 . . . . 0.0 111.407 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 18.6 mt-10 -131.07 142.57 50.3 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' VAL . 79.5 m95 -140.03 154.53 47.14 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.137 -0.977 . . . . 0.0 109.434 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.592 ' N ' ' OD1' ' A' ' 51' ' ' ASN . 9.9 p -87.46 154.52 20.58 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.212 -0.93 . . . . 0.0 109.385 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 HD12 ' CA ' ' A' ' 31' ' ' GLU . 1.5 mt -82.04 -17.53 46.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.952 -1.093 . . . . 0.0 108.868 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.2 p -88.18 -8.08 55.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 52' ' ' ILE . 0.4 OUTLIER -87.14 -19.95 27.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.098 -1.001 . . . . 0.0 109.832 -179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 51' ' ' ASN . 56.1 mt -67.14 128.35 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.42 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -92.85 -51.4 5.1 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.195 -0.94 . . . . 0.0 109.859 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -153.73 177.68 10.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.153 -0.967 . . . . 0.0 109.687 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -158.35 171.63 19.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.483 -0.761 . . . . 0.0 109.562 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.91 114.72 6.47 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.94 117.71 34.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.226 -0.921 . . . . 0.0 110.354 -178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -99.79 161.61 23.84 Favored Pre-proline 0 N--CA 1.487 1.402 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.33 3.37 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.277 1.318 . . . . 0.0 110.3 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 58' ' ' SER . 15.1 pttp -149.55 -26.36 0.27 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.797 -1.189 . . . . 0.0 111.295 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 78' ' ' THR . 59.2 p -126.09 171.93 10.42 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.972 0.891 . . . . 0.0 111.481 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -142.2 141.29 32.55 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.6 m -134.35 145.32 48.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.178 -0.951 . . . . 0.0 109.893 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.15 156.26 48.96 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -129.76 128.93 43.41 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.559 -0.713 . . . . 0.0 109.938 -178.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -92.12 -4.78 53.84 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.48 -4.7 67.13 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.0 OUTLIER -84.74 90.96 7.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -1.123 . . . . 0.0 109.425 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -43.22 -43.28 4.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.473 -0.767 . . . . 0.0 110.112 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -58.18 -52.63 64.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.506 -0.746 . . . . 0.0 110.429 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -65.75 -38.55 89.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.167 -0.958 . . . . 0.0 109.635 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.02 -175.08 49.98 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.533 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 32.1 m-85 -83.28 166.96 18.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 110.006 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -131.83 108.77 9.65 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.7 t -126.34 147.0 49.81 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.804 0.811 . . . . 0.0 110.49 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 m -148.68 170.76 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -79.35 136.44 36.99 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.091 -1.005 . . . . 0.0 109.269 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 60' ' ' LYS . 39.5 p -150.46 112.62 4.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.483 -0.761 . . . . 0.0 109.692 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.2 m -65.73 -23.56 66.77 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 80' ' ' GLU . 10.0 mp0 -114.89 32.03 6.29 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.321 0.581 . . . . 0.0 109.588 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -49.45 -16.73 1.01 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' N ' ' C ' ' A' ' 80' ' ' GLU . 16.1 tt0 -76.89 -57.9 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.537 -0.978 . . . . 0.0 109.03 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 51.2 mt-30 -52.28 -47.31 65.94 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 34.8 mt -55.57 -30.65 26.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.17 -29.66 26.45 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 36.1 tt0 -80.42 -38.43 30.2 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.618 HD11 ' CE2' ' A' ' 91' ' ' TYR . 37.1 tp -68.31 -40.7 81.59 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 84' ' ' ILE . 2.8 mm -67.19 -59.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.58 -16.98 2.77 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 88' ' ' ILE . . . -84.31 -39.53 9.06 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.618 ' CE2' HD11 ' A' ' 87' ' ' LEU . 26.8 m-85 -75.3 -33.83 61.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.67 -1.488 . . . . 0.0 109.272 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.92 -26.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 110.106 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.68 -21.19 30.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.925 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.2 mt -86.4 -24.93 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.87 . . . . 0.0 110.361 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 95' ' ' ILE . 13.3 pt -83.98 -31.29 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.145 -0.972 . . . . 0.0 109.318 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.543 HD23 ' NZ ' ' A' ' 99' ' ' LYS . 4.4 mt -76.22 -30.1 57.83 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.73 -0.606 . . . . 0.0 110.408 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -29.82 48.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.911 -1.118 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.0 -53.27 27.2 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.84 -1.163 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.543 ' NZ ' HD23 ' A' ' 96' ' ' LEU . 21.8 pttm -84.59 -13.13 52.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.233 -0.917 . . . . 0.0 109.707 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.551 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.412 ' O ' ' O ' ' B' ' 2' ' ' TRP . 5.8 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.289 0.566 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.412 ' O ' ' O ' ' B' ' 1' ' ' SER . 48.6 m95 51.08 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.91 . . . . 0.0 109.464 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -156.1 137.61 5.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 89.8 p -96.12 149.94 36.58 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.519 -0.738 . . . . 0.0 109.145 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.524 ' O ' ' N ' ' B' ' 8' ' ' HIS . 1.0 OUTLIER -58.68 -19.21 44.66 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 178.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt -49.68 90.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' B' ' 6' ' ' PRO . 17.5 p80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.517 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 1' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.508 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 11.3 mptt 45.5 17.44 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.426 -0.796 . . . . 0.0 109.667 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 1' ' ' LEU . 5.5 m -152.8 49.76 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.346 -0.846 . . . . 0.0 109.782 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' A' ' 6' ' ' VAL . 7.9 m-85 -80.96 -167.39 1.4 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.09 85.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 4' ' ' TYR . 82.9 t -122.9 140.28 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.675 -0.897 . . . . 0.0 109.256 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m -87.62 100.83 13.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -87.06 120.88 28.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -102.37 134.77 45.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.263 -0.898 . . . . 0.0 109.187 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tt -81.38 107.16 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 78' ' ' THR . 11.9 m -117.42 147.13 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.77 153.89 22.31 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 22' ' ' VAL . 19.3 mt-10 -127.34 157.72 39.16 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -107.75 106.09 16.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.416 -0.802 . . . . 0.0 109.469 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 53.3 mmm -71.23 151.99 43.76 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.07 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -54.73 -93.55 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.347 0.594 . . . . 0.0 111.06 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -37.38 -29.22 0.04 OUTLIER Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.687 -0.633 . . . . 0.0 111.907 -178.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 2.4 mptt -100.34 124.59 46.01 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.005 -1.291 . . . . 0.0 110.96 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -76.53 -5.01 45.77 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -171.98 0.25 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.827 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -123.67 157.54 33.61 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 13' ' ' GLU . 11.6 t -123.51 112.15 29.55 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -58.76 149.51 76.99 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 120.962 1.108 . . . . 0.0 110.781 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -154.31 142.86 20.73 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 36' ' ' VAL . 70.4 mt -101.43 140.85 35.17 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.2 tp -127.27 108.51 10.93 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.341 -0.849 . . . . 0.0 110.097 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.57 127.29 8.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 mm -107.52 111.77 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.748 -0.854 . . . . 0.0 108.846 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.46 ' OG1' ' SG ' ' A' ' 32' ' ' CYS . 5.1 p -95.7 177.37 5.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.012 . . . . 0.0 109.067 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -82.06 4.1 24.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.406 -0.809 . . . . 0.0 109.349 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -145.6 4.64 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.511 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -173.3 169.71 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.804 -1.185 . . . . 0.0 110.945 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.4 t -113.85 126.55 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.31 140.74 36.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.972 -1.08 . . . . 0.0 111.477 -177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.577 HH21 ' CG2' ' A' ' 44' ' ' ILE . 5.6 mtm180 -93.08 128.37 38.96 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 25' ' ' LEU . 41.7 t -135.74 126.98 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.859 . . . . 0.0 110.003 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -71.9 149.04 45.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -89.34 -23.23 22.29 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -75.08 -50.17 17.29 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.658 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 p -100.48 -4.89 27.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.646 -0.659 . . . . 0.0 110.41 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm 50.13 22.85 1.01 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.741 -1.224 . . . . 0.0 109.133 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.46 163.04 12.47 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.2 t -85.52 127.34 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.785 . . . . 0.0 109.31 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HH21 ' A' ' 35' ' ' ARG . 20.0 mm -102.82 -26.37 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.495 -0.753 . . . . 0.0 110.394 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 41.9 tt0 -169.95 165.62 9.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.829 -1.169 . . . . 0.0 110.509 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 17.9 mt-10 -140.86 157.46 45.35 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.667 0.746 . . . . 0.0 110.334 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.511 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.3 m0 -139.12 153.45 47.99 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.58 141.59 32.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.176 -0.952 . . . . 0.0 109.21 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 52' ' ' ILE . 1.2 mt -64.8 -38.16 90.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -0.842 . . . . 0.0 108.982 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.401 ' HA ' HD22 ' B' ' 7' ' ' LEU . 80.5 p -67.27 -3.85 9.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.288 -0.883 . . . . 0.0 109.682 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -89.48 -27.55 20.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.895 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 86.2 mt -63.87 121.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.974 . . . . 0.0 110.195 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.16 -51.15 6.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.398 -0.814 . . . . 0.0 109.081 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -152.02 177.53 10.38 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.117 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -158.61 171.49 20.02 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.514 -0.741 . . . . 0.0 109.209 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.33 124.95 11.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.185 -0.947 . . . . 0.0 108.684 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.35 109.93 22.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.941 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.17 162.44 26.5 Favored Pre-proline 0 N--CA 1.487 1.393 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -58.68 -8.53 5.8 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.308 1.339 . . . . 0.0 110.166 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -151.55 -9.36 0.22 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.966 -1.084 . . . . 0.0 111.181 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.2 m -129.0 162.03 28.56 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.903 0.858 . . . . 0.0 111.299 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.4 ' CB ' HG21 ' A' ' 78' ' ' THR . 60.8 t80 -134.92 140.8 46.03 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 m -136.26 144.13 44.64 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.14 -0.975 . . . . 0.0 109.789 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -133.96 152.69 51.95 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.522 ' OD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.4 132.15 45.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.598 -0.689 . . . . 0.0 109.477 -179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -97.53 -0.62 45.63 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.34 -14.13 61.86 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.66 72.24 9.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.383 -1.069 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -45.21 -40.06 6.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.401 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 17.7 pt20 -55.97 -49.02 74.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 15.7 t70 -63.38 -34.16 77.12 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.168 -0.958 . . . . 0.0 109.032 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.04 158.38 30.22 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.522 ' CD1' ' OD2' ' A' ' 65' ' ' ASP . 51.1 m-85 -75.24 171.63 13.84 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -131.43 107.91 9.23 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 p -127.7 155.51 43.85 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.867 0.841 . . . . 0.0 110.39 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.6 m -151.95 172.46 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -78.21 136.98 37.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 11' ' ' VAL . 68.3 p -146.78 120.44 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 91.9 m -64.8 -27.67 69.04 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 82' ' ' GLU . 14.7 mp0 -98.03 -71.82 0.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.536 0.684 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.04 -36.05 0.3 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 80' ' ' GLU . 14.1 tt0 -75.77 -57.61 3.78 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -1.105 . . . . 0.0 108.855 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 83' ' ' GLN . 52.6 mt-30 -50.76 -49.65 57.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 57.2 mt -53.88 -32.79 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.85 -25.07 28.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.746 -0.596 . . . . 0.0 109.416 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' GLU . 35.5 tt0 -84.13 -36.83 22.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 91' ' ' TYR . 25.6 tp -72.57 -40.88 66.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.9 mt -69.43 -51.05 46.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.24 -17.57 20.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -88.68 -29.13 19.65 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 87' ' ' LEU . 15.6 m-85 -78.99 -27.36 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.65 -1.5 . . . . 0.0 109.327 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.7 mt -67.58 -24.89 31.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.368 -0.832 . . . . 0.0 110.187 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.61 -20.64 31.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 110.025 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.0 mt -86.67 -25.01 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 110.38 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 95' ' ' ILE . 12.1 pt -83.16 -33.97 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.157 -0.965 . . . . 0.0 109.051 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -80.28 -23.57 40.63 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.349 0.595 . . . . 0.0 109.446 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -37.65 83.68 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.519 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -66.34 -48.54 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 109.25 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.401 ' O ' ' OXT' ' A' ' 100' ' ' LYS . 7.4 mtpm? -60.35 -42.14 95.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.298 -0.876 . . . . 0.0 109.737 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' OXT' ' O ' ' A' ' 99' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.258 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.489 ' O ' ' CG ' ' B' ' 2' ' ' TRP . 3.2 t . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.489 ' CG ' ' O ' ' B' ' 1' ' ' SER . 50.7 m95 -165.99 179.78 5.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.173 -0.954 . . . . 0.0 109.643 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -159.34 141.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.27 165.5 17.55 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.28 -87.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.001 1.134 . . . . 0.0 109.248 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 50' ' ' THR . 78.6 mt 39.78 75.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.451 -0.78 . . . . 0.0 110.513 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.534 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.524 ' O ' HG22 ' A' ' 3' ' ' THR . 31.4 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.5 OUTLIER 47.35 17.83 0.08 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.263 -0.898 . . . . 0.0 109.069 -179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 1' ' ' LEU . 8.8 t -146.68 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.587 -0.696 . . . . 0.0 109.301 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -68.63 85.85 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 43.59 77.11 0.09 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 40.4 t -128.29 140.7 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.525 -0.985 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -89.05 114.86 26.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.182 -0.949 . . . . 0.0 110.351 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -86.33 161.62 18.62 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.468 ' H ' ' H ' ' A' ' 26' ' ' LEU . 29.5 m-85 -142.01 129.08 20.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.228 -0.92 . . . . 0.0 108.597 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.17 102.75 6.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 108.691 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.4 m -116.72 147.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -106.94 145.86 31.73 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.572 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 28.3 mt-10 -119.06 160.66 21.63 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -110.23 103.32 11.99 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.513 ' O ' ' C ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -69.39 153.25 43.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.488 -0.757 . . . . 0.0 109.271 -179.567 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -23.42 -91.55 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 120.974 0.416 . . . . 0.0 111.665 -178.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.9 29.29 8.14 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' NZ ' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -43.38 132.37 4.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.364 -1.08 . . . . 0.0 111.533 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -96.88 -12.97 22.81 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.82 -173.15 2.95 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.478 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.9 mt -105.97 157.24 17.64 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.1 t -112.1 110.8 53.63 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.085 -1.009 . . . . 0.0 109.798 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -59.34 148.27 87.24 Favored 'Trans proline' 0 N--CA 1.481 0.777 0 C-N-CA 121.301 1.334 . . . . 0.0 110.648 177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -155.07 146.72 23.23 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.861 . . . . 0.0 109.218 179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' VAL . 54.6 mt -105.47 140.66 38.23 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' H ' ' H ' ' A' ' 9' ' ' PHE . 15.1 tp -128.17 108.49 10.67 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.356 -0.84 . . . . 0.0 110.322 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.35 128.08 8.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -102.35 111.65 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.456 -1.026 . . . . 0.0 109.232 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.01 165.43 11.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -72.98 -25.65 61.07 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.794 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -105.43 -7.93 18.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.503 -0.748 . . . . 0.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.56 165.64 4.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.58 -1.325 . . . . 0.0 111.115 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.26 134.64 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.6 mtm -102.27 137.87 39.95 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.904 -1.122 . . . . 0.0 110.908 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' HB3' ' A' ' 45' ' ' GLN . 5.8 mtm180 -93.03 116.15 28.78 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 25' ' ' LEU . 38.8 t -122.7 127.19 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.593 0.711 . . . . 0.0 110.311 -177.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -73.06 148.49 44.01 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -89.3 -23.21 22.33 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -71.46 -52.24 19.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 42' ' ' GLU . 3.4 m -100.35 -5.24 27.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.671 -0.643 . . . . 0.0 110.181 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm 52.37 24.2 2.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.732 -1.23 . . . . 0.0 109.257 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 40' ' ' THR . 0.5 OUTLIER -106.06 163.17 12.98 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.433 -0.792 . . . . 0.0 109.329 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.46 124.74 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.1 mm -99.66 -29.64 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.052 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 38.5 tt0 -170.53 165.97 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.923 -1.111 . . . . 0.0 110.317 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 27.5 mt-10 -133.03 162.25 32.2 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.475 0.655 . . . . 0.0 109.727 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 84.6 m95 -138.93 144.32 39.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.0 109.268 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -76.78 133.15 39.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.04 -1.037 . . . . 0.0 109.881 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD23 HD12 ' A' ' 52' ' ' ILE . 1.6 mt -66.04 -26.73 67.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -75.89 -8.09 56.08 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.456 -0.777 . . . . 0.0 109.659 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -90.76 -21.81 21.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.177 -0.952 . . . . 0.0 109.627 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 52' ' ' ILE . 22.1 mt -67.59 120.84 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -92.62 -44.73 8.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.275 -0.891 . . . . 0.0 109.53 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.56 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 2.3 ptp180 -151.49 175.09 12.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 0.0 109.398 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -158.75 170.24 22.58 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.599 -0.688 . . . . 0.0 109.251 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.74 115.1 5.87 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -98.54 107.4 19.84 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.189 -0.945 . . . . 0.0 109.889 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -86.53 162.09 46.31 Favored Pre-proline 0 N--CA 1.485 1.289 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -60.66 2.8 0.34 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 121.265 1.31 . . . . 0.0 109.936 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 58' ' ' SER . 28.8 pttt -152.28 -15.71 0.18 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.985 -1.072 . . . . 0.0 111.218 -178.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 m -134.44 168.32 19.14 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 122.023 0.916 . . . . 0.0 111.467 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -136.37 140.64 43.4 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 m -135.9 146.49 47.44 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.167 -0.958 . . . . 0.0 109.88 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 pp -144.22 153.68 42.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.408 -0.808 . . . . 0.0 109.07 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 14.5 p-10 -130.18 130.13 44.31 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.675 -0.641 . . . . 0.0 109.548 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.472 ' CE2' ' CE3' ' A' ' 47' ' ' TRP . 63.1 m-85 -91.37 2.56 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.63 -6.7 37.41 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.06 92.61 9.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -1.075 . . . . 0.0 109.743 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -46.1 -46.57 17.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.602 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.426 ' CG ' ' N ' ' A' ' 71' ' ' ASP . 1.8 pt20 -51.56 -52.32 48.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.511 -0.743 . . . . 0.0 109.914 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' N ' ' CG ' ' A' ' 70' ' ' GLN . 7.8 t70 -61.97 -35.38 78.32 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 109.361 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.57 176.79 51.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -77.34 159.83 29.24 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.203 -1.175 . . . . 0.0 109.763 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -132.33 108.24 9.06 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.0 t -134.55 151.16 50.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.377 -0.827 . . . . 0.0 110.153 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.5 171.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.49 138.05 38.24 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.129 -0.982 . . . . 0.0 109.269 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' LYS . 52.5 p -150.11 118.73 6.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.3 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 m -66.17 -23.12 66.4 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.511 ' CD ' HE21 ' A' ' 83' ' ' GLN . 71.0 mm-40 -130.05 42.56 3.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.658 -0.651 . . . . 0.0 109.967 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.36 -15.12 1.06 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' C ' ' A' ' 80' ' ' GLU . 14.3 tt0 -72.94 -57.86 3.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.4 -1.059 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.511 HE21 ' CD ' ' A' ' 80' ' ' GLU . 52.2 mt-30 -52.31 -43.9 64.77 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mt -57.41 -32.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 82' ' ' GLU . . . -84.18 -23.39 30.58 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -82.59 -38.99 22.85 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.364 -0.835 . . . . 0.0 108.84 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.0 tp -70.11 -39.67 75.37 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.05 -49.45 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.68 -17.65 16.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.1 -25.11 25.25 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -83.32 -28.01 29.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.925 -1.339 . . . . 0.0 109.194 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 99.4 mt -66.81 -24.7 33.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 121.417 -0.802 . . . . 0.0 110.132 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.53 -19.82 32.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.995 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.3 mt -86.69 -24.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 110.311 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -84.3 -30.23 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.979 . . . . 0.0 109.363 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.47 -28.52 41.53 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.73 -0.606 . . . . 0.0 110.57 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -72.88 -47.04 49.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.872 -1.142 . . . . 0.0 109.643 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 45.9 mtpt -54.15 -31.12 51.6 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.312 -0.868 . . . . 0.0 109.46 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -61.95 -32.47 72.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.333 -0.854 . . . . 0.0 109.375 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.439 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 25.3 m95 51.98 -173.26 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.23 139.19 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.11 163.37 44.56 Favored Pre-proline 0 N--CA 1.495 1.809 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.07 -26.36 82.75 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.171 1.248 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 25.3 mt -47.53 153.2 0.57 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.641 -179.858 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.568 ' N ' HD22 ' A' ' 1' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.521 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 10.3 mptt -63.95 1.74 0.62 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.32 -0.862 . . . . 0.0 109.143 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 1' ' ' LEU . 51.4 p -114.75 42.17 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.44 106.49 0.16 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.426 0.631 . . . . 0.0 110.199 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.29 65.47 2.73 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -128.85 140.28 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.487 -1.007 . . . . 0.0 108.816 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 m -82.88 99.6 9.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.229 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.73 147.47 26.87 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' H ' ' H ' ' A' ' 26' ' ' LEU . 37.3 m-85 -128.42 129.31 45.97 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 tp -77.26 103.02 6.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 0.0 109.033 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.558 HG12 HG22 ' A' ' 78' ' ' THR . 15.7 m -113.57 147.33 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -107.62 136.12 47.91 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.406 -0.809 . . . . 0.0 108.993 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' CD ' ' HE ' ' A' ' 24' ' ' ARG . 58.3 mt-10 -107.92 160.63 15.61 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.498 ' HZ2' HD23 ' A' ' 21' ' ' LEU . 9.5 mmmt -113.81 100.87 8.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.537 -0.727 . . . . 0.0 109.424 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.416 ' O ' ' O ' ' A' ' 18' ' ' LYS . 16.6 mmt -70.64 151.99 44.37 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.304 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.556 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -58.32 -88.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.686 -179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 16' ' ' LYS . . . -36.46 -28.93 0.02 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -101.02 124.37 46.63 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.165 -1.197 . . . . 0.0 110.609 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -78.12 -0.75 29.43 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -80.39 -171.41 3.02 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.69 -179.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD23 ' HZ2' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -121.23 158.85 27.17 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.0 t -124.62 114.69 26.98 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.568 -0.707 . . . . 0.0 109.319 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.65 148.52 73.39 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.915 1.076 . . . . 0.0 110.782 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.561 ' HE ' ' CD ' ' A' ' 13' ' ' GLU . 10.7 tpp180 -154.65 145.43 22.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.3 mt -106.25 141.35 37.73 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' H ' ' H ' ' A' ' 9' ' ' PHE . 19.2 tp -128.14 108.67 10.83 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.402 -0.811 . . . . 0.0 110.546 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' C ' HD12 ' A' ' 28' ' ' ILE . . . -86.04 124.94 7.1 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.728 ' N ' HD12 ' A' ' 28' ' ' ILE . 1.6 mp -99.25 111.51 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.355 -1.085 . . . . 0.0 108.353 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.12 165.09 11.88 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.243 -0.911 . . . . 0.0 108.725 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -72.72 -17.15 61.64 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.207 -0.933 . . . . 0.0 109.514 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.1 -12.91 13.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.596 -0.69 . . . . 0.0 110.472 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 47' ' ' TRP . 0.8 OUTLIER -173.63 166.42 4.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.621 -1.299 . . . . 0.0 110.982 -179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.6 t -106.89 129.8 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 16.1 ptp -102.86 142.21 34.36 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.912 -1.117 . . . . 0.0 111.108 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 -92.41 126.49 37.51 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.4 t -130.54 122.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 0.0 110.012 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -67.42 148.96 50.89 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -89.0 -18.82 26.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -77.95 -52.22 9.17 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.522 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 p -98.46 -5.99 31.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.564 -0.71 . . . . 0.0 110.071 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.6 mmmt 51.69 20.87 1.2 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.906 -1.121 . . . . 0.0 109.285 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -104.77 163.4 12.53 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.6 t -81.96 132.49 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.612 -0.68 . . . . 0.0 109.172 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.25 -28.23 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.55 -0.719 . . . . 0.0 110.136 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' CG ' ' N ' ' A' ' 46' ' ' GLU . 45.4 tt0 -163.31 165.51 24.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.857 -1.152 . . . . 0.0 110.862 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' N ' ' CG ' ' A' ' 45' ' ' GLN . 45.7 mt-10 -141.16 158.62 43.66 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.427 0.632 . . . . 0.0 109.72 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.49 ' O ' ' CB ' ' A' ' 32' ' ' CYS . 9.2 m0 -139.38 145.26 38.74 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 109.577 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -80.48 130.82 35.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 108.929 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.4 mt -53.82 -30.96 47.48 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.157 -0.964 . . . . 0.0 108.863 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.5 p -73.32 -4.12 31.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.32 -37.15 15.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.15 110.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.361 -0.837 . . . . 0.0 109.888 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HZ1' ' HE2' ' B' ' 4' ' ' PTR . 40.7 tttm -78.48 -45.93 20.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.038 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 65' ' ' ASP . 6.4 ptp180 -153.6 -179.93 8.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.355 -0.841 . . . . 0.0 109.011 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -156.97 170.06 23.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' CZ3' ' B' ' 2' ' ' TRP . . . -148.06 113.15 5.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.24 137.96 37.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.296 -0.878 . . . . 0.0 110.752 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -124.54 161.43 48.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.51 1.94 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.339 1.359 . . . . 0.0 110.227 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 78' ' ' THR . 21.1 pttm -150.49 -17.64 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.914 -1.116 . . . . 0.0 111.574 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.3 t -130.23 172.26 12.0 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 122.088 0.947 . . . . 0.0 111.51 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 46.3 t80 -147.26 140.34 25.17 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -138.23 148.26 44.58 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.961 -1.087 . . . . 0.0 110.743 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.636 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 45.1 mt -129.31 163.34 25.92 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.578 0.704 . . . . 0.0 109.671 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 53' ' ' LYS . 40.6 t0 -132.71 121.08 22.55 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 68' ' ' ASP . 85.6 m-85 -101.86 1.86 37.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.934 . . . . 0.0 109.161 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.13 -6.01 5.95 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.181 -1.567 . . . . 0.0 109.181 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 66' ' ' PHE . 5.0 m-20 -85.0 97.81 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -1.097 . . . . 0.0 109.417 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -45.44 -49.21 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.448 ' CG ' ' H ' ' A' ' 71' ' ' ASP . 12.5 pt20 -50.08 -57.26 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 70' ' ' GLN . 6.0 t70 -68.44 -33.75 74.75 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.263 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.44 -171.08 29.88 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -71.12 167.71 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.303 -1.116 . . . . 0.0 109.654 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -131.54 106.32 8.12 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.0 p -117.51 146.07 43.79 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.885 0.85 . . . . 0.0 110.979 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.48 166.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -79.1 133.07 36.77 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.968 -1.083 . . . . 0.0 109.419 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 HG12 ' A' ' 11' ' ' VAL . 44.0 p -145.63 124.56 12.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.412 -0.805 . . . . 0.0 109.711 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 90.5 m -73.99 -20.05 60.46 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.488 ' CD ' ' NE2' ' A' ' 83' ' ' GLN . 34.5 mt-10 -126.72 36.68 4.43 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.257 0.551 . . . . 0.0 109.874 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -50.86 -12.23 0.66 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' GLU . 34.8 tt0 -79.87 -58.29 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.437 -1.037 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.488 ' NE2' ' CD ' ' A' ' 80' ' ' GLU . 50.4 mt-30 -53.09 -48.45 67.76 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.4 mt -51.52 -29.12 9.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 82' ' ' GLU . . . -84.03 -30.97 25.68 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -80.04 -36.55 35.56 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 108.96 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.3 tp -70.61 -40.47 73.15 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.5 mt -75.1 -47.05 37.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.88 -17.12 21.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 108.796 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.28 -26.24 31.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -84.42 -21.48 30.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.87 -1.37 . . . . 0.0 109.706 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -70.3 -26.73 29.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.299 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.62 -19.29 33.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 109.948 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.68 -25.14 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.338 -0.851 . . . . 0.0 110.3 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.49 -34.13 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.238 -0.914 . . . . 0.0 109.004 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.83 -21.64 60.06 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.511 0.672 . . . . 0.0 109.3 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tttm -80.31 -47.24 14.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.418 -0.801 . . . . 0.0 110.39 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -64.77 -44.74 89.05 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.121 -0.987 . . . . 0.0 110.142 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -79.17 -5.78 55.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.926 -1.109 . . . . 0.0 109.822 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.344 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 2' ' ' TRP . 67.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 56' ' ' ALA . 34.9 m95 50.17 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.086 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -152.22 135.64 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PTR . . . . . 0.457 ' HE2' ' HZ1' ' A' ' 53' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.24 164.63 34.48 Favored Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.63 -23.43 76.38 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.185 1.256 . . . . 0.0 109.632 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 30.0 mt -47.11 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.55 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.571 179.964 . . . . . . . . 0 0 . 1 stop_ save_